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Summary 
Telomeres are nucleoprotein structures that protect and maintain the ends of eukaryotic 
linear chromosomes. Telomeres shorten at each round of DNA replication due to the end 
replication problem. The enzyme telomerase, by adding telomeric repeats to chromosome 
ends, can counteract this process. In the absence of telomerase, telomeres progressively 
shorten until they reach a critical length that activates the DNA damage response, thereby 
halting the cell cycle in a condition referred to as replicative senescence. Telomeres are 
transcribed into a long, non-coding RNA dubbed TERRA, which can hybridize with its 
template strand, thereby forming R-loops at S. cerevisiae and human telomeres. Recent 
data implicate telomeric R-loops in the promotion of homologous recombination at 
telomeres, leading to telomere lengthening events which can partially compensate for 
telomere shortening in the absence of telomerase. Telomeric R-loops are regulated by 
RNase H1 and H2 enzymes, which can degrade the RNA moiety of RNA-DNA hybrids. 
While the accumulation of telomeric R-loops in cells lacking both enzymes delays 
senescence onset by promoting homologous recombination at telomeres, the depletion of 
telomeric R-loops by overexpressing RNase H1 leads to premature senescence onset. 
This PhD thesis aims to better understand how telomeric R-loops are regulated especially 
during replicative senescence in S. cerevisiae. We found that RNase H2 localizes to long 
telomeres and physically interacts with the telomere-associated protein Rif2, which is 
required for RNase H2 recruitment to telomeres. Accordingly, in the absence of Rif2 
telomeric R-loops accumulate, indicating that Rif2 and RNase H2 play a pivotal role in 
restricting R-loops at long telomeres. Importantly, the interaction between RNase H2 and 
Rif2 is strongest in late S phase, which is reflected in the degradation of telomeric R-loops 
in this time frame. We propose that this cell cycle regulated telomeric R-loop degradation 
is required to avoid collisions of the replication machinery, which replicates long telomeres 
in late S phase, with R-loops, an event that could have detrimental effects on telomere 
stability.  
It was previously shown that, as telomeres shorten, Rif2 localization to telomeres is 
diminished. We show that decreased Rif2 association to short telomeres leads to impaired 
recruitment of RNase H2, which is functionally reflected in the accumulation of R-loops at 
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short telomeres. Moreover, while RNase H1 could not be detected at long telomeres, we 
observed its localization to short telomeres, thereby indicating a distinct requirement for 
the RNase H enzymes. By analyzing the effect of single RNase H enzymes deletion on 
the kinetics of senescence onset in telomerase negative cells, we revealed an opposing 
effect of the two enzymes, suggesting that, differently from what was proposed, RNase H 
enzymes do not have redundant functions at telomeres. In conclusion, we propose that, 
while at long telomeres R-loops are timely regulated by Rif2-RNase H2 to avoid collisions 
with the replication machinery, at short telomeres R-loops are allowed to accumulate, 
thereby promoting homologous recombination-mediated telomere extension. 
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Zusammenfassung 
Telomere sind Nukleoprotein-Strukturen, welche die Enden linearer Chromosomen in 
eukaryotischen Organismen schützen und erhalten. Aufgrund des 
„Endreplikationsproblems“ verkürzen sich die Telomere mit jedem Replikationszyklus. 
Das Enzym Telomerase kann diesem Verkürzungsprozess entgegenwirken, indem es 
repetitive telomerische Sequenzen an Chromosomenenden ergänzt. In Abwesenheit von 
Telomerase verkürzen sich Telomere fortschreitend bis hin zu einer kritischen Länge, was 
zur Aktivierung der zellulären Antwort auf DNA Schäden führt. Daraufhin bleibt die Zelle 
im Zellzyklus stehen, genannt replikative Seneszenz. 
Telomere werden in eine lange nicht-kodierende RNA transkribiert, die als TERRA 
bezeichnet wird. TERRA-RNA kann mit der telomerischen DNA einen RNA-DNA-Hybrid 
formen und dabei sogenannte R-Loops an den Telomeren von Human- und Hefezellen 
(S. cerevisiae) bilden. Telomerische R-Loops unterstützen die homologe Rekombination 
an Telomeren, was zu deren Verlängerung führen kann und so ihre Verkürzung in 
Abwesenheit von Telomerase teilweise ausgleicht. Die Enzyme RNase H1 und H2 
regulieren telomerische R-Loops, indem sie den RNA-Anteil von RNA-DNA-Hybriden 
abbauen. In Zellen, denen diese beiden Enzyme fehlen, reichern sich R-Loops an 
Telomeren an und verzögern den Seneszenzbeginn, indem sie homologe Rekombination 
an Telomeren begünstigen. Im Gegensatz dazu kommt es zu verfrühtem 
Seneszenzbeginn, wenn RNase H1 überexprimiert wird.  
Diese Doktorarbeit charakterisiert wie telomerische R-Loops reguliert werden, vor allem 
während der replikativen Seneszenz in S. cerevisiae. Wir zeigen hier, dass RNase H2 an 
lange Telomere lokalisiert und mit dem Telomer-assoziierten Protein Rif2 interagiert, was 
für die Rekrutierung von RNase H2 zu Telomeren notwendig ist. Dementsprechend 
reichern sich telomerische R-Loops in Abwesenheit von Rif2 an. Damit spielt RNase H2 
eine entscheidende Rolle in der Begrenzung von R-Loops an langen Telomeren. Die 
Interaktion zwischen RNase H2 und Rif2 ist in der späten S-Phase des Zellzyklus am 
stärksten, was sich darin widerspiegelt, dass telomerische R-Loops in dieser Zeitspanne 
abgebaut werden. Wir nehmen an, dass der regulierte Abbau von telomerischen R-Loops 
während des Zellzyklus nötig ist, um Zusammenstöße des Replikationsapparats, der 
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lange Telomere in der späten S-Phase repliziert, mit R-Loops zu verhindern. 
Zusammenstöße dieser Art könnten sich schädlich auf die Stabilität von Telomeren 
auswirken.        
Es wurde bereits gezeigt, dass die Lokalisierung von Rif2 an Telomere stark vermindert 
ist, wenn sie sich verkürzen. Wir haben herausgefunden, dass die verringerte 
Lokalisierung von Rif2 an kurze Telomere dazu führt, dass die Rekrutierung von 
RNase H2 beeinträchtigt ist. Dies verursacht die Anreicherung von R-Loops an kurzen 
Telomeren. Außerdem konnten wir RNase H1 nicht an langen Telomeren nachweisen, 
während das Enzym mit kurzen Telomeren assoziiert, was auf unterschiedliche 
Anforderungen an die beiden RNase H Enzyme hindeutet. Durch die Untersuchung von 
Gendeletionen einzelner RNase H Enzyme auf die Kinetik des Seneszenzbeginns 
konnten wir gegensätzliche Effekte der beiden Enzyme nachweisen. Dies deutet darauf 
hin, dass die RNase H Enzyme – anders als bisher angenommen – keine redundanten 
Funktionen an Telomeren haben. Zusammenfassend nehmen wir an, dass R-Loops an 
langen Telomeren von Rif2 und RNase H2 reguliert werden müssen, um Zusammenstöße 
mit der Replikationsmaschinerie zu vermeiden. An kurzen Telomeren hingegen können 
sich R-Loops anreichern, um deren Verlängerung mittels homologer Rekombination zu 
unterstützen.     
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1. Introduction 
1.1  Telomeres and their function 
Telomeres are indispensable nucleoprotein structures that provide a distinction between 
the ends of linear chromosomes and the ends of double strand breaks (DSBs), a function 
referred to as capping. They thereby protect the physical ends of eukaryotic chromosomes 
from degradation, fusions and recombination. Furthermore, telomeres are essential to 
solve the end replication problem, preventing sequence loss at each replication round. 
The work presented in this thesis was carried out in the budding yeast Saccharomyces 
cerevisiae, which therefore will be the main focus of the introduction on telomeres. 
 
1.1.1 Telomere structure and telomeric proteins 
In budding yeast, telomeres are made of 300 ± 75 base pairs (bp) of simple C1-3A/TG1-3 
double stranded (ds) repeats that end in a 3’ single stranded (ss) G-rich overhang (G-tail; 
Figure 1A). The G-tail is 12-15 nucleotides (nt) long during most of the cell cycle but 30-
100 nt long in late S/G2 phases (Larrivee et al., 2004; Wellinger et al., 1993) due to 
telomerase-mediated addition of telomeric repeats to the G-tail but also regulated 
degradation of the opposite strand (C-strand)(Dionne and Wellinger, 1998; Frank et al., 
2006). 
S. cerevisiae telomeres are bound by highly specialized proteins, which orchestrate all 
telomere-related processes (Figure 1B). Telomeric double stranded repeats are bound in 
a sequence-specific manner by Rap1. In vitro data indicates that one Rap1 molecule binds 
every 18 bp, suggesting that a telomere of normal length would be bound by 15-20 Rap1 
molecules (Gilson et al., 1993). Rap1 function is not restricted to telomeres, as it is also 
involved in transcription activation and repression at multiple loci in the genome (Shore 
and Nasmyth, 1987). The C-terminus of Rap1 is required for the recruitment of Rif1/Rif2 
and Sir3/Sir4 to telomeres, which compete with each other for Rap1 binding (Moretti et 
al., 1994). The single stranded G-tail is bound by Cdc13, which in turn recruits Stn1 and 
Ten1, thereby forming the CST complex. The CST complex has been dubbed “telomeric 
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RPA” due to its resemblance to the trimeric single stranded DNA (ssDNA) biding complex, 
RPA (Gao et al., 2007). Cdc13 has been proposed to outcompete RPA for G-tail binding 
due to its high affinity and sequence specificity for telomeric repeats, although RPA can 
be detected at telomeres especially in S phase, when the G-tail is longest (Anderson et 
al., 2002; Schramke et al., 2004). A Cdc13 minimum binding site is made up of 11 nt of 
telomeric repeats (Hughes et al., 2000), suggesting that during most of the cell cycle only 
one CST complex molecule is bound to each telomere. Finally, Yku70 and Yku80, which 
form the Yku complex, also bind telomeres although in a sequence-unspecific manner 
(Gravel et al., 1998). Yku binds at the border between telomeric repeats and subtelomeres 
as well as at internal telomeric repeats (Larcher et al., 2016), and was reported to be able 
to bind directly to the telomeric DNA but also to localize to telomeres additionally via 
protein-protein interaction with Sir4 (Martin et al., 1999; Roy et al., 2004). 
Centromere-proximal to telomeres are gene-poor regions referred to as subtelomeres. In 
S. cerevisiae, all subtelomeres contain the so-called X element, while about half of the 
subtelomeres additionally contain Y’ elements that always lie between the X element and 
the telomeric repeats (Chan and Tye, 1983a). While X elements vary in sequence and 
size and are always present in single copy at each telomere, Y’ elements can either be 
6.7 kb (kilobases; Y’ long) or 5.2 kb (Y’ short) long  and can be present in zero to four 
tandem copies (Chan and Tye, 1983a); both X and Y’ elements contain potential 
autonomously replicating sequences (ARS; Figure 1A)(Chan and Tye, 1983b) and binding 
sites for the transcription factor Tbf1 (Brigati et al., 1993; Koering et al., 2000). Often, short 
tracts of telomeric repeats are found between X-Y’ and Y’-Y’ elements (Walmsley et al., 
1984). 
While telomeric repeats are presumably nucleosome free, S. cerevisiae subtelomeres are 
organized in nucleosomes (Wright et al., 1992) and are characterized by heterochromatin 
formation, causing the silencing of genes that lie near the telomeres, a phenomenon 
referred to as telomere position effect (TPE)(Gottschling et al., 1990). Telomeric 
heterochromatin formation is established by the Sir2-4 complex, which localizes to 
telomeres by Sir3/Sir4 interaction with Rap1 (Aparicio et al., 1991), but also by Sir4 
interaction with the Yku complex (Boulton and Jackson, 1998). Sir2 is a histone 
deacetylase which preferentially targets H3 and H4 (Imai et al., 2000), and TPE spreads 
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for kilobases from telomeres thanks to the interaction of Sir3 and Sir4 with deacetylated 
H3 and H4 (Hecht et al., 1996; Strahl-Bolsinger et al., 1997). 
 
 
Figure 1. Telomere structure and associated proteins. 
 
A) Telomeric DNA composition. S. cerevisiae telomeres are composed of 300 ± 75 ds repetitive sequences which end 
in a ss 3’ G-tail of 12-15 bases. Subtelomeric sequences located on the centromere-oriented side of telomeres always 
contain an X element and 0-4 copies of Y’ elements, often separated by short tracts of telomeric repeats. X elements 
bear a core X element and subtelomeric repeated elements (STR), and are of heterogeneous length; Y’ elements can 
be long or short (5.2 - 6.7 kb). Both X and Y’ elements contain Tbf1 binding sites and an ARS. B) Telomere binding 
proteins. The G-tail is bound by the CST complex and the ds telomeric repeats are bound by Rap1, which in turn recruits 
either Rif1 and Rif2 or Sir2-4. Rif2 binds more towards the distal tip of the telomere, while Rif1 more at the centromere-
proximal part. The yKu complex was proposed to bind independently at the border between ss and ds telomeric repeats, 
but also localize to telomeres by interacting with Sir4. The subtelomere is organized in nucleosomes. Modified from 
(Wellinger and Zakian, 2012).  
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Telomeres cluster in three to eight foci at the nuclear periphery (Gotta et al., 1996; 
Palladino et al., 1993) and are anchored to the nuclear envelope by two redundant 
pathways, established by Sir4 and Yku80 (Schober et al., 2009; Taddei et al., 2004). 
These telomeric foci are enriched in Sir proteins and are repressive for transcription and 
subtelomeric recombination (Schober et al., 2009; Taddei et al., 2009).  
 
1.1.2 End protection  
The ends of linear chromosomes structurally resemble the ends of DSBs and therefore 
could be mistakenly recognized by the cell as such. An essential function that telomeres 
provide is the capping of the ends of linear chromosomes, thereby preventing unwanted 
repair activities. DSBs can be repaired by two pathways: non-homologous end joining 
(NHEJ) and homologous recombination (HR). NHEJ is prevalent in G1 and directly re-
joins the two extremities of a break in a fast but error-prone manner; a critical player in 
this process is the Yku complex (Lieber, 2010). Alternatively, the ends of the DSB can be 
resected by nucleases in order to generate single stranded overhangs that can invade 
homologous sequences and use them as a template to repair the break. HR depends on 
the MRX complex (made up of Mre11, Rad50 and Xrs2) and the Rad52 epistasis group, 
and is active in S and G2, when a homologous sequence is present in the sister chromatid 
(San Filippo et al., 2008). Both pathways are inhibited at telomeres: NHEJ especially 
would result in catastrophic end-to-end chromosome fusions, while HR would result in 
recombination between telomeres. Additionally, capping of telomeres also prevents the 
activation of the checkpoint response, which is triggered by free DNA ends; in yeast, the 
major checkpoint kinases are Mec1 (homolog of human ATR) and Tel1 (homolog of 
human ATM). Loss of a single telomere in budding yeast, and thereby loss of capping, 
leads to the activation of a Rad9-dependent checkpoint (Sandell and Zakian, 1993), 
highlighting the active discrimination between functional telomeres and broken DNA ends 
by the checkpoint machinery. The capping of telomeres is accomplished by multiple 
players that will be described in the next paragraphs. 
As a first barrier, the single-stranded telomeric G-tail is shielded by the CST complex 
(Grandin et al., 2001). All components of the CST complex are essential, and loss of CST 
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function has been primarily studied by exposing cdc13-1 mutants to restrictive 
temperature, which results in resection of the C-strand for many kb and Rad9-dependent 
(Mec1 mediated) G2/M checkpoint activation (Garvik et al., 1995; Weinert and Hartwell, 
1993). Thereby, the CST complex is essential in preventing resection and activation of 
the checkpoint at telomeres. 
On the other hand, also the Rap1-Rif1-Rif2 complex that localizes to the double stranded 
telomeric DNA plays an important role in capping. Rap1, Rif2 and to a lesser extent Rif1 
inhibit telomere fusions by NHEJ and end resection (Bonetti et al., 2010; Marcand et al., 
2008; Vodenicharov et al., 2010). Additionally, Rif2 inhibits localization of Tel1 and MRX 
to telomeres, thereby preventing Tel1-mediated checkpoint activation (Bonetti et al., 2010; 
Hirano et al., 2009). Rif1 can promote viability when Cdc13 capping function is 
compromised by preventing ssDNA formation and checkpoint activation at these 
telomeres (Addinall et al., 2011; Anbalagan et al., 2011).  
Lastly, the Yku complex provides capping function in G1 by inhibiting resection, although 
in this phase it would happen at such low levels that the DNA damage checkpoint would 
not be activated (Bonetti et al., 2010; Vodenicharov et al., 2010).  
 
1.1.3 End replication 
Telomeres are subjected to the end replication problem, as the canonical replication 
machinery, while capable of continuously replicating the leading strand in its entirety, 
causes the loss of genetic material from the lagging strand at each replication round after 
the removal of the last Okazaki fragment primer (Watson, 1972). The need for a special 
mechanism to replicate chromosome ends is thereby intrinsic to the process of semi-
conservative DNA replication, as very early stated by Watson. This calls for the need of 
an additional mechanism to avoid loss of genetic information in most unicellular organisms 
and stem cells. The answer comes from the enzyme telomerase, a reverse transcriptase 
which is capable of adding telomeric repeats to 3’ single stranded telomeric ends, in a 
process that will be described in Section 1.2.1.  
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In a recent work, the Teixeira lab demonstrated that replication-driven telomere shortening 
arises from distinct processing of leading and lagging strands at each replication cycle 
(Figure 2; (Soudet et al., 2014)). As previously postulated, the shortening of the lagging 
strand telomere is indeed determined by the position of the last Okazaki fragment, which 
they observed to be always located at the very end of telomeric repeats, thereby leaving 
only a 5-10 nt gap after Okazaki primer degradation. On the other hand, replication of the 
leading strand creates a blunt end, which needs to be further processed to generate a 3’ 
single stranded G-tail. This nucleolytic processing occurs after telomere replication, and 
is mediated by Tel1 and, likely, MRX. End-processing creates a G-tail overhang of about 
40 nt, and is followed by fill-in synthesis of the C-strand, again accomplished by 
positioning the last Okazaki fragment at the very end and leaving a gap of 5-10 nt. This 
model is consistent with the measured approximate rate of telomere shortening of 2.5-5 
nt per replication (Marcand et al., 1999; Singer and Gottschling, 1994). 
 
In addition to telomerase action, the bulk of telomere replication is accomplished by the 
canonical replication machinery. Telomere replication is initiated at replication origins 
proximal to telomeres or by the ARS contained in Y’ and X elements, although some X 
elements’ ARS are inactive (Louis and Vershinin, 2005). Importantly, the timing of 
telomere replication, which directly correlates with origin firing, is dictated by telomere 
length: while telomeres of wild type length replicate in late S phase (McCarroll and 
Fangman, 1988; Raghuraman et al., 2001), short telomere replication is anticipated to 
early S phase (Bianchi and Shore, 2007). Rif1 is involved in preventing early firing of 
telomeric origins, as rif1 mutants, despite having extended telomeres, replicate early (Lian 
et al., 2011). Tel1, which binds to short telomeres (Sabourin et al., 2007), was shown to 
act upstream of Rif1 in regulating telomeric origin firing, and to phosphorylate Rif1 at short 
telomeres, although preventing this event is not sufficient to inhibit early replication of 
short telomeres (Sridhar et al., 2014). Consistently, tel1 mutants, which have short 
telomeres, replicate late (Sridhar et al., 2014). 
Telomere replication and telomerase action are tightly regulated, as will be described in 
Section 1.2.1, and early replication of short telomeres might promote telomerase 
recruitment and action, as Cdc13 and Est1 recruitment to short telomeres occurs in early 
S phase (Bianchi and Shore, 2007). 
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Figure 2. The end replication problem.  
 
b) During the synthesis of the lagging strand, the last Okazaki primer is positioned near the end of the telomere, leaving 
a gap of 5-10 nt after primer removal. c) Synthesis of the leading strand reaches the end of the chromosome creating a 
blunt end and therefore the C-strand needs to be resected in 5’-3’ direction, d) a process mediated by Tel1, generating 
a 40 nt overhang e) which is replenished by conventional replication, accomplished by positioning the last Okazaki 
primer near the end of the telomere, leaving a 5-10 nt gap after primer removal. a) This processing leads to the 
shortening of the leading strand telomere, with an average loss of 2.5-5 nt per replication round. Taken from (Soudet et 
al., 2014). 
 
 
1.2  Telomere maintenance mechanisms 
1.2.1 Telomerase       
The predominant mechanisms by which yeast cells solve the end replication problem is 
the reverse transcriptase telomerase. Telomerase is a ribonucleoprotein complex, and in 
yeast it comprises the proteins Est1-2-3 and the RNA moiety TLC1. Est2 is the catalytic 
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subunit of the complex, and catalyzes the polymerization of telomeric DNA in 5’3’ 
orientation to the 3’ G-tail by reverse transcribing TLC1 (Counter et al., 1997; Lendvay et 
al., 1996; Singer and Gottschling, 1994). Completion of telomere elongation is provided 
by Cdc13-mediated recruitment of Polα-primase to promote fill-in synthesis of the 
complementary C-strand via conventional replication (Grossi et al., 2004; Qi and Zakian, 
2000). Deletion of any of the abovementioned telomerase components leads to 
progressive telomere shortening and replicative senescence onset, a condition in which 
cells stop dividing, eventually leading to cell death (Lundblad and Szostak, 1989). This 
suggests that telomerase is the predominant mechanism for telomere maintenance in wild 
type cells. The low abundance of each telomerase component (making up approximately 
30 copies of telomerase per haploid cell, for 64 telomeres in late S phase)(Mozdy and 
Cech, 2006) suggests the need to act at a limited amount of telomeres per replication 
round. Telomerase access and action at telomeres is therefore tightly coordinated by 
multiple telomeric factors. 
Telomere elongation by telomerase is cell cycle regulated: although Est2 can bind 
telomeres throughout the cell cycle thanks to TLC1 interaction with Yku80, this localization 
alone is not productive in terms of elongating telomeres (Taggart et al., 2002). Cdk1-
dependent phosphorylation of Cdc13 in late S and G2 promotes Cdc13 interaction with 
Est1 (Liu et al., 2013), which leads to Est3 recruitment and formation of a functional 
complex. Telomerase cannot act on blunt ends, which are generated after the replication 
of the leading strand, thereby requiring the action of MRX to degrade the C-strand at 
leading strand telomeres (Takata et al., 2005); Cdk1 activity is also necessary to generate 
the single stranded overhang in late S phase (Frank et al., 2006). The transit of the 
replication fork in S phase promotes recruitment of MRX to the telomeres (Dionne and 
Wellinger, 1998; Takata et al., 2005), thereby it is plausible that telomerase acts in late 
S/G2 because that is when bulk replication is completed and MRX-dependent telomere 
overhang formation has taken place. This is also consistent with preferential action of 
telomerase at leading strand telomeres, where MRX processes blunt ends (Faure et al., 
2010; Soudet et al., 2014).  
The main regulator of telomere elongation is the checkpoint kinase Tel1. Tel1 is recruited 
to telomeres by the MRX complex, and its kinase activity is necessary to promote telomere 
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elongation, although how this is accomplished is still elusive. So far, Tel1-dependent 
phosphorylation of Cdc13 has been proposed to regulate Cdc13-Est1 interaction (Tseng 
et al., 2006). Importantly, Tel1 binding to telomeres is inhibited by Rif1 and Rif2, which 
are thereby two critical negative regulators of telomerase action. Rif1 and Rif2 act via two 
different pathways: Rif2 inhibits Tel1 and MRX localization to telomeres by competing with 
Tel1 for the binding of Xrn2 (Hirano et al., 2009), while Rif1 inhibition of Tel1 recruitment 
occurs in a still unknown manner, which is different from the Rif2 pathway (Hirano et al., 
2009). The differential regulation of telomerase by the Rif proteins is demonstrated by the 
non epistatic effect of RIF genes deletions. In fact, while rif1 and rif2 mutants display long 
telomeres, the double mutant rif1 rif2 has synergistically extended telomeres (Wotton and 
Shore, 1997). 
Telomerase does not act on every telomere in a cell but preferentially elongates the 
shortest ones (Marcand et al., 1999; Teixeira et al., 2004). Additionally, telomerase is 
more processive at critically short telomeres, in a process promoted by Tel1 (Chang et al., 
2007a). Indeed, the amount of Rap1, Rif1 and Rif2 molecules bound to telomeres was 
proposed to establish a ‘counting mechanism’ (Marcand et al., 1997), thereby connecting 
telomere length to the need for telomerase extension. By this model, loss of Rap1 binding 
sites at short telomeres leads to decreased Rap1-Rif1-Rif2 binding, which relieves Tel1-
mediated telomerase inhibition and thereby allows telomere elongation; once the telomere 
is long again, the increased amount of Rap1-Rif1-Rif2 re-establishes telomerase 
inhibition. Loss of telomeric repeats is associated to loss of Rif2, and to a lesser extent 
Rif1, from short telomeres (McGee et al., 2010; Sabourin et al., 2007), suggesting a 
differential distribution of the Rif proteins along the telomere, with Rif2 binding more 
towards the distal tip and Rif1 towards the centromere-proximal telomeric tract. 
Diminished Rif2 binding to short telomeres relieves MRX-Tel1 inhibition, thus establishing 
a positive feedback loop that promotes telomere elongation. 
Finally, the Pif1 helicase is also a regulator of telomerase in a telomere-length dependent 
manner. Pif1, which in vitro was shown to dissolve RNA-DNA hybrids, binds preferentially 
to long telomeres (Phillips et al., 2015), where it acts as a potent telomerase inhibitor, 
presumably by displacing telomerase from chromosome ends (Boule et al., 2005). 
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1.2.2 Telomere recombination 
Although, as stated before, homologous recombination between telomeres is usually 
repressed to avoid the risk of generating harmful recombination intermediates and derived 
genome instability, it can be a means to maintain telomeres in telomerase deficient cells. 
While in telomerase positive cells the exchange of genetic material between telomeres 
would have virtually no beneficial effect on telomere stability, when a short telomere is 
generated in telomerase negative cells recombination between this telomere and another 
telomere would benefit cell viability by replenishing the pool of telomeric repeats and 
preventing checkpoint activation (Fallet et al., 2014). When telomerase deficient cells are 
propagated for long periods, they lose viability due to checkpoint activation stemming from 
short uncapped telomeres (senescence)(Lundblad and Szostak, 1989). In yeast, one 
critically short telomere is enough to trigger senescence, indicating that continuous 
shortening of bulk telomeres in a telomerase negative cell is not the leading cause for its 
growth arrest, but it is rather the length of the shortest telomere in a cell (Abdallah et al., 
2009). Recombination at telomeres can occur when telomerase negative cells are on the 
way to senescence as a mean to elongate critically short telomeres, thereby delaying 
senescence onset (Churikov et al., 2014). Most telomerase negative cells experience a 
few subsequent terminal cell cycle arrests followed by cell death, consistent with 
telomeres reaching a critical (short) length (Xu et al., 2015). But interestingly ~40% of cells 
instead undergo early cell cycle arrests followed by re-gained cell growth, in a process 
dependent on Pol32 and HR (Xu et al., 2015), indicating that generation of short telomeres 
happens stochastically, probably due to replication stress, and recombination plays a 
protective role upon these events. Thereby, homologous recombination between short 
telomeres in pre-senescent cells can delay, but is not enough to avoid, senescence onset. 
Strikingly, rare ‘survivor’ cells can overcome senescence and re-gain almost wild type 
growth kinetics. These survivors are dependent on Rad52-mediated recombination and 
on the Pol32-mediated break-induced replication (BIR) pathway (Lundblad and Blackburn, 
1993; Lydeard et al., 2007). Two types of survivors have been described based on their 
arrangement of telomeric DNA and genetic requirements (Le et al., 1999). Type I survivors 
maintain telomeres by recombining Y’ elements, while telomeric repeats remain short (50-
150 bp). This is the leading cause of the poor growth of type I survivors, which experience 
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frequent cell cycle arrests probably due to damage signaling stemming from these short 
uncapped telomeres (Cohen and Sinclair, 2001; Teng and Zakian, 1999). In type I 
survivors Y’ repeats are expanded by recombination between telomeres, but also possibly 
by amplification of extrachromosomal circular Y’ elements that are found in these cells 
(Larrivee and Wellinger, 2006). Type I survivors rely on the homologous recombination 
proteins Rad51, Rad54, Rad57 and Rad55 (Chen et al., 2001; Le et al., 1999). Type II 
survivors maintain telomeres by recombining telomeric repeats with other chromosomes, 
and additionally contain extrachromosomal circles of telomeric repeats, which could be 
used to elongate telomeres by rolling circle amplification (Larrivee and Wellinger, 2006). 
Telomere length in type II survivors is extremely heterogeneous, ranging from extremely 
long (up to 12 kb) to critically short (Teng and Zakian, 1999), but this type of survivor, 
differently from type I survivors, divide with kinetics very similar to wild type. Interestingly, 
telomeres of type II survivors shorten at every replication round, as happens in telomerase 
positive cells, and abruptly recombine only when a critical length is reached (Teng et al., 
2000). This survivor pathway relies on the MRX complex, Rad59 and Sgs1 (Chen et al., 
2001; Johnson et al., 2001; Le et al., 1999).   
 
1.3  Telomere maintenance in other organisms 
1.3.1 Human telomeres 
Human telomeres are made up of double-stranded TTAGGG repeats that typically range 
between 10 and 15 kb, and end in a single stranded overhang of 50-500 nt. The protein 
complex that associates to telomeric repeats has been dubbed Shelterin and is composed 
of TRF1 and TRF2, which directly bind the double stranded telomeric repeats, POT1, 
which binds the single stranded overhang, TIN2 and TPP2, which bridge POT1 to TRF1/2, 
and finally RAP1, which binds to TRF2 (Palm and de Lange, 2008). In humans, the single 
stranded overhang loops back into the double stranded repeats, forming a lariat structure 
or t-loop, which protects telomere integrity by sequestering the ssDNA and thereby 
protecting telomeres against nucleases and checkpoint activation (Doksani et al., 2013; 
Griffith et al., 1999). Additionally, the Shelterin complex inhibits the activation of the DNA 
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damage response at telomeres, with TRF2 repressing ATM signaling and POT1 inhibiting 
ATR activation (Denchi and de Lange, 2007). Human telomerase is composed of TERT, 
the reverse transcriptase enzyme, and the RNA moiety TERC (Feng et al., 1995; Lingner 
et al., 1997); telomere shortening in the absence of telomerase activity leads to checkpoint 
activation and replicative senescence onset, eventually leading to apoptosis, analogously 
to yeast (d'Adda di Fagagna et al., 2003; Hayflick, 1965). Interestingly, in human cells the 
generation of four to five critically short telomeres is necessary to induce senescence, 
while in yeast one is sufficient (Kaul et al., 2012). 
Human telomeres are organized in nucleosomes and are heterochromatic, being 
characterized by abundant H3K9me3 mark, which in mouse was shown to be imposed by 
the histone methyltransferase Suv39h and to recruit HP1α, and H4K20me mark, and 
finally are rich in deacetylated histones (Arnoult et al., 2012; Garcia-Cao et al., 2004). 
Indeed, SIRT6, a component of the Sir2 family, deacetylates H3K9 at human 
subtelomeres (Michishita et al., 2008). Additionally, human subtelomeres are highly 
methylated (Steinert et al., 2004). 
 
1.3.1.1 Telomeres and cancer 
In humans, most somatic cells do not express telomerase, leading to telomere shortening 
at each replication round (Harley et al., 1990). Cancer cells acquire the ability to divide 
indefinitely, and thereby require the activation of telomere lengthening mechanisms. 
Indeed, telomerase expression seems to correlate with lifespan, as generally short-lived 
organisms express telomerase (e.g. mice), while long-lived organisms do not. Repression 
of telomerase activity in long-lived organisms, which display increased cancer risk, is 
thought to be a safeguard mechanism against cancer, given to the anti-cancer role of 
replicative senescence. While around 85% of cancer types gain immortality by reactivating 
telomerase, the remaining 15% of cancers maintain their telomeres by BIR-based 
telomere maintenance mechanisms, which defines these cancers as alternative 
lengthening of telomeres (ALT) cancers (Henson and Reddel, 2010; Kim et al., 1994). 
ALT cancers are associated with the following hallmarks: extreme telomere length 
heterogeneity, accumulation of extra-chromosomal telomeric DNA, clustering of 
 Introduction 
13 
telomeres in promyelocytic leukaemia (PML) bodies thereby forming ALT-associated PML 
bodies (APBs), and rampant recombination between telomeres. Additionally, ALT cells 
often display decreased or absent expression of the ATRX helicase, an impaired DNA 
damage response and finally elevated TERRA levels, which was also found to associate 
with APBs (see Section 1.4)(Arora et al., 2014; Azzalin et al., 2007; Episkopou et al., 
2014). TERRA accumulation in ALT cells seems to be caused by increased transcription, 
as TERRA CpG promoters are hypomethylated and RNA Pol II is enriched at these 
telomeres (Arora et al., 2014; Episkopou et al., 2014; Nergadze et al., 2009).  
 
1.3.2 Drosophila telomeres  
Although most eukaryotic telomeres are maintained by telomerase, there are a few 
exceptions, of which Drosophila is well-studied. Drosophila telomeres are not maintained 
by telomerase but by an array of transposable elements. The capping in these organisms 
is sequence-independent, as it is made up of tandem copies of HeT-A, TART and TAHRE 
(together called HTT) non-LTR (long terminal repeat) retrotransposon elements, 
separated by varying extents of A repetitions (Pardue and DeBaryshe, 2008). The HeT-A 
retrotransposon accounts for 80-90% of the HTT arrays (George et al., 2006), and codes 
exclusively for a Gag nucleic acid binding protein but not for a reverse transcriptase. TART 
elements represent 10% of the telomeric arrays and code for a Gag protein and a Pol 
reverse transcriptase. TAHRE elements are very rare (1-2%) and are related to HeT-A, 
but contain additionally the Pol ORF. All have very long 3’ non coding regions, which might 
be important for heterochromatin formation at telomeres (Danilevskaya et al., 1998). Also 
in Drosophila, telomeres shorten at each replication round, and chromosome length 
maintenance is achieved by retrotransposition of the HTT elements (Biessmann et al., 
1992). The process starts by transcription of the HTT elements, after which the RNA is 
transported to the cytoplasm where it is translated into Gag proteins and 
retrotranscriptases. Gag proteins bind preferentially to their encoding RNA and efficiently 
return to the nucleus, where the RNA is reverse transcribed directly at the telomeric end, 
thereby providing a telomere elongation mechanism (Rashkova et al., 2002); the opposite 
strand can then be produced either by the reverse transcriptase or by the canonical 
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replication machinery. Interestingly, the HTT elements are inter-dependent, as HeT-A 
elements need TART or TAHRE reverse transcriptases to replicate, and TART and 
TAHRE need HeT-A Gag protein for efficient localization to telomeres (Fuller et al., 2010; 
Rashkova et al., 2002). Finally, although to a lesser extent, Drosophila telomeres were 
shown to be able to amplify in a recombination-mediated manner (Mikhailovsky et al., 
1999), as mammalian and yeast telomeres. Interestingly, several proteins involved in 
maintenance of yeast and human telomeres were found to be also required at Drosophila 
telomeres, as for example MRE11, RAD50, ATM and the Ku complex (Cenci et al., 2005). 
 
1.3.3 Telomeres in bacteria and viruses with linear chromosomes 
The paradigm that eukaryotes possess linear chromosomes while prokaryotes have 
circular genomes was challenged by the discovery of the linear genome of the Lyme 
disease agent Borrelia burgdorferi (Ferdows and Barbour, 1989), after which more 
prokaryotes and viruses followed in being identified to have a similar genome 
organization. In general, prokaryotes and viruses that possess linear chromosomes or 
plasmids seem to employ a slight variation of two main genome-end organization 
strategies, which will be presented. 
Borrelia linear chromosomes possess terminal regions made up of palindromic AT-rich 
sequences, which are stabilized by forming covalently closed hairpin structures 
(Chaconas and Kobryn, 2010). Replication of the genome from a central, bidirectional 
origin might lead to generation of a circular intermediate, connected by the newly 
replicated hairpin structures, which have to be eventually resolved. Similar terminal 
structures are also found in the E. coli prophage N15 and in various viruses, as for 
example poxviruses (Traktman and Boyle, 2004). These organisms express a 
topoisomerase-like resolvase that cleaves the terminal hairpin structures to allow genome 
replication. 
Differently, Streptomyces linear chromosome and plasmids end as dsDNA comprising 
palindromic terminal repeats, which are covalently bound by a specialized protein during 
replication (Huang et al., 2007) and are probably capable of forming peculiar secondary 
structures (Huang et al., 1998). In Steptomyces, the telomere is the origin of genome 
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replication, and the telomere end binding protein promotes beginning of replication by 
recruiting DNA polymerase and priming its own replication. This end structure is 
conserved in adenoviruses (de Jong et al., 2003).  
On the other hand, Herpesviruses possess GC-rich terminal repeats of different 
extension, which are essential for gene expression, replication and recombination. Some 
Herpesvirus family members integrate into the host telomeres thanks to the GC-rich 
terminal repeats that are highly similar to host telomeres (Arbuckle and Medveczky, 2011), 
possibly via homologous recombination, during latency (Arbuckle et al., 2010). This 
process might be mediated by TRF1 and TRF2 binding to viral end repeats. 
In conclusion, although different mechanisms to protect linear chromosome ends have 
evolved in different organisms, some common features can be identified. First of all, 
chromosome ends are typically defined by peculiar, repeated sequences, including short 
repeats, palindromic sequences or unique transposable elements. Secondly, dedicated 
proteins recognize these repeats and orchestrate telomere maintenance, and finally a 
special replication process is required to maintain all chromosome-end structures. 
 
1.4  TERRA 
1.4.1 TERRA transcription 
Despite being heterochromatic, telomeres are transcribed into long, non-coding RNAs 
dubbed TERRA (telomeric repeat containing RNA). TERRA is majorly transcribed by RNA 
Pol II (Azzalin et al., 2007; Luke et al., 2008), although it has been reported that RNA Pol 
II inhibition does not fully abolish TERRA generation, suggesting that other polymerases 
might contribute to TERRA transcription (Schoeftner and Blasco, 2008). TERRA is 
transcribed from the telomeric C-strand and comprises both telomeric and subtelomeric 
sequences (Azzalin et al., 2007; Luke et al., 2008). To date, TERRA has been detected 
in all eukaryotes tested (Luke and Lingner, 2009; Schoeftner and Blasco, 2008). 
In S. cerevisiae, TERRA length ranges between 100 and 1200 bases, with the bulk being 
around 380 bases long (Luke et al., 2008), a variance that likely stems from different 
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transcription end points rather than multiple transcription start sites (TSS). In fact, only a 
few TSSs have been mapped so far in yeast, one being located at the 3’ end of the X 
element at the 1L telomere, and six at the 3’ end of Y’ elements (Pfeiffer and Lingner, 
2012). Recently, additional TSSs were identified in the X element of several X-only 
telomeres, and importantly only one TSS was identified for each telomere-derived TERRA 
molecule (Marco Graf PhD thesis). The majority of yeast TERRA molecules is 
polyadenylated by Pap1, contributing to its stability (Luke et al., 2008). TERRA levels are 
low in the cell, an outcome that is achieved by two means. First, TERRA transcription is 
limited by the Sir2-4 complex, which establishes heterochromatin at telomeres and 
presumably represses TERRA transcription (Iglesias et al., 2011). Second, the 5’3’ 
exonuclease Rat1 degrades TERRA molecules (Luke et al., 2008). Both Sir2-4 and Rat1 
actions are orchestrated by telomeric proteins: regulation of TERRA levels transcribed 
from X-only telomeres is dictated by Rap1 both on the transcriptional (mediated by Sir2-
4) and degradation level (mediated by Rat1), while at Y’ telomeres Rap1 mediates TERRA 
transcription inhibition through Rif1 and Rif2, while it directly promotes Rat1-mediated 
degradation (Iglesias et al., 2011). Rat1-mediated TERRA degradation is regulated 
throughout the cell cycle and by telomere length. In fact, TERRA levels peak in early S 
phase, when it is transcribed, and decrease as cells progress through S phase, a time 
when Rat1 localizes to telomeres (Graf et al., 2017). On the contrary, Rat1 is lost from 
critically short telomeres, causing loss of TERRA cell-cycle regulation and resulting in 
increased TERRA levels (Graf et al., 2017), consistent with previous reports (Cusanelli et 
al., 2013; Iglesias et al., 2011). Importantly, the increase of TERRA levels at short 
telomeres in budding yeast is not caused by increased transcription (Graf et al., 2017). 
In human cells, TERRA length varies between 100 bases – 9 kb (Azzalin et al., 2007) and 
TSSs have been mapped at CpG islands, which are present at about 25% of human 
telomeres. Contrary to yeast, only around 7% of mammalian TERRA is polyadenylated 
(Azzalin and Lingner, 2008), which in human cells contributes to its stability (Porro et al., 
2010) but also to its localization: while polyadenylated TERRA is mainly found diffusely in 
the nucleoplasm, non-polyadenylated TERRA is majorly chromatin-associated (Porro et 
al., 2010). Additionally, the human TERRA 5’ end is protected by a 7-methylguanosine 
cap (Porro et al., 2010). Human TERRA levels appear to be largely regulated on the 
transcriptional level. TERRA transcription is promoted by the transcriptional regulator 
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CTCF and the cohesin subunit Rad21. Indeed, CTCF depletion leads to decreased Rad21 
and RNA Pol II binding to subtelomeres, causing decreased TERRA levels and damage 
signaling stemming from telomeres (Deng et al., 2012). Also the Shelterin components 
TRF1 and TRF2 regulate TERRA expression: they physically interact with TERRA and 
their depletion leads to increased TERRA levels (Arora et al., 2014; Deng et al., 2009). 
Additionally, TERRA transcription is highly dependent on the chromatin status of 
telomeres. Treatment with Trichostatin, a histone deacetylase inhibitor, causes TERRA 
levels increase (Azzalin and Lingner, 2008). DNMT1/3b DNA methyltransferases 
methylate CpG islands and thereby repress TERRA transcription; their depletion leads to 
increased TERRA levels and telomere shortening (Nergadze et al., 2009; Yehezkel et al., 
2008). Also the H3K9 methyltransferase SUV39H1 and the H3K9me3 binding protein 
HP1α repress TERRA transcription; additionally, TERRA interacts with both proteins and 
recruits them to telomeres, thereby establishing a negative feedback loop on TERRA 
transcription (Arnoult et al., 2012; Deng et al., 2009; Porro et al., 2014). Finally, the 
expression of the ATRX helicase, which deposits the H3.3 histone variant at telomeres, is 
almost always repressed in ALT cancer cells, in which TERRA levels are high (Arora et 
al., 2014; Flynn et al., 2015; Lovejoy et al., 2012). 
Also in human cells, TERRA expression is cell cycle regulated, with a peak at the transition 
between G1 and S phase, followed by a sharp decrease as cells progress in S phase and 
re-accumulation only in the next G1 phase (Porro et al., 2010). Interestingly, while in 
telomerase positive human cells TERRA foci that colocalize with telomeres are removed 
through S phase and in G2/M, in ALT cancer cells and in cells depleted for ATRX this 
regulation is abolished (Flynn et al., 2015).  
 
1.4.2 TERRA localization 
TERRA is present only in the nucleus (Azzalin et al., 2007), and both in yeast and human 
cells it was shown to localize to specific areas of the nucleus. In yeast, live-cell microscopy 
of TERRA molecules allowed the analysis of the dynamics of its localization (Cusanelli et 
al., 2013). After transcription, TERRA derived from a single short telomere was shown to 
move away from the telomere of origin and form a perinuclear focus. This TERRA focus 
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acts as a scaffold for telomerase assembly in S phase, followed by the cluster returning 
preferentially to the telomere of TERRA origin (Cusanelli et al., 2013). An implication of 
TERRA in telomerase recruitment to short telomeres has been proposed also in S. 
Pombe, where polyadenylated TERRA generated from short telomeres is mostly 
nucleoplasmic and interacts with telomerase; induction of TERRA expression leads to 
telomerase-mediated telomere elongation in cis (Moravec et al., 2016). 
In human cells, non-polyadenylated TERRA has been reported to form foci which 
colocalize with a fraction of telomeres, while polyadenylated TERRA is nucleoplasmic 
(Azzalin et al., 2007; Porro et al., 2010). While TERRA was reported to be present 
exclusively in the nucleus, short forms of TERRA (~200 nt) have been recently found in 
human cell cultures to be part of extracellular exosomes which are potent stimulators of 
the inflammatory response (Wang et al., 2015). In conclusion, both in yeast and human 
cells two pools of TERRA can be identified: “free TERRA”, which is nucleoplasmic, and 
telomere-associated TERRA, the implications of which will be discussed in Section 1.5.4. 
 
1.5  R-loops 
An R-loop is a three-stranded structure that is generated when an RNA transcript anneals 
co- or post-transcriptionally to its template DNA strand, thereby forming an RNA-DNA 
hybrid and displacing the non-template ssDNA strand. R-loops occur physiologically along 
the genomes and can exert positive functions, but, especially when deregulated, R-loops 
are a potent source of genome instability. Apart from R-loops, other shorter RNA-DNA 
hybrids can be found physiologically in the genome. These are formed by the RNA primers 
that are required for replication especially of lagging strands, which form hybrids of 7-12 
bp (Pellegrini, 2012), and the hybrids formed in the RNA polymerase core during 
transcription (~8 bp in the active site of RNA Pol II)(Westover et al., 2004).  
The prevalent model that explains how an RNA molecule can gain access to its template 
strand, which is normally in the form of dsDNA, to form an R-loop is the “thread back 
model” (Roy et al., 2008). Transcribing RNA polymerases generate negative supercoils in 
the DNA behind them (Liu and Wang, 1987), a feature that facilitates dsDNA unwinding, 
and therefore allows RNA invasion and the formation of an RNA-DNA hybrid. This model 
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is limited to being able to explain the formation of co-transcriptional R-loops, while it 
cannot account for why mutants affecting RNA post-transcriptional processing also 
accumulate R-loops. The latter scenario could be possibly explained by the RNA being 
more accessible and being locally retained at the transcription locus in these mutants, 
increasing the chances of interaction with the template DNA. Recently, R-loop formation 
in trans has been detected in a study carried out in S. cerevisiae, in which RNA transcribed 
from one locus could form R-loops at another untranscribed locus that shared the same 
sequence present on a yeast artificial chromosome (YAC) when RNA biogenesis factors 
were mutated, in a process mediated by the recombination protein Rad51 (Wahba et al., 
2013).  
RNA-DNA hybrids are thermodynamically more stable than dsDNA, particularly when they 
have a high GC composition, and adopt a peculiar conformation that is neither the one of 
a molecule composed exclusively of DNA nor exclusively of RNA (Roberts and Crothers, 
1992). R-loop formation is favored by particular DNA characteristics, such as high GC 
skew (asymmetric distribution of Gs and Cs; in this case the enrichment of Gs in the non-
template strand and in the RNA is favorable)(Roy and Lieber, 2009), presence of nicks on 
the non-template DNA strand (Roy et al., 2010), and finally the propensity of the displaced 
ssDNA strand to form G-quadruplex structures (Duquette et al., 2004). 
 
1.5.1 R-loop regulation 
Cells possess a myriad of mechanisms to keep R-loop levels in check, which act at 
different steps and hence can be subdivided in processes that inhibit R-loop formation or 
remove them once formed.  
Amid the inhibitors of R-loop formation, there are topoisomerases, which by releasing the 
torsional stress generated after the transcription machinery passage can prevent RNA 
invasion in the DNA duplex. In yeast, loss of Top1 and Top2 leads to R-loop accumulation 
in the ribosomal DNA (rDNA), causing RNA Pol I stalling and defective pre-rRNA synthesis 
(El Hage et al., 2010). In human cells defective for TOP1, the DNA breaks at highly 
transcribed genes, a phenotype which can be completely reversed by RNH1 
overexpression (Tuduri et al., 2009), an enzyme that can degrade the RNA in RNA-DNA 
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hybrids (see Section 1.5.3); also TOP3B, an enzyme that selectively relaxes negative 
supercoils, counteracts R-loop formation in human and mouse and suppresses 
chromosomal translocations (Yang et al., 2014). Likewise, a large amount of proteins 
involved in messenger ribonucleoprotein particle (mRNP) formation prevent the formation 
of R-loops, possibly by shielding the RNA molecule, thereby preventing invasion of the 
template DNA. The THO/TREX complex has been well characterized in yeast and human 
cells for its role in R-loop prevention, and the THO component Hrs1 was the first mutant 
identified that linked defective mRNP formation to R-loop accumulation as a cause of 
genome instability, since this mutant’s hyper-recombination phenotypes could be 
reversed by RNH1 overexpression (Aguilera and Klein, 1990; Huertas and Aguilera, 
2003). Additionally, the TREX-2 complex, which localizes to the inner part of nuclear pore, 
can also prevent R-loop formation, as deletion of its components causes hyper 
recombination and defective transcription, phenotypes that can be rescued by RNH1 
overexpression. In addition to hiding the RNA molecule, the TREX-2 complex might 
suppress R-loop formation by directly coupling RNA production to nuclear export, thereby 
decreasing the chances of RNA-DNA hybrid formation (Gallardo et al., 2003; Gonzalez-
Aguilera et al., 2008). Indeed, localization of transcribed genes to the nuclear pore 
complex (NPC) represses the formation of R-loops (Garcia-Benitez et al., 2017). Many 
more factors involved in prevention of R-loop formation have been identified, highlighting 
the multiplicity of pathways that cells use to inhibit this phenomenon (Li and Manley, 2005; 
Paulsen et al., 2009; Wahba et al., 2011). 
If the mechanisms just described fail to avert R-loop formation, there are several other 
mechanisms in place which can remove them. Helicases like Pif1 in yeast (Boule and 
Zakian, 2007), but also Sen1 (Senataxin in humans)(Mischo et al., 2011; Skourti-Stathaki 
et al., 2011) can resolve R-loops by unwinding the RNA-DNA hybrid and releasing the 
RNA counterpart. Sen1 can resolve R-loops, thereby preventing transcription-associated 
instability (Mischo et al., 2011). Sen1 associates with the replisome, indicating a direct 
role in fork stability protection when it encounters R-loops (Alzu et al., 2012). Human 
Senataxin is involved in removing R-loops at G-rich pause sites to promote removal of the 
RNA by Xrn2 (Skourti-Stathaki et al., 2011). Finally, Ribonuclease H enzymes can 
selectively degrade the RNA counterpart of a RNA-DNA hybrid; this class of enzymes will 
be described in detail in Section 1.5.3.  
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Importantly, impairment of most of the abovementioned pathways that restrict R-loops 
lead to R-loop accumulation, suggesting that, although redundant, most of these factors 
have access and specificity (spatial/temporal) to a unique subset of R-loop substrates. 
Ultimately, albeit being highly regulated, hotspots for R-loop accumulation have been 
identified in the yeast genome, including the rDNA, telomeres, Ty transposons, tRNA 
genes and finally highly Pol II transcribed genes (Chan et al., 2014; El Hage et al., 2014). 
 
1.5.2 R-loop impact on the genome 
R-loops exert a number of positive physiological roles (Figure 3, bottom). The most 
prominent example for an R-loop-mediated process in mammals is their involvement in 
immunoglobulin class switch recombination (CSR) in activated B cells. Formation of an 
R-loop following transcription of the switch region at the IgH locus creates the ssDNA 
substrate that is target of activation-induced cytidine deaminase (AID) action. The 
deoxyuridine residues that are produced on the ssDNA are further processed and 
eventually generate DSBs, which start genomic rearrangements that allow for generation 
of different Ig isotypes (Roy et al., 2008). R-loop formation is also an essential step for 
mitochondrial DNA (mDNA) replication in yeast and mammals (Xu and Clayton, 1996), 
and primes replication in E. coli ColE1 plasmids, in a process that requires formation of a 
co-transcriptional R-loop within origin elements that must be cleaved by RNase H to serve 
as primer for replication (Itoh and Tomizawa, 1980). A recent study in S. pombe indicates 
that R-loop formation is required for efficient DSB repair and implicates R-loops in 
regulation of RPA accumulation and resection, suggesting that R-loop formation but also 
their timely resolution are critical to accomplish efficient repair (Ohle et al., 2016).  
R-loops can also regulate gene expression. A striking example is Arabidopsis antisense 
non coding RNAs COOLAIR, generated from the flowering locus C (FLC). COOLAIR 
normally negatively regulate FLC expression, but stabilization of an R-loop at the 
COOLAIR promoter silences its expression, which in turn allows FLC expression, thereby 
regulating plant flowering (Sun et al., 2013). In human cells, R-loops form at active CpG 
islands characterized by a high GC skew, protecting them from DNMT3B1 access and 
thereby promoting gene expression in the unmethylated state (Ginno et al., 2012). In 
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addition, R-loops can also help to terminate transcription by inducing RNA Pol II pausing 
at G-rich pause sites, which, in turn recruits Senataxin and promotes Xrn1-mediated 
transcription termination (Skourti-Stathaki et al., 2011). These R-loops at pause sites can 
additionally induce antisense RNA transcription, which in turn recruit epigenetic modifiers 
that cause H3K9me2 heterochromatin formation in cis to further promote efficient 
transcription termination (Skourti-Stathaki et al., 2014). Further evidence of R-loops 
influence on chromatin status is suggested by the correlation of their accumulation with 
the presence of H3S10P heterochromatin mark in S. cerevisiae and human cells, a marker 
that is associated with chromatin condensation (Castellano-Pozo et al., 2013).  
Apart from their positive roles, in the past years R-loops have been heavily studied for 
their propensity to generate genome instability, thereby emphasizing their negative role. 
R-loops are indeed hazardous structures in many circumstances, which will be shortly 
introduced (figure 3, top).  
 
Figure 3. R-loops have both positive and negative impact on the genome. 
 
An R-loop is a three-stranded structure, comprising an RNA-DNA hybrid and a displaced ssDNA. Top: R-loops can lead 
to genome instability by exposing the unstable ssDNA filament which becomes also accessible to detrimental enzymatic 
activities; R-loops can interfere with transcription and cause replication stress and fork collapse. Bottom: R-loops can 
positively contribute in promoting transcriptional regulation and efficient termination; they can lead to local changes in 
chromatin status and finally contribute to repair of DSBs.Taken from (Costantino and Koshland, 2015). 
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To begin with, the structure of an R-loop by definition contains a displaced ssDNA strand. 
Exposed ssDNA is chemically unstable and susceptible to damaging agents (Lindahl, 
1993), and can be targeted by enzymes such as AID, which can lead to nicks and DSB 
formation. Moreover, R-loops were shown to be targeted by the replication-coupled 
nucleotide excision repair (NER) machinery in human cells and yeast, leading to DSB 
formation (Sollier et al., 2014). Furthermore, recent findings indicate that R-loops are 
capable of priming origin-independent replication within the S. cerevisiae rDNA locus 
when persistent R-loops are allowed to accumulate, a process that could potentially 
contribute to genome instability (Stuckey et al., 2015). Of note, an increasing number of 
studies link R-loop-induced genome instability to replication processes. Indeed, 
transcription-induced recombination in hpr1 mutants ensues only at genes transcribed in 
S phase, which could cause collision between the transcription and replication 
machineries (Wellinger et al., 2006). The helicase Rrm3, which relieves replication stress, 
accumulates at highly transcribed genes in THO mutants, in an RNase H1 sensitive 
manner (Gomez-Gonzalez et al., 2011). Sen1 helicase localizes to replication forks and 
suppresses R-loop accumulation in S phase, helping progression through RNA Pol II 
transcribed genes (Alzu et al., 2012). Also in mammalian cells, Top1 depletion leads to 
transcription-dependent replication stress, in a process mediated by R-loops (Tuduri et 
al., 2009). Indeed, multiple reports have shown that R-loops are obstacles for replication 
fork progression, and collision of the replication machinery with R-loops can result in 
genome instability (Alzu et al., 2012; Gan et al., 2011; Gomez-Gonzalez et al., 2011; 
Santos-Pereira et al., 2013; Tuduri et al., 2009). A recent study in S. cerevisiae identified 
the chromatin mark H3S10P to be associated exclusively with genome instability-
generating R-loops, thereby indicating that R-loop accumulation per se does not cause 
genomic instability but only when causing local chromatin modifications, the 
consequences of which still have to be identified (Garcia-Pichardo et al., 2017). 
 
1.5.3 Ribonucleases H 
Ribonucleases H (RNases H) are a class of enzymes capable of hydrolyzing the RNA 
counterpart of an RNA-DNA hybrid (Cerritelli and Crouch, 2009). In bacteria and 
eukaryotes two different RNase H enzymes are present that have been dubbed RNase 
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H1 (or HI in prokaryotes) and RNase H2 (or HII), which degrade the RNA in a sequence 
unspecific manner but have only partially overlapping substrate specificity. 
RNase H1 is monomeric, and possesses in its N-terminus a hybrid binding domain (HBD), 
which binds to RNA-DNA hybrids with a 25 fold preference over dsRNA (Nowotny et al., 
2008). Importantly, RNase H1 can only recognize and degrade RNA-DNA hybrids 
containing at least four ribonucleotides (Figure 4). In higher eukaryotes, RNase H1 is 
important for mitochondrial DNA replication, and indeed RNase H1 null mouse embryos 
arrest development because they are incapable of amplifying mitochondrial DNA (Cerritelli 
et al., 2003). So far no human genetic disease has been found to be associated with 
RNH1 mutations, possibly due to the essentiality of this enzyme (probably leading to 
embryonic lethality). On the contrary, in yeast RNase H1 is not required for mitochondrial 
DNA replication (Arudchandran et al., 2000). A recent work in human cells identified a 
functional interaction between RPA and RNase H1, whereby RPA recruits RNase H1 to 
R-loops and promotes its activity (Nguyen et al., 2017b). 
Differently from bacterial RNase HII, eukaryotic RNase H2 is a trimeric complex, 
composed of Rnh201/202/203 in S. cerevisiae and RNASEH2A/2B/2C in mammals. In 
addition to being able to degrade longer RNA-DNA hybrids, RNase H2 can also remove 
single ribonucleotides embedded in the DNA (Figure 4)(Eder et al., 1993), which can arise 
from misincorporation events by DNA polymerases. RNase H2 provides the most 
abundant RNase H activity in the cell and its function seems to be linked at least partially 
to replication, as RNASEH2B and Rnh202 are capable of interacting with the DNA 
polymerases clamp loader PCNA via their PIP-box domain located in the C-terminus 
(Chon et al., 2009; Nguyen et al., 2011). Importantly, human RNase H2, but not RNase 
H1, localizes to replication foci via RNase H2B, possibly explaining why RNase H2 
provides the majority of RNase H activity in the cells (Bubeck et al., 2011). Finally, RNase 
H2 takes part in Okazaki primer removal, in a process in which a ribonucleotide is left 
attached to the newly synthetized DNA strand, requiring further processing by 
Rad27/FEN1 (Rydberg and Game, 2002).  
In S. cerevisiae, Rnh201 is the catalytic subunit of the RNase H2 complex, but the enzyme 
is only functional when all subunits are present (Nguyen et al., 2011). Mutants in both 
RNase H enzymes are highly sensitive to low doses of replication stress (Lazzaro et al., 
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2012) and, interestingly, mutation of RNH201, but not RNH1, increases genome 
instability, a phenotype related to its R-loop removal activity. However, combined mutation 
of both enzymes leads to synergistically increased recombination rates, suggesting a 
partial, although not total, redundancy in RNase H1 and H2 activities (O'Connell et al., 
2015). rnh201 sgs1 mutants are synthetic sick due to accumulation of R-loops that cannot 
be resolved by homologous recombination in the absence of Sgs1. Importantly, 
overexpression of RNH1 in this mutant does not rescue this phenotype, suggesting that 
Rnh1 does not have access to, or act on, at least a fraction of the R-loops that are normally 
taken care of by RNase H2 (Chon et al., 2013).  
In humans, RNASEH2A is the catalytic subunit of RNase H2, and importantly mutations 
in any of the components of human RNase H2 are cause of the severe childhood 
inflammatory disorder Aicardi-Goutières syndrome (AGS), which results in, amongst other 
symptoms, neurological dysfunction and psychomotor retardation (Rice et al., 2007). Only 
recently it was shown that patients’ cells display global DNA hypomethylation and 
excessive accumulation of R-loops, possibly being the cause for the acute immune 
response (Lim et al., 2015). 
RNase H enzymes are not essential in yeast, which could be explained by the existence 
of compensatory pathways for Okazaki processing, removal of single ribonucleotides 
insertions in the DNA and R-loop removal. Some novel data from S. cerevisiae indicate 
that RNase H activity is required for efficient repair of R-loop-induced damage, in a 
process that probably involves R-loop removal to allow efficient repair, and prevent repair 
by the mutagenic BIR pathway (Amon and Koshland, 2016). 
 
Figure 4. RNase H1 and H2 have different substrate specificity. 
 
A) Single ribonucleotides inserted in the DNA can only be removed by RNase H2, while B) stretches of four or more 
ribonucleotides in the DNA can be removed by both RNase H1 and H2. Modified from (Cerritelli and Crouch, 2009). 
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1.5.4 Telomeric R-loops 
TERRA has been proposed to form R-loops at telomeres as early as its discovery (Azzalin 
et al., 2007; Luke et al., 2008; Schoeftner and Blasco, 2008). Indeed, its G-rich 
composition and the ability of the displaced single strand to form G-quadruplexes are 
known promoters of R-loop stability (Duquette et al., 2004; Roy and Lieber, 2009). First 
hints that TERRA could form R-loops came from the fact that in yeast RNase H2 
overexpression reduces TERRA levels in a rat1-1 mutant (Luke et al., 2008), and from the 
finding that TERRA colocalizes with Rap1 in human cells, indicating that it is part of 
telomeric heterochromatin (Azzalin et al., 2007). R-loops can be detected using the S9.6 
antibody, which specifically recognize RNA-DNA hybrids of at least 6-8 bp (Phillips et al., 
2013); by this method, R-loops could indeed be identified at yeast and human telomeres 
in the recent years (Arora et al., 2014; Balk et al., 2013; Pfeiffer et al., 2013; Wahba et al., 
2016; Yu et al., 2014). 
In yeast, telomeric R-loops are restricted by the RNase H enzymes and THO-TREX 
components (Balk et al., 2013; Pfeiffer et al., 2013; Yu et al., 2014). Telomeric R-loops 
appear to be relevant in telomerase negative pre-senescent cells, where they promote 
telomere elongation by homologous recombination and thereby partially compensate for 
telomere shortening and hence, delay senescence onset (Balk et al., 2013). Indeed, rnh1 
rnh201 mutants, which accumulate R-loops at telomeres, senesce slower than otherwise 
wild type telomerase mutants, and RNase H1 overexpression, by decreasing telomeric R-
loops, anticipates senescence onset (Balk et al., 2013). Interestingly, R-loop accumulation 
at telomeres influences the survivor pathway choice, as telomerase mutants that 
accumulate telomeric R-loops preferentially generate type II survivors in an R-loop-
dependent manner (Yu et al., 2014). How exactly R-loops promote recombination at 
telomeres remains elusive, but it was proposed to be due to induction of replication stress 
at telomeres (Balk et al., 2013). 
Also in human cells, TERRA has been implicated in maintenance of telomeres in 
telomerase negative ALT cancer cells by forming recombinogenic R-loops at telomeres. 
Indeed, RNase H1 accumulates specifically at ALT telomeres (Arora et al., 2014), and 
deregulation of RNase H1 expression is deleterious for ALT cells maintenance: while 
 Introduction 
27 
RNH1 deletion causes increased accumulation of telomeric R-loops and telomere loss 
due to abrupt telomere excision, overexpression of RNase H1 leads to reduced telomeric 
R-loops and decreased recombinogenic potential of telomeres, and thus results in 
telomere shortening (Arora et al., 2014). Therefore, RNase H1 controls the 
recombinogenic propensity of ALT telomeres by regulating telomeric R-loops. In contrast, 
alteration of RNase H1 levels in telomerase positive cells has no effect on telomere 
maintenance (Arora et al., 2014). Finally, ATRX re-expression in ALT cells was recently 
shown to reduce telomeric R-loops, which could explain why most ALT cancer cell lose 
ATRX expression (Nguyen et al., 2017a). 
 
1.6  Replicative senescence and senescence-associated diseases 
Telomeres progressively shorten in human cells due to lack of telomerase activity in most 
somatic cells (Harley et al., 1990), leading to replicative senescence onset. Replicative 
senescence is therefore a potent barrier against cancer development, setting a limit to the 
amount of duplications that a cell can undergo and therefore limiting uncontrolled 
proliferation. The drawback of this defense mechanism is that the accumulation of 
senescent cells can accelerate organismal aging, which is defined as the age-dependent 
progressive deterioration of tissue and organ function. 
 
1.6.1 Senescence and aging 
Senescent cells are characterized by a set of common features: permanent proliferative 
arrest, although senescent cells are still metabolically active; expression of anti-
proliferative molecules, such as p16INK4a; persistent DNA damage response activation and 
expression of senescence-associated secretory phenotype (SASP) pro-inflammatory 
cytokines (Childs et al., 2015). Different stressors can induce cellular senescence: short 
or dysfunctional telomeres, oxidative stress, proteotoxic stress, and other cellular insults 
(Childs et al., 2015). Cellular senescence, as already introduced, also has some positive 
roles: apart from counteracting carcinogenesis, it can also have a tissue remodeling role 
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during programmed senescence in embryogenesis (Munoz-Espin et al., 2013) and in 
wound healing (Demaria et al., 2014). 
Importantly, senescence seems to ensue when cells accumulate damage until a threshold 
is reached, whereby the cell permanently exits from the cell cycle. The amount of 
senescent cells increase as a function of age in humans (Dimri et al., 1995; Liu et al., 
2009), which can be explained by both the increasing number of cells entering the 
senescence state but also by decreased ability of the organism to clear them, given the 
typical decline in immune system function with age (Munoz-Espin et al., 2013). 
Accumulation of senescent cells in aged tissues can disrupt tissue structure and function, 
and renders tissues more susceptible when hit by subsequent stresses. Aging and cancer 
onset share the same driver: they both ensue during ongoing genomic instability. Indeed, 
aging is one of the most important causes of cancer, with cancer incidence drastically 
raising with increased age (Siegel et al., 2015). Therefore, preserving genome stability is 
thought to be the main means to prevent cancer and delay/overcome aging diseases.  
Selective clearance of senescent cells is currently being investigated as a mean to benefit 
the organism fitness and delay aging pathologies. Pioneering studies induced the 
selective apoptosis of p16INK4a-expressing senescent cells in a mouse progeroid model 
and subsequently also in normally aging mice, which resulted in extended mouse lifespan, 
delayed onset of cancer and aging-related pathologies, and delayed decline of tissue 
aging (Baker et al., 2016; Baker et al., 2011). Additional studies that targeted senescent 
cells by pharmacological means demonstrated rejuvenation of stem cells within aged 
tissues and improvement of cardiovascular dysfunctions in aged and atherosclerotic mice 
(Chang et al., 2016; Roos et al., 2016). These studies propose therefore an alternative to 
the prevention of cellular senescence and aging onset, although their translation to human 
therapies has still to be approached. 
 
1.6.2 Telomeropathies 
Telomeropathies are inherited diseases whereby patients suffer from premature aging 
and display telomere shortening compared to age-matched controls. Poor immune system 
functionality and susceptibility to a subset of cancers are hallmarks of telomeropathies 
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(Armanios and Blackburn, 2012). They are characterized by different symptoms and age 
of onset, and can be caused by mutations in genes either directly or indirectly involved in 
telomere maintenance (Holohan et al., 2014). 
Dyskeratosis congenita (DKC) and Idiopathic pulmonary fibrosis (IPF) are diseases 
caused by mutations in telomere maintenance mechanisms. DKC is a rare cancer-prone 
inherited bone marrow failure syndrome, caused in 60% of cases by mutations in genes 
involved in telomere maintenance (Mitchell et al., 1999). Mutations are found in the 
telomerase complex genes (as in TERC or TERT) or in Dyskerin (DKC1), a telomerase 
interactor (Parry et al., 2011). Patients suffer from organ failure, especially bone marrow 
failure during childhood, although pulmonary fibrosis is the most frequent cause of death 
in adulthood (Dokal, 2011). Importantly, patients display very short telomere length in 
leukocytes (Vulliamy et al., 2001). IPF is a more diffused manifestation of telomeropathy, 
whereby patients suffer from progressive lung failure, linked to fibrosis and inflammation 
(Armanios et al., 2007); 8-20% of familial cases are caused by mutations in TERT or 
TERC (Tsakiri et al., 2007). While telomerase disease patients do not display an overall 
progeroid phenotype, they suffer from progressive organ failure, with patterns of onset 
that reflect that of aging (Armanios and Blackburn, 2012). Furthermore, patients are 
predisposed to cancer, especially at highly proliferative tissues, with an eleven-fold higher 
risk for DKC patients compared to the non-affected population (Alter et al., 2009). In 
general, telomerase diseases are associated with the failure of highly proliferative tissues 
(e.g. the hematopoietic compartment), but also slow turnover tissues (e.g. lungs), which 
may have to be hit by a second insult in order to develop the disease, as modelled in 
mouse (Alder et al., 2011). 
These diseases put forward a clear link between impaired telomere maintenance, 
excessive telomere shortening and accelerated organismal aging, thereby suggesting that 
telomere shortening must be tightly regulated in order not to induce premature cellular 
senescence onset and aging. 
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1.7  Rationale 
A growing amount of studies allege the relevance of R-loops in several biological 
processes. R-loops were shown not only to be a cause of genome instability, but also to 
partake in physiological processes in the cell. Of note, recent studies have implicated R-
loops in DSB repair, thereby suggesting that R-loops not only generate such lesions but 
are also involved in promoting their efficient repair (Ohle et al., 2016). An important step 
in this process was proposed to be the timely removal of the RNA-DNA hybrid itself to 
allow completion of repair, in a process that requires the action of RNase H enzymes 
(Amon and Koshland, 2016; Ohle et al., 2016). How RNase H enzyme activity is 
exquisitely regulated to ensure an equilibrium of these processes is still largely unknown. 
A novel study implicated telomeric R-loops as an essential intermediate of telomere 
maintenance in ALT cancer cells, by boosting the recombinogenic potential of telomeres 
(Arora et al., 2014). This phenomenon seems to be highly conserved, as telomeric R-
loops in telomerase negative S. cerevisiae also promote recombination between 
telomeres, thereby sustaining cellular viability (Balk et al., 2013; Yu et al., 2014). 
Understanding how telomeric R-loops are regulated and what is the role of RNase H 
enzymes in this context is of fundamental biological importance for understanding the 
molecular mechanisms of ALT telomere maintenance. Indeed, S. cerevisiae has proved 
to be an excellent model for the study of telomeric R-loops. 
Notably, what renders telomeric R-loops relevant especially in pre-senescent yeast cells 
and ALT cancers is still to be understood. A differential regulation of their occurrence 
and/or a differential processing at normal compared to short/recombinogenic telomeres 
could be relevant factors in this context. Indeed, ALT telomeres are uniquely bound by 
RNase H1, an important factor that removes telomeric R-loops, suggesting that regulation 
of R-loops at ALT telomeres is an essential and distinctive process (Arora et al., 2014). 
Finally, an important link that is to date still missing is the mechanism by which telomeric 
R-loops promote recombination, both at yeast and ALT telomeres. Indeed, collision of the 
replication machinery with stable R-loops results in replication stress and DSB formation, 
which can promote recombination (Hamperl and Cimprich, 2014; Santos-Pereira and 
Aguilera, 2015), but this has not been shown yet to happen at telomeres. Prompted by 
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novel studies, an important question to be answered is also how telomeric R-loops are 
taken care of during the recombination process. 
This work aims to gain a deeper understanding of R-loop regulation at S. cerevisiae 
telomeres. A focus was set on the RNase H enzymes, being involved in telomeric R-loop 
restriction in S. cerevisiae (Balk et al., 2013) and at ALT telomeres (Arora et al., 2014), 
but also having been identified as novel important factors in damage repair processes 
(Amon and Koshland, 2016; Ohle et al., 2016). Furthermore, we investigated the role of 
the Rap1/Rif1/Rif2 complex, as its differential binding to long, compared to short, 
telomeres (McGee et al., 2010; Sabourin et al., 2007) could provide a molecular 
discrimination between long and short telomeres, which might be a critical step in the 
regulation of telomeric R-loops during senescence. 
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2. Materials and methods 
2.1 Materials 
2.1.1 Yeast strains used in this study 
Strains derivatives of the S288C background: 
Strain 
number Name Genotype Source 
yAL141 tlc1 RNH1-TAP 
het. diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; TLC1/tlc1::NAT; 
RNH1/RNH1-TAP-HIS 
this study 
yBL7 wild type MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0 Euroscarf 
yBL442 RNH201-TAP MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS 
Open 
Biosystems 
yAL12 rif1 RNH201-
TAP 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS; rif1::KAN 
this study 
yAL14 rif2 RNH201-
TAP 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS; rif2::KAN 
this study 
yAL24 RNH201-TAP MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS 
this study 
yAL13 rif2 RNH201-
TAP 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS; rif2::KAN 
this study 
yAL11 rif1 RNH201-
TAP 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH201-TAP-HIS; rif1::KAN 
this study 
yAL213 rnh1 RNH201-
TAP het. 
diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; RNH1/rnh1::KAN; 
RNH201/RNH201-TAP-HIS 
this study 
yAL212 rnh201 RNH1-
TAP het. 
diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; RNH201/rnh201::NAT; 
RNH1/RNH1-TAP-HIS 
this study 
ySLG428 rnh1 rnh201 MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::HYG; rnh1::KAN 
S. Luke-
Glaser 
yAL168 wt + HA-
RNH201 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0;   
pBL188 
this study 
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yAL169 RIF2-9MYC + 
EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; pBL186 
this study 
yAL170 RIF2-9MYC + 
HA-RNH201 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; pBL188 
this study 
yAL224 RIF2-9MYC + 
EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; pBL183 
this study 
yAL225 RIF2-9MYC + 
RNH201-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; pBL452 
this study 
yAL226 RIF2-9MYC 
rnh202 + EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh202::HIS; pBL183 
this study 
yAL227 RIF2-9MYC 
rnh202 + 
RNH201-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh202::HIS; pBL452 
this study 
yAL228 RIF2-9MYC 
rnh203 + EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh203::HIS; pBL183 
this study 
yAL229 RIF2-9MYC 
rnh203 + 
RNH201-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh203::HIS; pBL452 
this study 
yAL268 RIF2-9MYC 
rnh202 rnh203 
+ EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh202::HIS; 
rnh203::HYG; pBL183 
this study 
yAL269 RIF2-9MYC 
rnh203 rnh202 
+ RNH201-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; rnh202::HIS; 
rnh203::HYG; pBL452 
this study 
yAL250 RIF1-9MYC + 
EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF1-9MYC-NAT; pBL186 
this study 
yAL251 RIF1-9MYC + 
HA-RNH201 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF1-9MYC-NAT; pBL188 
this study 
yAL252 RIF1-9MYC + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF1-9MYC-NAT; pBL352 
this study 
yAL254 RIF2-9MYC + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RIF2-9MYC-KAN; pBL352 
this study 
yAL85 wt + EV MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
pBL189 
this study 
yAL86 wt + RNH1-HA MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
pBB39 
this study 
yAL89 rif2 + EV MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rif2::KAN; pBL189 
this study 
yAL90 rif2 + RNH1-HA MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rif2::KAN; pBB39 
this study 
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yDB227 RIF2AID MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
leu2::AFB2::LEU2; RIF2-AID*-9MYC::HIS3; 
bar1::NAT 
D. Bonetti 
yDB229 RIF1AID MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
leu2::AFB2::LEU2; RIF1-AID*-9MYC::HIS3; 
bar1::NAT 
D. Bonetti 
yDB241 RIF1AID RIF2AID MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
leu2::AFB2::LEU2; RIF1-AID*-9MYC::HIS3; 
RIF2-AID*-9MYC::HIS3 
D. Bonetti 
yBL1004 rif2 rnh1 
rnh201 het. 
diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; LYS2/lys2Δ0; 
RIF2/rif2::HYG; RNH1/rnh1::KAN; 
RNH201/rnh201::NAT 
B. Luke 
yAL142 tlc1 RIF2-
9MYC 
RNH201-TAP 
het. diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; TLC1/tlc1::NAT; 
RIF2/RIF2-9MYC-KAN; RNH201/RNH201-
TAP-HIS 
this study 
yAL95 tlc1 het. diploid MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; TLC1/tlc1::NAT 
this study 
yAL204 rif2 tlc1 het. 
diploid + EV 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; RIF2/rif2::HYG; 
TLC1/tlc1::HIS; pBL189 
this study 
yAL205 rif2 tlc1 het. 
diploid + 
RNH1-HA 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; RIF2/rif2::HYG; 
TLC1/tlc1::HIS; pBB39 
this study 
yBB236 rnh1 rnh201 
est2 het. 
diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; RNH1/rnh1::KAN; 
RNH201/rnh201::NAT; EST2/est2::HYG 
B. Balk 
yAL196 est2 + EST2 + 
EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
est2::KAN; pBL354; pBL190 
this study 
yAL198 est2 + EST2 + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
est2::KAN; pBL354; pBL192 
this study 
yAL202 est2 + EST2 + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
est2::KAN; pBL354; pBL336 
this study 
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yVK1290 est2 rtt101 
rnh201 het. 
diploid 
MATa/MATα; his3Δ1/his3Δ1; 
leu2Δ0/leu2Δ0; ura3Δ0/ura3Δ0; 
MET15/met15Δ0; EST2/est2::HIS; 
RTT101/rtt101::KAN; 
RNH201/rnh201::NAT 
V. Kellner 
yAL296 S-RNH1-TAP MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
NAT-S-RNH1-TAP-HIS 
this study 
yAL297 G2-RNH1-TAP MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
NAT-G2-RNH1-TAP-HIS 
this study 
ySLG252 RNH1-TAP MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0;  
RNH1-TAP-HIS 
G. Pereira 
yAL300 rnh1 MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN 
this study 
yAL301 rnh201 S-
RNH1-TAP 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::HYG; NAT-S-RNH1-TAP-HIS 
this study 
yAL303 rnh201 G2-
RNH1-TAP 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::HYG; NAT-G2-RNH1-TAP-HIS 
this study 
yBL435 rnh201 MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0;   
rnh201::KAN 
B. Luke 
yAM196 rnh1 rnh201 MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; rnh201::HYG 
A. Maicher 
yVK1220 rnh1 rnh201 + 
EV 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; rnh201::HYG; pBL189 
V. Kellner 
yVK1221 rnh1 rnh201 + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; rnh201::HYG; pBB39 
V. Kellner 
yAL321 rnh201 S-
RNH1-TAP + 
EV 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::HYG; NAT-S-RNH1-TAP-HIS; 
pBL189 
this study 
yAL323 rnh201 G2-
RNH1-TAP + 
EV 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::HYG; NAT-G2-RNH1-TAP-HIS; 
pBL189 
this study 
yAL315 rnh201 + EV MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::KAN; pBL189 
this study 
yAL316 rnh201 + 
RNH1-HA 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh201::KAN; pBB39 
this study 
yAL325 S-RNH1-TAP 
rnh201 rad52 
est2 het. 
diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
RNH1/NAT-S-RNH1-TAP-HIS; 
RNH201/rnh201::HYG; 
RAD52/rad52::NAT; EST2/est2::KAN 
this study 
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yAL326 rnh1 rnh201 
rad52 est2 het. 
diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
RNH1/rnh1::HIS; RNH201/rnh201::HYG; 
RAD52/rad52::NAT; EST2/est2::KAN 
this study 
yAL327 G2-RNH1-TAP 
rnh201 rad52 
est2 het. 
diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
RNH1/NAT-G2-RNH1-TAP-HIS; 
RNH201/rnh201::HYG; 
RAD52/rad52::NAT; EST2/est2::KAN 
this study 
yAL352 est2 rnh201 S-
RNH1-TAP het. 
diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
EST2/est2::KAN; RNH201/rnh201::HYG; 
RNH1/NAT-S-RNH1-TAP-HIS 
this study 
yAL353 est2 rnh201 
G2-RNH1-TAP 
het. diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
EST2/est2::KAN; RNH201/rnh201::HYG; 
RNH1/NAT-G2-RNH1-TAP-HIS 
this study 
yAL350 RNH202-TAP MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
RNH202-TAP-HIS 
Open 
Biosystems 
yAL351 S-RNH202-
TAP 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
NAT-S-RNH202-TAP-HIS 
this study 
yAL206 rnh202 MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
Rnh202::KAN 
Dharmacon 
yAL365 rnh1 rnh202 MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; rnh202::HIS 
this study 
yAL379 rnh1 S-
RNH202-TAP 
MATα; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; NAT-S-RNH202-TAP-HIS 
this study 
yAL373 rnh1 RNH202-
TAP 
MATa; his3Δ1; leu2Δ0; ura3Δ0; met15Δ0; 
rnh1::KAN; RNH202-TAP-HIS 
this study 
yAL361 est2 S-
RNH202-TAP 
het. diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
EST2/est2::KAN; RNH202/NAT-S-
RNH202-TAP-HIS 
this study 
yAL362 est2 rnh202 
het. diploid 
MATa/α; his3Δ1/his3Δ1; leu2Δ0/leu2Δ0; 
ura3Δ0/ura3Δ0; met15Δ0/met15Δ0; 
EST2/est2::KAN; RNH202/rnh202::HIS 
this study 
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Strains derivatives of the FY23 background: 
Strain 
number Name Genotype Source 
yAL174 wt + EV MATa; ura3-52; trp1-Δ63; leu2Δ1; RAP1-
mCherry-KAN; 2MS2-tel6R; pBL449; pBL211 
this 
study 
yAL175 wt + RNH1-HA MATa; ura3-52; trp1-Δ63; leu2Δ1; RAP1-
mCherry-KAN; 2MS2-tel6R; pBL449; pBL352 
this 
study 
yAL176 rif2 + EV MATa; ura3-52; trp1-Δ63; leu2Δ1; RAP1-
mCherry-KAN; 2MS2-tel6R; rif2::HYG; 
pBL449; pBL211 
this 
study 
yAL177 rif2 + RNH1-HA MATa; ura3-52; trp1-Δ63; leu2Δ1; RAP1-
mCherry-KAN; 2MS2-tel6R; rif2::HYG; 
pBL449; pBL352 
this 
study 
 
2.1.2 Plasmids used in this study 
Code Name Description Source 
pBL186  pRS423 pGAL, 2µ, HIS3 M. Peter 
pBL188  pRS423 pGAL-HA-RNH201, 2µ, 
HIS3 
this study 
pBL183 BG1805 
 
BG1805 pGAL, 2µ, URA3 B. Grayhack 
pBL452  BG1805 pGAL-RNH201-HA-6HIS-
Prot3C-Prot A(ZZ), 2µ, URA3 
 
Dharmacon 
pBL352  pRS425 pGAL-RNH1-HA, 2µ, LEU2 this study 
pBL189  pRS426 pGPD, 2µ, URA3 (Balk et al., 2013) 
pBB39  pRS426 pGPD-RNH1-HA, 2µ, URA3 (Balk et al., 2013) 
pBL211  pRS425 pGAL, 2µ, LEU2 M. Peter 
pBL449  pGPD-MS2BP-GFP, 2µ, TRP1 P. Chartrand 
pBL190  pRS423 pGPD, 2µ, HIS3 M. Peter 
pBL192  pRS423 pGPD-RNH1-HA, 2µ, HIS3 this study 
pBL336 pT44 pGPD-RNH1-HA, CEN, HIS3 T. Teixeira 
pBL354  pRS416, EST2, CEN, URA3 R. Knies 
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pBL97  pRS316, CEN, URA3 M. Peter 
pBL399  pRS316, RNH201-P45D-Y219A, 
CEN, URA3 
this study 
pBL423  pSP100, contains probe for Southern 
Blot 
M.P. Longhese 
pBL327 pYM18 contains 9MYC-KAN cassette  (Janke et al., 2004) 
pBL334 pYM21 contains 9MYC-NAT cassette (Janke et al., 2004) 
pBL491 pRDK1597 contains S NAT cassette (Hombauer et al., 2011) 
pBL492 pGIK43 contains G2 NAT cassette (Karras and Jentsch, 
2010) 
 
2.1.3 Oligonucleotides used in this study 
Code Sequence 5’3’ Use 
oBL295 CGGTGGGTGAGTGGTAGTAAGTAGA 1L fw qPCR 
oBL296 ACCCTGTCCCATTCAACCATAC 1L rev qPCR 
oLK57 GGGTAACGAGTGGGGAGGTAA 15L fw qPCR 
oLK58 CAACACTACCCTAATCTAACCCTGT 15L rev qPCR 
oLK49 GGCTTGGAGGAGACGTACATG 6Y’ fw qPCR 
oLK50 CTCGCTGTCACTCCTTACCCG 6Y’ rev qPCR 
oAM47 TCCAATTGTTCCTCGTTAAG 18S rDNA fw qPCR 
oAM48 ATTCAGGGAGGTAGTGACAA 18S rDNA rev qPCR 
oAL22 AGAAAAACCAGCGTCTTCCACTTAAGTTAACTCG
AAAAGTACATGATAGACGTACGCTGCAGGTCGA
C 
RIF2-9MYC fw 
oAL23 TGCCATCTCTTTGTATTGTTCGAACTCTTTCAAAA
GACCTTGGTAATTTAATCGATGAATTCGAGCTCG 
RIF2-9MYC rev 
oAL24 CTCGCTTGTCACATGCCAGT check RIF2-9MYC fw  
oLP1 TTGTAATTAATTTATTGCCATTTTGATCTATTCTA
CATACTAACAATCAATCGATGAATTCGAGCTCG 
RIF1-9MYC fw  
oLP2 ATTATTAGATTTTATGATGAGGCTCGAATATTACT
CAAACAGGGATAATGATATGAATCGTACGCTGC
AGGTCGAC 
RIF1-9MYC rev  
oLP3 GAACAACCCGAAGTTGCTGA check RIF1-9MYC fw 
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oBL29 CTGCAGCGAGGAGCCGTAAT NAT KAN rev 
oAL47 GTTAAAGTGTCACTCCTTGCTTATCGAAGGAACT
ATCGATTCCTAATTATGCGTACGCTGCAGGTCGA
C 
S- and G2-RNH1 fw 
oAL48 GATCCCAGTTTCCCTGCCCTTTCTAACCGCGTA
GAAGTTCCCTTGCCTTGCCAATTTAACAACATTT
TGTGATAA 
S-RNH1 rev 
oAL49 GATCCCAGTTTCCCTGCCCTTTCTAACCGCGTA
GAAGTTCCCTTGCCTTGCATCAGTTTCACTTTCG
GTATTTCT 
G2-RNH1 rev 
oAL53 CGGTTGATCTTGGCTGTAG check S- and 
G2-RNH1 fw 
oAL54 TCGCTTGCTCGTAGCTGT check S- and 
G2-RNH1 rev 
oAL61 TCTGTCGCAATAGTTGACTTTCTTTTCTGGCCTC
TCGAACAAAAAGCATGCGTACGCTGCAGGTCGA
C 
S-RNH202 fw 
oAL62 TCGTCTGGTAAAATTATTAGTCGTTCTTCCCCCC
CAATGTTGGAAACGGTCAATTTAACAACATTTTG
TGATAA 
S-RNH202 rev 
oAL64 CAAGTTTGTCAAAAGCACG check S-RNH202 fw 
oAL65 GCTCGATACGAGGTTTGG check S-RNH202 rev 
 
2.1.4 Liquid media 
YPD medium (1 l) 
Peptone 17.6 g 
Bacto Yeast Extract 8.8 g 
ddH20 900 ml 
Autoclave 20 min at 121˚C 
20% glucose (autoclaved, 2% final) 100 ml 
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LB medium (1 l) no drug with carbenicillin 
NaCl 10 g 10 g 
Bacto Tryptone 10 g 10 g 
Bacto Yeast Extract 5 g 5 g 
NaOH to adjust pH to 7.0   
ddH2O to 1 l to 1 l 
Autoclave 20 min at 121˚C 
Carbenicillin 100 mg/ml (100 µg/ml final)  1 ml 
 
Sporulation medium (1 l) 
Zinc acetate (5 mg/ml)(0.005% final) 10 ml 
Potassium acetate (1% final) 10 g 
ddH2O 990 ml 
Autoclave 20 min at 121˚C 
 
SC medium (1 l) SC - aa RAFF 2% RAFF 1%/GAL 2% 
Yeast Synthetic Complete Medium 
Supplemented without aminoacids 
1.9 g 1.9 g 1.9 g 
Yeast Nitrogen Base without 
aminoacids 
6.7 g 6.7 g 6.7 g 
Raffinose x 5 H2O  23.6 g 11.8 g 
ddH2O 900 ml 1 l 900 ml 
Autoclave 20 min at 121˚C 
20% glucose (autoclaved, 2% final) 100 ml   
20% galactose (sterile filtered)   100 ml 
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2.1.5 Agar plates 
YPD agar plates (1 l) no drug NAT KAN HYG 
Peptone 100 g 100 g 100 g 100 g 
Bacto Yeast Extract 50 g 50 g 50 g 50 g 
20% glucose (2% final) 100 ml 100 ml 100 ml 100 ml 
Agar 100 g 100 g 100 g 100 g 
ddH2O to 1 l to 1 l to 1 l to 1 l 
Autoclave 20 min at 121˚C 
NAT 100 mg/ml (100 µg/ml final)  1 ml   
KAN (G418) 50 mg/ml (250 
µg/ml final) 
  5 ml  
HYG 100 mg/ml (300 µg/ml final)    3 ml 
 
More than one drug can be added to the same plates. 
 
SC plates (1 l) SC complete SC - aa SC 
Yeast Synthetic Complete Medium 
Supplemented without aminoacids 
1.9 g 1.9 g  
Yeast Nitrogen Base without 
aminoacids 
6.7 g 6.7 g 6.7 g 
Agar 24 g 24 g 24 g 
ddH2O 890 ml 900 ml 900 ml 
100x amino acid 10 ml   
Autoclave 20 min at 121˚C 
20% glucose (autoclaved, 2% final) 100 ml 100 ml 100 ml 
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SC -HIS + 5-FOA plates (500 ml) 
Yeast Synthetic Complete Medium Supplemented 
without uracil, histidine, leucine and tryptophan 
0.95 g 
Yeast Nitrogen Base without aminoacids 3.35 g 
Uracil 0.025 g 
Glucose 10 g 
Agar 10 g 
ddH2O 385 ml 
Autoclave 20 min at 121˚C 
Leucine 50X 10 ml 
Tryptophan 100X  5 ml 
5-FOA 0.5 g in 100 ml ddH2O at 65˚C 
 
LB plates (1 l) no drug with ampicillin 
Bacto Yeast Extract 5 g 5 g 
Bacto Tryptone 10 g 10 g 
NaCl 10 g 10 g 
NaOH to adjust pH to 7.0  
Agar 15 g 15 g 
ddH2O to 1 l to 1 l 
Autoclave 20 min at 121˚C 
Ampicillin  100 µg/ml 
 
Pre-sporulation plates (1l) 
Standard nutrient broth 30 g 
Bacto Yeast Extract 10 g 
Agar 20 g 
ddH2O 750 ml 
Autoclave 20 min at 121˚C 
20% glucose (autoclaved, 5% final) 250 ml 
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2.1.6 Buffers 
 
 
 
FA Lysis Buffer (1 l) -SOD +SOD 
1 M HEPES pH 7.5 (50 mM final) 50 ml 50 ml 
5 M NaCl (140 mM final) 28 ml 28 ml 
0.5 M EDTA pH 8.0 (1 mM final) 2 ml 2 ml 
Triton X-100 (1% final) 10 ml 10 ml 
Sodium deoxycholate (0.1% final)  1 g 
ddH2O 910 ml 910 ml 
 
 
 
LiAc-Mix (100 ml) 
1 M LiAc (sterile, 0.1 M final) 10 ml 
10x TE (sterile) 10 ml 
ddH2O 80 ml 
PEG-Mix (100 ml) 
Polyethylene glycol 400 40 g 
Li-Ac Mix to 100 ml 
Autoclave 20 min at 121˚C 
10x PBS (1 l) 
NaCl (1.37 M final) 80 g 
KCl (30 mM final) 2 g 
Na2HPO4 x 2 H2O (80 mM final) 14.4 g 
KH2PO4 (20 mM final) 2.4 g 
HCl to adjust pH to 7.4  
ddH2O to 1 l 
Autoclave 20 min at 121˚C 
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FA Lysis Buffer 500 (1 l) 
1 M HEPES pH 7.5 (50 mM final) 50 ml 
5 M NaCl (0.5 M final) 100 ml 
0.5 M EDTA pH 8.0 (1 mM final) 2 ml 
Triton X-100 (1% final) 10 ml 
Sodium deoxycholate (0.1% final) 1 g 
ddH2O 838 ml 
 
Buffer III (1 l) 
1 M Tris-HCl pH 8.0 (10 mM final) 10 ml 
0.5 M EDTA pH 8.0 (1 mM final) 2 ml 
1 M LiCl (250 mM final) 250 ml 
NP-40 (1% final) 10 ml 
Sodium deoxycholate (1% final) 10 g 
ddH2O 728 ml 
 
10X TE (1 l) 
1 M TRIS pH 7.5 (0.1 M final) 100 ml 
0.5 M EDTA pH 8 (10 mM final) 20 ml 
ddH2O 1 l 
Autoclave 20 min at 121˚C 
 
Elution Buffer B (1 l) 
1 M Tris-HCl pH 7.5 (50 mM final) 50 ml 
20% SDS (1% final) 50 ml 
0.5 M EDTA pH 8.0 (10 mM final) 20 ml 
ddH2O 880 ml 
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10X TBE (1 l) 
Tris base (0.89 M final) 108 g 
Boric acid (0.89 M final) 55 g 
0.5 M Na2EDTA pH 8.0 (20 mM final) 40 ml 
ddH2O to 1 l 
Sterile filter  
 
Solution 1 (20 ml) 
10 M NaOH (1.85 M final) 3.7 ml 
14.34 M β-mercaptoethanol (1.09 M final) 1.52 ml 
ddH2O 14.78 ml 
 
Solution 2 (20 ml) 
100% Trichloroacetic acid (50% final) 10 ml 
ddH2O 10 ml 
 
Solution 3 (20 ml) 
100% Acetone 20 ml 
 
Urea Buffer (10 ml) 
1M Tris-HCl pH 6.8 (120 mM final) 1.2 ml 
70% Glycerol  (5% final) 714 µl 
Urea (8 M final) 4.8 g 
14.34 M β-mercaptoethanol (143 mM final) 100 µl 
20% SDS (8% final) 4 ml 
ddH2O to 10 ml 
Bromophenol blue to color  
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10x SDS running buffer (1 l) 
SDS (0.1% final) 10 g 
Tris base (250 mM final) 30.3 g 
Glycine (1,92 M final) 144.1 g 
ddH2O to 1 l 
Sterile filter  
 
Transfer buffer (100 ml) 
5x Bio-Rad transfer buffer 20 ml 
Absolute ethanol (20% final) 20 ml 
ddH2O 60 ml 
 
PBS-Tween (1 l) 
10x PBS 100 ml 
Tween-20 (0.1% final) 1 ml 
ddH2O to 1 l 
 
Blocking buffer (50 ml) 
PBS-Tween 50 ml 
Skim milk powder (5% final) 2.5 g 
 
IP buffer (50 ml) - NP40 + NP40 
1 M Tris pH 7.5 (50 mM final) 2.5 ml 2.5 ml 
5 M Nacl (150 mM final) 1.5 ml 1.5 ml 
1 M MgCl2 (5 mM final) 250 µl 250 µl 
NP40 (0.2% final)  100 µl 
ddH2O 44 ml 43.9 ml 
Protease Inhibitor Cocktail tablets 4 4 
200 mM PMSF (1 mM final) 250 µl 250 µl 
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20X SSC (1 l) 
NaCl (3 M final) 175.3 g 
Sodium citrate tribasic dihydrate (0.3 M 
final) 
88.2 g 
HCl to adjust pH to 7.0  
ddH2O to 1 l 
 
Denaturing solution (1 l) 
NaOH (0.4 M final) 16 g 
NaCl (0.6 M final) 35.1 g 
ddH2O to 1 l 
 
Neutralizing solution (1 l) 
Trizma base (1 M final) 121.4 g 
NaCl (1.5 M final) 87.75 g 
HCl to adjust pH to 7.4  
ddH2O to 1 l 
 
Church Buffer (500 ml) 
1 M NaPO4 pH 7.4 (0.5 M final) 250 ml 
0.5 M EDTA pH 8.0 (1 mM final) 1 ml 
20% SDS (7% final) 175 ml 
BSA (1% final) 5 g 
ddH2O 74 ml 
 
Washing solution (100 ml) 
1 M NaPO4 pH 7.2 (0.2 M final) 20 ml 
20% SDS (1% final) 5 ml 
ddH2O 75 ml 
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2.1.7 Enzymes 
Name Source 
Proteinase K Qiagen  
RNase A Thermo Scientific  
DNase I (RNase free) Qiagen 
Lyticase Sigma-Aldrich 
Zymolyase 100T Zymo Research 
XhoI New England Biolabs  
EcoRI-HF New England Biolabs  
2X Phusion HF Mastermix GC buffer New England Biolabs 
2X Taq Mastermix New England Biolabs 
 
2.1.8 Primary antibodies used in this study 
name Source Application Amount used 
Mouse monoclonal anti-
MYC-tag (9B11) 
Cell Signaling/New 
England Biolabs 
2276S 
ChIP and 
western blot 
3 µl for ChIP, 1:1,000 
dilution for WB 
Rabbit peroxidase anti-
peroxidase soluble 
complex 
Sigma-Aldrich P1291 western blot 1:1,000 dilution 
Mouse monoclonal anti-
phosphoglycerate 
kinase (22C5D8) 
Invitrogen 459250 western blot 1:200,000 dilution 
Mouse monoclonal anti-
HA.11 (16B12) 
Covance MMS-101P-
1000 
western blot 1:2,000 dilution 
Rabbit polyclonal anti-
Rap1 (y-300) 
Santa Cruz sc-20167 western blot 1:1,000 dilution 
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Mouse monoclonal 
S9.6 anti-RNA-DNA 
hybrid 
Kerafast ENH001 ChIP 2 µl 
Rabbit polyclonal anti-
Sic1 (FL-284) 
Santa Cruz sc-50441 western blot 1:500 dilution 
Rabbit polyclonal anti-
Clb2 (y-180) 
Santa Cruz sc-9071 western blot 1:1,000 dilution 
 
2.1.9 Secondary antibodies used in this study 
Name Source Application Amount used 
Goat Immun-Star anti-mouse 
(GAM)-HRP conjugate 
Bio-Rad 170-
5047 
western blot 1:3,000 dilution 
Goat Immun-Star anti-rabbit 
(GAR)-HRP conjugate 
Bio-Rad 170-
5046 
western blot 1:3,000 dilution 
 
2.1.10 Ladders  
Name Source Use 
1 kb DNA ladder New England Biolabs agarose gels 
100 bp DNA ladder New England Biolabs agarose gels 
Prestained Protein Marker, Broad range 
(11-190 kDa) 
New England Biolabs western blot 
Prestained Protein Marker, Broad range 
(7-175 kDa) 
New England Biolabs western blot 
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2.1.11 Kits 
Name Source 
DECAprime II DNA Labeling Kit Thermo Scientific 
DyNAmo Flash SYBR Green qRT-PCR Kit Thermo Scientific 
Puregene Yeast/Bact. Kit B Qiagen 
QIAprep Spin Miniprep Kit Qiagen 
QIAquick Gel Extraction Kit Qiagen 
QIAquick PCR Purification Kit Qiagen 
Trans-Blot Turbo RTA Midi Nitrocellulose Transfer Kit Bio-Rad 
 
2.1.12 Electronic devices 
Name Source 
Analytical Balance ED224S Sartorius 
Balance Extend ED822-0CE Sartorius 
BD FACSVerse Becton Dickinson 
Benchtop Shaker Excella E24 Eppendorf 
BioRuptor Pico Diagenode 
Bioruptor Water Cooler Minichiller Diagenode 
Centrifuge 5430 R Eppendorf 
Centrifuge 5810 R Eppendorf 
ChemiDoc Touch Imaging System Bio-Rad 
Chromatography Refrigerator FRCR4504V  Thermo Scientific 
Dissection Microscope MSM 400 Singer Instruments 
FastPrep-25 MP Biomedicals 
Freezer LGex 3410 MediLine Liebherr 
Freezer LGUex 1500 MediLine Liebherr 
Refrigerator LKUexv1610-21 MediLine Liebherr 
Refrigerator /Freezer LCv 4010 MediLine Liebherr 
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Heraeus Pico 17 Centrifuge Thermo Scientific 
Hybridisation Oven OV3 Biometra 
IKA VORTEX genius 3 Sigma-Aldrich 
Incubator Heratherm IMC18 Thermo Scientific 
Incubator Heratherm IMH60 Thermo Scientific 
Leica DM1000 LED Leica 
Magnetic Stirrer D-6010 NeoLab 
Micro-Cubes Ice Machine Wessamat 
Microwave R941 SHARP 
Mini Centrifuge CD1008 Phoenix Instrument 
NanoDrop 2000 Thermo Scientific 
pH Meter PB-11 Sartorius 
PowerPac Basic Bio-Rad 
Real Time PCD Detection system CFX384 Touch Bio-Rad 
Shaker Duomax 1030 Heidolph 
Shaker Multitron Standard Infors HT 
Sonifier 450 Branson 
Spectrophotometer Ultrospec 2100 pro Biochrom 
Test-tube Rotator Labinco 
Thermal Cycler C1000 Touch  Bio-Rad 
Thermal Printer DPU-414 Seiko Instruments 
ThermoMixer F1.5 Eppendorf 
Trans-Blot turbo Starter System Bio-Rad 
Typhoon FLA 9500 GE Healthcare 
Ultra-Low Temperature Freezer MDF-U74V Sanyo 
Ultra-Low Temperature Freezer V86-8301 Ewald 
Ultrapure Water System GenPure TKA 
UV Stratalinker 2400 Stratagene 
Water Bath Shaker New Brunswick Innova 3100 Eppendorf 
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2.1.13 Software 
Name Source 
Adobe Illustrator CC 21.1.0 Adobe 
CFX Manager 3.1 Bio-Rad 
EndNote X5 Thomson Reuters 
FACSuite 1.0.5 Becton Dickinson 
FileMaker Pro 13.0v1 FileMaker Inc. 
Image Lab 5.2 Bio-Rad 
ImageJ 1.6.0 NIH 
Microsoft Office for Windows 2013 Microsoft 
Prism 7 GraphPad 
SnapGene 3.3.4 GSL Biotech 
 
2.1.14 Additional Reagents 
Name Source 
5-FOA Zymo Research 
3-Indoleacetic acid Sigma-Aldrich 
Acetone Sigma-Aldrich 
Agarose Sigma-Aldrich 
β-mercaptoethanol Sigma-Aldrich 
Bovine Serum Albumin, Acetylated Promega 
Bradford Solution AppliChem 
Carbecillin Disodium Salt Sigma-Aldrich 
ClonNat WERNER BioAgents 
cOmplete Mini EDTA-free Protease Inhibitor Cocktail Tablets Roche 
Concanavalin A Sigma-Aldrich 
CutSmart Buffer New England Biolabs 
dATP [α-32P] Perkin Elmer 
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Dimethyl sulfoxide (DMSO) Sigma-Aldrich 
Ethanol absolute Sigma-Aldrich 
Formaldehyde 37% AppliChem 
G418 Disulfate Solution AppliChem 
Glycerol Grüssing 
Glycine AppliChem 
HEPES buffer pH 7.5 AppliChem 
Hydoxyurea Sigma-Aldrich 
Hygromycin B Gold Solution InvivoGen 
IgG Sepharose 6 Fast Flow GE Healthcare 
Isopropanol Sigma-Aldrich 
Methyl methanesulfonate Sigma-Aldrich 
Nonidet P40 AppliChem 
nProtein A Sepharose 4 Fast Flow GE Healthcare 
Pierce Anti-HA Magnetic Beads Thermo Scientific 
Poly(ethylene glycol) (PEG 400) Sigma-Aldrich 
Ponceau S Solution Sigma-Aldrich 
Reagents for yeast media Sigma-Aldrich 
RedSafe Nucleic Acid Staining Solution iNtRON Biotechnology 
SC Medium Supplemented without amino acids MP Biomedicals 
SDS Solution 20% AppliChem 
Sodium deoxycholate (SOD) Sigma-Aldrich 
SuperSignal West Dura Extended Duration Substrate Thermo Scientific 
SuperSignal West Pico Chemiluminescent Substrate Thermo Scientific 
SYTOX Green Thermo Scientific 
Trichloroacetic acid (TCA) Sigma-Aldrich 
Triton X-100 Sigma-Aldrich 
Tween-20 Sigma-Aldrich 
Urea Sigma-Aldrich 
Water Molecular Biology Reagent Sigma-Aldrich 
Yeastmarker Carrier DNA  Clontech 
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α-factor Zymo Research 
 
2.1.15 Additional Materials 
Name Source 
15 ml Bioruptor Pico Tubes and sonication beads Diagenode 
96-Well Plates Corning 
Amersham Hybond-NX Nylon Membrane GE Healthcare 
Amersham Protran Premium Nitrocellulose Membrane GE Healthcare 
Hard-Shell 384-Well PCR plates Bio-Rad 
Magnetic Rack DynaMag-2 Thermo Scientific 
Microseal ‘B’ PCR Adhesive Seal Bio-Rad 
Mini-PROTEAN TGX Precast Gels 4-15% Bio-Rad 
Mini-PROTEAN TGX Precast Gels 7.5% Bio-Rad 
Nunc 8-Well Chambered Coverglass Lab-Tek 
Replica plater for 96-Well plate Sigma-Aldrich 
TubeSpin Bioreactor 50 TPP 
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2.2  Methods 
2.2.1 Yeast mating and sporulation 
Yeast cells were mated by patching haploid strains of opposite mating types (Mata and 
MATα) on YPD plates, which were incubated overnight at the appropriate temperature. 
Diploids were selected by streaking out the cells for single colonies on double-selection 
plates, which were incubated at the appropriate temperature for 2-3 days. Single clones 
of diploids were then patched on pre-sporulation plates and grown overnight at the 
appropriate temperature, after which cells were transferred into 3 ml sporulation medium 
and incubated at 23°C, until sporulation was efficiently induced (3-4 days). 10 µl of 
cultures were mixed with 10 µl of lyticase, and after incubation at room temperature for 15 
min, cells were transferred onto YPD or selective plates and tetrads were dissected by 
micromanipulation. Plates were then grown for 3 days at the appropriate temperature. 
 
2.2.2 Transformation of yeast 
25 ml of exponentially growing liquid yeast cultures (OD600 0.4-0.8) were spun down at 
3,000 rpm for 3 min and cells were washed with 5 ml LiAc-mix. Cells were spun down 
again at 3,000 rpm for 3 min and resuspended in 250 µl of the same solution. The 
transformation reaction was composed of 100 µl of competent cells, 700 µl of PEG-mix, 
10 µl of Yeastmarker Carrier DNA and 0.5 µg of plasmid or 7-10 µl of PCR product, and 
incubated 30 min rotating at room temperature. After a 15 min heat shock at 42˚C, cells 
were spun down at 3,000 rpm for 1 min and resuspended in 300 µl of YPD, and 
subsequently incubated for 30 min at 30˚C (for plasmid transformation) or up to 6 hours 
(for integration). Cells were then plated on appropriate selective plates and grown at 30˚C 
for 2-3 days. 
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2.2.3 Transformation of bacteria 
0.5 µg of plasmid were added to 50 µl of competent DH5α E. coli, mixed gently and 
incubated for 30 min on ice. After a 1 min heat shock at 42°C, the reactions were incubated 
for 1 min on ice and subsequently 300 µl of LB media were added. The reactions were 
then incubated for 30 min at 37°C and finally 100 µl of the reactions were plated on LB 
plates containing ampicillin and incubated overnight at 37°C. 
 
2.2.4 Construction of strains 
2.2.4.1 Generation of 9myc C-terminally tagged Rif2  
The RIF2-9MYC strain was created by amplifying the 9MYC-KAN cassette by PCR from 
the plasmid pBL327 by using the oligonucleotides oAL22 and oAL23, which were 
designed in accordance to (Janke et al., 2004). The PCR reaction was composed of 100 
ng pBL327, 25 µl Phusion HF 2x Mastermix, 0.64 µl of each 5 µM oligonucleotide and 
water to 50 µl. The PCR was performed as follows: 98°C 30 sec, 98°C 10 sec, 72°C 30 
sec, 72°C 1 min (to step 2 x 34 times), 72°C 10 min. Correct PCR product length was 
verified by agarose gel, and subsequently 10 µl of cassette were transformed in yBL7 and 
plated on YPD + KAN plates, which were grown at 30°C for 3 days. Colonies that grew 
were restreaked on YPD + KAN to exclude false positives, and those which could re-grow 
were verified for correct integration by PCR on genomic DNA, which was extracted with 
Puregene Yeast/Bact. Kit B. The PCR to verify correct construct integration and for 
subsequent sequencing was performed with the oligonucleotides oAL24 and oBL29, and 
the reaction was composed of 200 ng genomic DNA, 5 µl of each 5 µM oligonucleotide, 
12.5 µl Phusion HF 2X Mastermix and water to 25 µl. The PCR was performed as follows: 
98°C 30 sec, 98°C 10 sec, 64°C 30 sec, 72°C 1 min 30 sec (to step 2 x 34 times), 72°C 
10 min. Correct product length was verified by agarose gel and sequencing was performed 
on the PCR product purified with QIAquick PCR Purification Kit, using oAL24 and oBL29. 
Expression of the tagged protein was confirmed by western blot. 
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2.2.4.2 Generation of 9myc C-terminally tagged Rif1 
The RIF1-9MYC strain was created by amplifying by PCR the 9MYC-NAT cassette from 
the plasmid pBL334 by using the oligonucleotides oLP1 and oLP2, which were designed 
in accordance to (Janke et al., 2004). The PCR reaction was composed of 100 ng pBL334, 
25 µl Phusion HF 2x Mastermix, 0.64 µl of each 5 µM oligonucleotide, 3% DMSO and 
water to 50 µl. The PCR was performed as follows: 98°C 30 sec, 98°C 10 sec, 62°C 30 
sec, 72°C 1 min 10 sec (to step 2 x 34 times), 72°C 10 min. Correct PCR product length 
was verified by agarose gel and subsequently 10 µl of cassette were transformed in yBL7 
and plated on YPD + NAT plates, which were grown at 30°C for 3 days. Grown colonies 
were restreaked on YPD + NAT to exclude false positives, and those which could re-grow 
were verified for correct integration by PCR on genomic DNA, which was extracted with 
Puregene Yeast/Bact. Kit B. The PCR to verify correct construct integration and for 
subsequent sequencing was performed with the oligonucleotides oLP3 and oBL29, and 
was composed of 200 ng genomic DNA, 5 µl of each 2.5 µM oligonucleotide, 12.5 µl 
Phusion HF 2X Mastermix and water to 25 µl. The PCR was performed as follows: 98°C 
30 sec, 98°C 10 sec, 65°C 30 sec, 72°C 1 min (to step 2 x 34 times), 72°C 5 min. Correct 
PCR product length was verified by agarose gel and sequencing was performed on the 
PCR product purified with QIAquick PCR Purification Kit, using oLP3 and oBL29. 
Expression of the tagged protein was confirmed by western blot. 
 
2.2.4.3 Generation of S- and G2-RNH1-TAP alleles 
The S- and G2-RNH1-TAP alleles were created by amplifying the S cassette (containing 
the CLB6 promoter, the first 585 bp of CLB6 and the NAT resistance cassette) from the 
plasmid pBL491 with the oligonucleotides oAL47 and oAL48, or the G2 cassette 
(containing the CLB2 promoter, the first 540 bp of CLB2 and the NAT resistance cassette) 
from the plasmid pBL492 with the oligonucleotides oAL47 and oAL49. The PCR reactions 
were composed of 100 ng plasmid DNA, 0.64 µl of each 5 µM oligonucleotide, 25 µl 
Phusion HF 2x Mastermix and water to 50 µl. The PCRs were performed as in (Janke et 
al., 2004): 97°C 3 min, 97°C 1 min, 54°C 30 sec, 72°C 2 min 40 sec (to step 2 x 10 times), 
97°C 1 min, 54°C 30 sec, 72°C 2 min 40 sec (to step 5 x 20 times, extending the elongation 
time of 20 sec per cycle). Correct cassette lengths were verified by agarose gel, and 
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ySLG252 was transformed independently with 7.5 µl of each cassette, and plated on YPD 
+ NAT plates, which were grown at 30°C for 3 days. Grown colonies were restreaked on 
YPD + NAT to exclude false positives, and those which could re-grow were verified for 
correct integration by PCR on genomic DNA, with the oligonucleotide pairs oAL53 + 
oAL54 and oAL53 + oBL29. The PCR reactions were composed of: 2 µl of cells (boiled 
10 min in 0.02 N NaOH), 2 µl of each 5 µM oligonucleotide, 10 µl Taq 2x Mastermix and 
water to 20 µl. The PCRs were performed as follows: 98°C 3 min, 98°C 10 sec, 52°C 30 
sec, 68°C 4 min (to step 2 x 34 times), 68°C 5 min. Correct product lengths were verified 
on an agarose gel, and correct expression of RNH1 in the desired cell cycle phases was 
assayed by western blot (Figure 15). 
 
2.2.4.4 Generation of the S-RNH202-TAP allele 
The S-RNH202-TAP allele was created by amplifying the S cassette (containing the CLB6 
promoter, the first 585 bp of CLB6 and the NAT resistance cassette) from the plasmid 
pBL491 with the oligonucleotides oAL61 and oAL62. The PCR reaction was composed of 
100 ng pBL491, 0.64 µl of each 5 µM oligonucleotide, 25 µl Phusion HF 2x Mastermix and 
water to 50 µl. The PCR program was as in (Janke et al., 2004): 97°C 3 min, 97°C 1 min, 
54°C 30 sec, 72°C 2 min 40 sec (to step 2 x 10 times), 97°C 1 min, 54°C 30 sec, 72°C 2 
min 40 sec (to step 5 x 20 times, extending the elongation time of 20 sec per cycle). 
Correct cassette length was verified by agarose gel, and yAL350 was transformed with 
10 µl cassette and plated on YPD + NAT plates, which were grown at 30°C for 3 days. 
Grown colonies were restreaked on YPD + NAT to exclude false positives, and those 
which could re-grow were verified for correct integration by PCR on genomic DNA with 
the oligonucleotide pairs yAL64 + yAL65 and yAL64 + oBL29. The PCR reactions were 
composed of: 2 µl cells (boiled 10 min in 0.02 N NaOH), 2 µl of each oligonucleotide, 10 
µl Taq 2x Mastermix and water to 20 µl. The PCRs were performed as follows: 98°C 3 
min, 98°C 10 sec, 52°C 30 sec, 68°C 4min (to step 2 x 34 times), 68°C 5 min. Correct 
product length was verified on an agarose gel, and correct expression of RNH1 in the 
desired cell cycle phase was assayed by western blot (Figure 19). 
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2.2.5 Chromatin Immunoprecipitation (ChIP) and DNA-RNA Immunoprecipitation 
(DRIP) 
Exponentially growing liquid yeast cultures (OD600 0.7-0.9) were diluted to the same OD600 
value and crosslinked for 10 min with formaldehyde (1.2% final concentration). Quenching 
was performed for 5 min with glycine (360 mM final concentration), after which cells were 
incubated for at least 5 min on ice. Cell were pelleted at 3,000 rpm for 3 min at 4˚C and 
pellets were then washed twice with 20 ml of ice-cold PBS and resuspended in 200 µl of 
ice-cold FA lysis buffer - SOD + protease inhibitor. Cells were lysed in Lysing Matrix C 
tubes via FastPrep (2 times 30 sec at 6.5M/S with 1 min on ice between runs) at 4˚C. Cell 
extracts were recovered by adding 800 µl of ice-cold FA lysis buffer + SOD + protease 
inhibitor, and after centrifugation at 13,000 rpm for 7 min at 4˚C, the pellet was 
resuspended in 1.5 ml of FA lysis buffer + SOD + protease inhibitor tablets and SDS 
(0.263% final concentration). Chromatin fragments of <500 bp length were obtained by 19 
cycles of sonication 30 s on/off at 4˚C via Biorupter Pico. After centrifugation at 13,000 
rpm for 15 min at 4˚C, the supernatant (ChIP Extract) concentration was measured by 
Bradford and was diluted to 1 mg/ml protein concentration in FA lysis buffer + SOD + 
protease inhibitor and used for immunoprecipitation. In addition, an input volume 
representing 5% of the IP volume was used as normalization control in the qPCR reaction. 
Sonication efficiency was verified by incubating 100 µl of ChIP extract overnight at 65˚C, 
followed by treatment with 7.5 µl of Proteinase K (20 mg/ml stock) for 2 hours at 37˚C, 
purification of the DNA via QIAquick PCR Purification Kit and additional treatment with 1 
µl RNase A (10 mg/ml stock) for 30 min at 37˚C. DNA fragment length was then analyzed 
by loading the samples on a 1.5% agarose gel and analyzed by ChemiDoc. 
To perform the immunoprecipitation reaction, the appropriate sepharose beads were 
washed once with ice-cold PBS, incubated for 1 hour at 4˚C in the same media 
supplemented with 5% BSA, rinsed in ice-cold PBS and finally washed with ice-cold FA 
lysis buffer + SOD. 
For TAP ChIPs, 50 µl IgG sepharose beads were used per sample. For the MYC ChIP, 
Protein A sepharose beads were used; samples were precleared for 1 hour at 4˚C with 
30 µl beads alone and then 3 µl of anti-myc antibody were added to each sample with 50 
µl fresh beads. For DRIP, Protein A sepharose beads were used; samples were 
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precleared for 1 hour at 4 ˚C with 30 µl beads alone and then 2 µl of S9.6 antibody were 
added to each sample with 50 µl fresh beads. 
Immunoprecipitation was performed overnight at 4˚C and was followed with washes at 
4˚C for 5 min each with 1 ml of the following ice-cold solutions: FA lysis buffer + SOD, FA 
lysis buffer 500, buffer III and 1X TE; centrifugation happened at 3,000 rpm for 2 min at 
4˚C. DNA bound to the beads was eluted twice in 100 µl of Elution Buffer B for 8 min at 
65˚C, following centrifugation at 13,000 rpm for 2 min. Immunoprecipitated samples and 
inputs were reverse-crosslinked with 7.5 µl of Proteinase K (10 mg/ml stock) overnight at 
65˚C. Finally, DNA was purified with QIAquick PCR Purification Kit and eluted in 50 µl 
ultrapure water. 
qPCR were performed using CFX384 Real Time PCR with SYBR-Green, and the 
annealing was set at 60˚C. All primers used are listed in Section 2.1.2. The measured Cq 
values were corrected to input values. 
For ChIPs and DRIPs performed on telomerase negative strains, PD60 was obtained by 
streaking out for single colonies telomerase negative spores taken directly from the 
dissection plates (grown 3 days at 30 ˚C), further incubated 3 days at 30˚C, and 
subsequently inoculated overnight for the experiment. 
 
2.2.6 Protein extraction and western blot 
2.2.6.1 Protein extraction and SDS-PAGE 
Liquid culture volumes corresponding to 2 OD600 units were spun down at 13,000 rpm for 
2 min, and cell pellets were resuspended in 150 µl of ice-cold Solution 1 and incubated 
for 10 min on ice. 150 µl of ice-cold Solution 2 were then added and, after a brief vortexing, 
samples were incubated for 10 min on ice. Samples were then centrifuged at 13,000 rpm 
for 2 min at 4˚C and the pellets were washed with 1 ml of ice-cold Solution 3. Samples 
were spun down again at 13,000 rpm for 2 min at 4˚C and pellets were resuspended in 
100 µl of urea buffer and incubated for 5 min at 75˚C. After a brief spin down at 8,000 rpm 
for 30 sec, typically 8-10 µl of protein samples were loaded onto pre-casted 
polyacrylamide gels, and run at 150 V with 1X SDS running buffer.  
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2.2.6.2 Western Blot 
Gels were blotted onto nitrocellulose membranes using the TurboBlot system selecting 
the “High Molecular Weight” program after being wetted in 1X Transfer buffer. After having 
assessed the efficiency of transfer by Ponceau staining, the membranes were blocked 
with Blocking buffer shaking for 1 h at room temperature. The membranes were then 
incubated overnight at 4˚C with the primary antibody at the appropriate dilution in Blocking 
buffer (see Section 2.1.8). After washing three times the membranes with PBS-Tween, 
blots were incubated for 1 h with the secondary antibody in Blocking buffer at room 
temperature (see Section 2.1.9). Membranes were then washed four times in PBS-Tween 
and treated with ECL, and the signal was detected using the ChemiDoc. 
 
2.2.7 Spotting assay 
Cells from overnight cultures in the appropriate media were diluted to 0.5 OD600 and 
spotted on appropriate agar plates in ten-fold dilutions. The plates were then incubated at 
30˚C for the indicated times, and subsequently imaged with the ChemiDoc. 
 
2.2.8 Co-immunoprecipitation (Co-IP) 
Liquid cultures were grown overnight in selective media containing raffinose at 30°C, and 
diluted in the morning in 100 ml selective media containing galactose to induce 
overexpression of the plasmids. Liquid cultures were then grown to OD600 0.8-1 at 30°C 
in untreated conditions, arrested in α-factor or treated with the indicated concentrations of 
HU (see Section 2.2.8.1) when cells were pelleted at 13,000 rpm for 3 min. Pellets were 
then resuspended in 200 µl of ice-cold IP buffer and cells were lysed using Lysing Matrix 
C tubes via FastPrep (2 times 30 sec at 6.5M/S with 1 min on ice between runs) at 4°C. 
Samples were recovered by adding 800 µl of ice-cold IP buffer + NP40, and were then 
centrifuged twice at 13,000 rpm for 5 min at 4°C, always recovering the supernatant. After 
protein concentration measurement by Bradford assay, 2 mg of proteins in 1 ml final 
volume of ice-cold IP buffer + NP40 were added to 25 µl prewashed Pierce anti-HA 
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magnetic beads (two washes with 1 ml IP buffer + NP40). 4 μl of DNase I were added to 
each sample and the IP occurred for 2 h at room temperature; the sample Rif2-9myc 
Rnh201-HA in Figure 6B was additionally treated with 2 μl of RNase A (10 mg/ml stock) 
for 30 min at room temperature prior to the IP. In addition, 2.5% of the IP volume was 
resuspended in urea buffer in 15 µl final volume and served as input. IPs were washed 4 
times for 5 min each with ice-cold IP buffer + NP40. After removal of the buffer, beads 
were resuspended in 50 µl urea buffer and vortexed gently. Finally, input and IPs were 
incubated for 7 min 30 sec at 95°C, and 15 µl of each sample were loaded onto a pre-
casted polyacrylamide gels, following western blot as in Section 2.2.6.2. All Co-IPs were 
performed with IP buffer and IP buffer + NP40 containing 150 mM NaCl, excluding the 
one shown in Figure 7B in which IP buffer and IP buffer + NP40 contained 300 mM NaCl. 
 
2.2.8.1 Cell cycle arrest in G1 and S phases for Co-IP 
For the experiment shown in Figure 7, liquid cultures of the indicated genotypes of mating 
type a were grown overnight in SC -HIS medium containing raffinose at 30°C, and diluted 
in the morning in SC -HIS medium containing galactose to induce overexpression of the 
plasmids at 30°C. A faction of the exponential liquid cultures was incubated until OD600 
0.8-1 was reached, following collection of exponential samples for Co-IP and FACS, while 
the rest was treated with 3 µg/ml of α-factor when it reached OD600 0.2-0.4, and incubated 
further for 2 h 30 min at 30˚C. After checking efficient G1 arrest at the light microscope, 
part of the culture was collected for Co-IP and FACS analysis (α-factor sample), while the 
rest was spun down and washed three times with pre-warmed water (30˚C), and then 
finally resuspended in fresh pre-warmed SC -HIS medium containing galactose (30˚C) 
and either 250 mM or 75 mM hydroxyurea (HU), and cultures were further grown for 2 h 
30 min at 30˚C. S phase arrest efficiency was verified at the light microscope by presence 
of large-budded cells, and samples were spun down for FACS and Co-IP (HU samples). 
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2.2.9 FACS for DNA content 
0.18 OD600 units of cells were spun down at 13,000 rpm for 2 min and washed with 1 ml 
of ultrapure water, and subsequently resuspended in 70% ethanol and fixed overnight at 
4˚C. After spinning out the ethanol at 13,000 rpm for 5 min, cells were washed with 
ultrapure water and resuspended in 500 µl of 50 mM Tris-Cl pH 7.5. 10 µl of RNase A (10 
mg/ml stock) were added to each sample, and samples were incubated for 3 h at 37˚C. 
Subsequently, 25 µl of Proteinase K (20 mg/ml stock) were added to each sample and 
they were further incubated for 1 h at 50˚C. After spinning down the cells at 13,000 rpm 
for 5 min, they were resuspended in 500 µl of 50 mM Tris-Cl pH 7.5 and sonicated 
manually for 10 sec at 4˚C. Samples were then transferred to FACS tubes and 500 µl of 
1x Sytox Green (1 µM final) in 50 mM Tris-Cl pH 7.5 were added. Each sample was 
vortexed immediately before analysis with BD FACSVerse. 
 
2.2.10 Microscopy detection of TERRA and Rap1 foci 
Liquid cultures of the interested genotypes were grown overnight at 30˚C in SC -LEU -TRP 
medium containing raffinose and diluted in the morning to OD600 0.1 into SC -LEU -TRP 
medium containing galactose to induce RNH1 overexpression. 0.06 OD600 units of 
exponentially growing yeast cells at 30˚C were spun down at 13,000 rpm for 2 min, 
resuspended in 200 µl of fresh SC -LEU -TRP medium containing galactose and 
transferred to microscopy chambers coated with concanavalin A (200 µl of concanavalin 
A (stock 2 mg/ml) were incubated in each chamber for 15 min, and then removed). 
Detection of TERRA and Rap1 foci was performed at 30˚C with Leica AF7000 widefield 
fluorescence microscope using a 63x NA/1.4 oil immersion objective, and images were 
taken with Hamamatsu CCD Camera ORCA-R2 and analyzed with Image J. Only TERRA 
foci overlapping or adjacent to Rap1 signal were counted and matched with the total of 
cells analyzed. 
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2.2.11 Southern blot for telomere length measurement 
2.2.11.1 Yeast genomic DNA extraction 
50 ml of exponentially growing cultures (OD600 0.7-0.9) were spun down at 3,000 rpm for 
3 min and resuspended in 1 ml of a 0.9 M sorbitol + 0.1 M EDTA pH 8 solution. Cells were 
then pelleted by centrifugation at 13,000 rpm for 1 min and resuspended in 0.4 ml of the 
same solution supplemented with 14.3 mM β-mercaptoethanol, and the cell wall was 
digested by incubation for 45 min at 37˚C after addition of 20 µl of 100T zymolyase (2.5 
mg/ml stock) to the samples. Spheroplasts were recovered by centrifugation at 14,000 
rpm for 30 sec and were resuspended in 400 µl of 1X TE. 90 µl of a solution containing 
0.5 ml 0.5 M EDTA pH 8, 0.2 ml 1M Tris-base and 0.2 ml 10% SDS were added and 
samples were incubated for 30 min at 65˚C, after which 80 µl of 5 M potassium acetate 
were added and samples were kept on ice for at least 1 hour. Cell residues were 
eliminated by centrifugation at 14,000 rpm for 15 min at 4˚C and the DNA was precipitated 
by mixing the supernatant with 600 µl ice-cold ethanol. DNA was pelleted at 14,000 rpm 
at 4˚C and, after air drying, was resuspended in 500 µl of 1X TE. Samples were further 
incubated for 30 min at 37˚C with 1.5 µl RNase A (10 mg/ml stock) and DNA was 
precipitated by adding 500 µl of isopropanol. After pelleting the DNA at 14,000 rpm for 30 
min, it was washed with 70% ethanol and finally resuspended in 50 µl of 1X TE. 
 
2.2.11.2 Southern blot 
5 µg of DNA were digested for 5 hours at 37˚C with XhoI (1 µl XhoI and 2.5 µl CutSmart 
buffer, in 25 µl total volume of reaction), and subsequently loaded on a 0.8% agarose gel 
which was run overnight at 50 V. The DNA in the gel was then denatured for 1 hour in 1 l 
denaturing solution and then neutralized for 1 hour with 1 l neutralizing solution. The DNA 
was subsequently transferred to a neutral nylon membrane (GE HybondNX) via capillary 
transfer in 10X SSC overnight. After rinsing the membrane in water and letting it dry, the 
DNA was crosslinked to the membrane with UV light, selecting the “auto X-link” program 
on the Stratalinker. The membrane was then pre-hybridized with 25 ml Church buffer for 
5 hours at 55˚C. Hybridization took place overnight at 55˚C with a telomere-specific probe, 
which was generated by random primed radioactive labelling with dATP [α-32P] of a DNA 
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fragment obtained by EcoRI digestion of pBL423 followed by gel extraction. The 
membrane was washed in pre-warmed (55°C) washing solution for 1 hour and again for 
30 min and then was air dried. A radio-sensitive film (Fujifilm) was then exposed to the 
membrane for 3 days and the signal was detected via Typhoon FLA 9500. 
 
2.2.12 Senescence curve 
Freshly dissected telomerase negative spores, which had grown for 3 days at 30˚C after 
dissection, were inoculated to 0.01 (in YPD medium) or 0.02 OD600 (in SC medium) in 5 
ml of appropriate media and incubated for 24 h at 30˚C. The OD600 of the cultures was 
then measured and each of the cultures was re-diluted to the starting OD600 in 5 ml of new 
media. This process was repeated every 24 h until cultures re-gained the initial viability. 
Viability was measured by setting the starting culture OD600 to 100% and comparing each 
daily measurement to the initial one, for each sample. 4-6 biological replicates were 
performed for each genotype. Population doublings for each genotype were calculated as 
log2(OD600/0.01) or log2(OD600/0.02) were OD600 is the average value measured every 24 
h for each genotype. 
For the senescence curve shown in Figure 14, the strain yVK1290 was transformed with 
either pBL97 or pBL399, following dissection on selective plates, after which the 
senescence curve was started. Differently, for the senescence curve shown in Figure 13B, 
haploid est2 strains covered with a wild type copy of the EST2 gene on a URA plasmid 
(pBL354) were streaked out for single colonies on SD -HIS + 5-FOA plates to counter 
select for the pBL354 plasmid. Plates were incubated for 3 days at 30˚C and then single 
clones which lost pBL354 plasmid were inoculated for the senescence curve. 
 
2.2.13 Cell cycle arrest in G1 and release 
Exponentially growing liquid yeast cultures (OD600 0.2-0.4) of mating type a in YPD 
medium at 30˚C were treated with 4 µg/ml of α-factor and incubated further for 2 h 15 min 
at 30˚C. After checking efficient G1 arrest at the light microscope, cells were spun down 
 Materials and Methods 
68 
at 3,000 rpm for 3 min and washed three times with pre-warmed water (25˚C), and finally 
resuspended in new pre-warmed YPD medium (25˚C) and further grown at 25˚C in a water 
bath. Protein and FACS samples were collected every 15 min. 
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3. Results 
3.1 RNase H2 localizes to telomeres in a Rif2-dependent manner 
Both RNase H1 and H2 enzymes regulate R-loops at yeast telomeres (Balk et al., 2013; 
Pfeiffer et al., 2013). So far, only studies on the deletion or overexpression of these 
proteins have been performed to study their role in telomere biology. To investigate how 
the endogenous proteins are regulated relative to their telomeric role, we decided to 
approach the question by testing whether these proteins localize to telomeres. We 
performed a Chromatin Immunoprecipitation (ChIP) assay followed by quantitative PCR 
(qPCR) pulling down endogenously TAP-tagged Rnh1 (Rnh1-TAP) or TAP-tagged 
Rnh201 (Rnh201-TAP), the catalytic subunit of the RNase H2 complex. While telomeric 
sequences were not enriched by qPCR following Rnh1-TAP immunoprecipitation 
compared to untagged wild type cells (Figure 5A), we found that they were significantly 
enriched over background after Rnh201-TAP immunoprecipitation (Figure 5B), 
suggesting that RNase H2 localizes to telomeres. 
The telomeric protein Rif2 interacts with Rnh201, as it was reported by a large-scale two-
hybrid screen (Jeong et al., 2004). Besides its unique roles, Rif2 also shares some 
redundant functions with Rif1, as described in Section 1. Based on these data, we asked 
whether RNase H2 localization to telomeres is dependent on the presence of either of the 
two Rif proteins. While RIF1 deletion had no effect on Rnh201-TAP localization to 
telomeres as seen by ChIP-qPCR, deletion of RIF2 completely abrogated Rnh201-TAP 
binding to telomeres (Figure 5B). As a control, we excluded, by western blot analysis, that 
deletion of either RIF1 or RIF2 affects Rnh201-TAP protein levels (Figure 5C). We also 
confirmed by spotting assay that endogenously expressed TAP-tagged Rnh1 and Rnh201 
were functional. As a readout, we took advantage of the sensitivity of the double mutant 
rnh1 rnh201 to the genotoxic agent methyl methanesulfonate (MMS)(Lazzaro et al., 
2012). As expected, we observed high sensitivity of the rnh1 rnh201 mutant to the drug, 
while mutants bearing the combinations of RNH1-TAP rnh201 or rnh1 RNH201-TAP grew 
at wild type levels (Figure 5D), indicating that the tagged alleles are functional. Taken 
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together, these results show that RNase H2, but not RNase H1, localizes to telomeres in 
a Rif2-dependent manner. 
 
Figure 5. Rif2 recruits RNase H2 to telomeres. 
(A) RNase H1 does not localize to telomeres in wild type cells. Exponentially growing cultures of the indicated genotypes 
were crosslinked and subjected to ChIP using IgG coupled beads. Chromatin associated to Rnh1-TAP was analyzed 
by qRT-PCR. Values are presented as % input of DNA recovered relative to wild type, which is set to 1 for each primer 
set. Data are shown as mean + SEM; n=3. (B) Rnh201 is recruited to telomeres by Rif2. Exponentially growing cultures 
of the indicated genotypes were crosslinked and subjected to ChIP using IgG coupled beads. Chromatin associated to 
Rnh201-TAP was analyzed by qRT-PCR. Data is presented as mean % input + SEM; n=3 (wt), 6 (Rnh201-TAP; 
Rnh201-TAP rif1) and 4 (Rnh201-TAP rif2). *: p<0.05; **: p<0.01 (Student’s t-test). (C) Rnh201-TAP protein levels are 
not affected by RIF1 and RIF2 deletion. Protein extracts from cells of the indicated genotypes were analyzed by western 
blot. Rnh201-TAP was detected with PAP antibody, and Pgk1 serves as a loading control. (D) Rnh1-TAP and Rnh201-
TAP are functional. Cells of the indicated genotypes were spotted in serial dilutions onto YPD and MMS-containing YPD 
plates. Plates were imaged after 36 h of incubation at 30˚C. 
 
3.2 RNase H2 and Rif2 interact 
We then set out to confirm in a more direct and targeted way the physical interaction 
between Rnh201 and Rif2. We performed a Co-Immunoprecipitation (Co-IP) assay with 
endogenously expressed 9myc-tagged Rif2 and HA-tagged Rnh201, which was 
transiently overexpressed from a plasmid under the control of a galactose-inducible 
promoter. When HA-Rnh201 was immunoprecipitated with anti-HA antibodies, we were 
 Results 
71 
able to recover Rif2-9myc in the eluate as seen by western blot (Figure 6A). When the 
HA-immunoprecipitation was performed in cells containing RIF2-9MYC and an empty 
vector (EV), or when cells expressed HA-Rnh201 but untagged Rif2, we could not detect 
Rif2-9myc in the eluate (Figure 6A). Thus, we could confirm that Rif2 and Rnh201 can 
physically interact with each other in the conditions described. 
Rnh201 is the catalytic component of the RNase H2 trimeric complex, which additionally 
contains the proteins Rnh202 and Rnh203. We therefore asked whether the interaction 
between Rif2 and Rnh201 is mediated by the other components of the RNase H2 
complex. To test this, we performed an immunoprecipitation against transiently 
overexpressed HA-tagged Rnh201 in cells lacking either RNH202, RNH203 (Figure 6B) 
or both (Figure 6C) and bearing the RIF2-9MYC allele. In the tested settings we were 
always able to recover Rif2-9myc in the eluate, suggesting that the interaction between 
Rif2 and Rnh201 is independent of the presence of the other two components of the 
RNase H2 complex. As a control, HA-immunoprecipitations performed in cells containing 
an empty vector (EV) did not lead to Rif2-9myc recovery in the eluate (Figures 6B and C). 
Moreover, each immunoprecipitation reaction presented in this work (Figures 6, 7 and 8) 
was treated with DNase I to exclude DNA-mediated interactions, and the Co-IP of Rif2-
9myc and Rnh201-HA in Figure 6B was additionally treated with RNase A to exclude RNA-
mediated interactions.  
 
Figure 6. Rif2 interacts with RNase H2. 
(A-C) Rif2-9myc co-immunoprecipitates with RNase H2. Cell extracts derived from exponentially growing cells of the 
indicated genotypes containing either an empty vector (EV) or transiently overexpressed HA-Rnh201 (A) or Rnh201-
HA (B-C) were immunoprecipitated with anti-HA antibody coupled magnetic beads. Samples were then analyzed by 
western blot and probed with anti-HA and anti-myc antibodies. 2.5% of input protein was loaded as control. (A-C) All 
samples were treated with DNase I during immunoprecipitation and sample Rif2-9myc Rnh201-HA (B) was treated 
additionally with RNase A. 
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We were also able to co-immunoprecipitate Rif2-9myc with overexpressed HA-tagged 
Rnh202 and Rnh203 (data not shown), indicating that the entire RNase H2 complex is 
able to interact with Rif2. 
We next wondered whether the interaction between Rif2 and Rnh201 is regulated 
throughout the cell cycle. To assess this, we arrested Rif2-9myc tagged cells 
overexpressing HA-RNH201 in G1 with α-factor, and subsequently released them into 
media containing either 250 mM or 75 mM hydroxyurea (HU), thereby halting the cultures 
in early and late S phase, respectively (Figure 7A)(Graf et al., 2017). Interestingly, even 
though HA-Rnh201 was expressed from a GAL-inducible promoter, we observed a drop 
of its levels in G1 and an increase towards the end of S phase (Figure 7B); nonetheless, 
we were able to immunoprecipitate similar amounts of the protein in all cell cycle phases 
using antibodies against HA. We observed interaction between Rif2 and Rnh201 through 
all the tested phases, but while interaction was clearly lowest in G1 and early S, the 
highest amount of Rif2-9myc was recovered when the Co-IP was performed in late S 
phase-arrested cells (Figure 7B).  
 
Figure 7. Rif2-Rnh201 interaction is strongest in late S phase. 
(A) Efficient synchronization of cultures in G1 and early/late S phase. Exponentially growing cultures of the indicated 
strains were arrested in G1 with α-factor and subsequently released at 30˚C in media containing either 250 mM or 75 
mM HU for 2 h 30 min, when samples for FACS and Co-IP were collected. (B) Rif2-Rnh201 interaction varies in the cell 
cycle. Cell extracts deriving from cells of the indicated genotypes in different cell cycle stages (A) and containing either 
an empty vector (EV) or transiently overexpressing HA-Rnh201 were immunoprecipitated with anti-HA antibody coupled 
magnetic beads. Samples were then analyzed by western blot and probed with anti-HA and anti-myc antibodies. 2.5% 
of input protein was loaded as control. (A-B) All samples were treated with DNase I during immunoprecipitation. 
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This result is consistent with the finding that Rnh201 binding to telomeres is highest in late 
S phase (Graf et al., 2017), and suggests that the increased interaction between Rif2 and 
Rnh201 in late S phase is reflected in increased recruitment of RNase H2 to telomeres. 
We then decided to test whether Rif2 also interacts with RNase H1, and furthermore if 
Rif1 is capable of interacting with RNase H enzymes as well. To do this, we transiently 
overexpressed either RNH1-HA or HA-RNH201 from plasmids in cells in which Rif1 or 
Rif2 were 9myc-tagged (Figure 8A). We observed that in all tested conditions, HA-
immunoprecipitation led to recovery of Rif1 and Rif2 in the eluate, indicating that both Rif2 
and Rif1 are able to interact with RNase H1 and RNase H2. As a control, we tested for 
presence of Rap1, an interactor of both Rif1 and Rif2 in the immunoprecipitate. We were 
not able to detect Rap1 in the eluate following Rnh1-HA and HA-Rnh201 
immunoprecipitations (Figure 8B), indicating specificity of the interactions of RNases H 
with Rif1 and Rif2. Although both RNase H enzymes can interact physically with both Rif1 
and Rif2 (Figure 8A), it seems that only RNase H2 can be found at telomeres by ChIP 
(Figures 5A and B). Perhaps there is a competition between the two enzymes that we 
were unable to detect in these conditions (see below for more on this). 
 
 
Figure 8. Rif1 and Rif2 interact with RNase H1 and H2. 
(A-B) Rif1 and Rif2 co-immunoprecipitate with Rnh1 and Rnh201. Cell extracts deriving from exponentially growing 
cells of the indicated genotypes containing either an empty vector (EV) or transiently overexpressing HA-RNH201 or 
RNH1-HA were immunoprecipitated with anti-HA antibody coupled magnetic beads. Samples were then analyzed by 
western blot and probed with anti-HA and anti-myc antibodies. In addition, samples in (B) were also probed with anti-
Rap1 antibodies. 2.5% of input protein was loaded as control. (A-B) All samples were treated with DNase I during 
immunoprecipitation. 
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3.3 Rif2 regulates telomeric R-loops 
RNase H enzymes can catalyze the nucleolytic degradation of RNA molecules that are 
hybridized to DNA (RNA-DNA hybrids or R-loops; reviewed in (Cerritelli and Crouch, 
2009)). Several studies in recent years have identified the presence of R-loops at 
telomeres in diverse organisms, including budding yeast (Arora et al., 2014; Balk et al., 
2013; Pfeiffer et al., 2013; Wahba et al., 2016; Yu et al., 2014). Given the interaction 
between Rif2 and RNase H2, as well as the Rif2-mediated association of RNase H2 to 
telomeres, we speculated that the Rif2-RNase H2 axis might impact R-loop levels at 
telomeres. 
To assess this, we utilized the S9.6 antibody, which selectively binds RNA-DNA hybrids 
of at least 6-8 bp (Phillips et al., 2013), to perform a DNA-RNA Immunoprecipitation 
(DRIP) experiment followed by qPCR. When we performed the DRIP in wild type and Rif2 
depleted cells, we could observe that rif2 mutants displayed an approximate 1.5-2 fold 
increase of R-loops at telomeres compared to wild type cells (Figure 9A), consistent with 
the loss of Rnh201 from telomeres in this mutant (Figure 5B). Furthermore, constitutive in 
vivo overexpression of RNH1 from a plasmid reduced the telomeric R-loop signal in rif2 
mutants to wild type levels, while not significantly affecting the wild type telomeric R-loop 
levels. As a positive control, we measured R-loops at the 18S rDNA locus, which is highly 
prone to forming R-loops (El Hage et al., 2010). RIF2 deletion had no effect on R-loops at 
rDNA, suggesting that Rif2 regulates RNA-DNA hybrids specifically at telomeres. 
Altogether, these results suggest that the Rif2-mediated Rnh201 localization to telomeres 
is functional in restricting R-loops, and that the R-loops that accumulate at telomeres in 
rif2 mutants are sensitive to RNH1 overexpression. The latter result also further confirms 
that the telomeric DRIP signal that accumulates in rif2 mutants stems from RNA-DNA 
hybrids, and furthermore indicates that Rnh1 can act at telomeres even though we could 
not detect it by ChIP (Figure 5A). 
rif2 mutants, as well as rif1 mutants, display elongated telomeres (Wotton and Shore, 
1997). To control for possible effects of telomere length on the DRIP results, we made 
use of auxin-inducible degron (AID) alleles of these proteins. This system allows rapid 
degradation of the targeted proteins upon addition of auxin (indole-3-acetic acid, IAA) to 
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the growth media (Morawska and Ulrich, 2013)(Figure 9B). We performed DRIP 
experiments in RIF1AID, RIF2AID and RIF2AID RIF1AID in presence or absence of IAA 
treatment, in order to analyze the effect of the depletion of these proteins on R-loops 
without affecting telomere length. We could confirm that, also in these conditions, 
depletion of Rif2 leads to the accumulation of R-loops at telomeres, but not at the rDNA 
locus (Figure 9C); furthermore, depletion of Rif1 had no effect on telomeric R-loop levels 
and did not contribute to the R-loop accumulation in RIF2AID RIF1AID cells. This result 
confirms previous findings and suggests that Rif1 is not a regulator of R-loops at wild type 
telomeres. 
RNase H2 has a genome-wide role in promoting genome stability (Lazzaro et al., 2012; 
O'Connell et al., 2015), so we decided to investigate whether the Rif2 interaction with 
Rnh201 has implications on the genome-wide role of RNase H2. To test this, we again 
took advantage of the high sensitivity of the rnh1 rnh201 mutant to MMS, as a readout. 
We performed a spotting assay to test sensitivity to MMS of several mutants. As seen 
previously (Figure 5D), rnh1 rnh201 mutants are highly sensitive to MMS, while the double 
mutant rif2 rnh1 grew at wild type levels (Figure 9D), indicating that Rif2 is not required 
for RNase H2 function in response to genome-wide MMS-induced genotoxic stress. 
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Figure 9. Rif2 restricts telomeric R-loops. 
(A) rif2 mutants accumulate telomeric R-loops. Exponentially growing cultures of the indicated genotypes containing 
either an empty vector (-) or overexpressed RNH1 (+) were crosslinked and subjected to DRIP using the S9.6 antibody. 
R-loop associated chromatin was further analyzed by qRT-PCR. Values are presented as % input of DNA recovered 
relative to wild type, which is set to 1 for each primer set. Data are shown as mean + SEM; n=3. *: p<0.05; **: p<0.01 
(Student’s t-test). (B) IAA-inducible degradation of Rif1 and Rif2. Cells of the indicated genotypes were collected before 
and after 1 h treatment with 500 µM IAA. Protein extracts were analyzed by western blot. Rif1 and Rif2 were detected 
with anti-myc antibodies, and Pgk1 serves as a loading control. (C) RIF2AID mutants accumulate R-loops in the presence 
of IAA. Cultures of the indicated genotypes were grown to exponential phase and half of each culture was treated with 
500 µM IAA for 3 h, after which cultures were crosslinked and subjected to DRIP using the S9.6 antibody. R-loop 
associated chromatin was analyzed by qRT-PCR. Values are plotted as % input of DNA recovered relative to the 
correspondent uninduced control, which is set to 1 for each primer set. Data are shown as mean + SEM; n=4. *: p<0.05; 
**: p<0.01 (Student’s t-test). (D) Rif2 does not contribute to Rnh201 genome-wide function. Cells of the indicated 
genotypes were spotted in serial dilutions onto YPD and MMS-containing YPD plates. The YPD plate was imaged after 
48 h of incubation at 30˚C and the MMS plate was further incubated 48 h at room temperature before being imaged. 
Experiments presented in (B-C) were performed by Diego Bonetti. 
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3.4 Rif2 regulates TERRA-telomere R-loops 
The long non-coding RNA TERRA has been proposed to form R-loops at telomeres 
because of its G-rich composition and because of it was found to colocalize with telomeres 
in microscopy experiments (Arora et al., 2014; Azzalin et al., 2007; Balk et al., 2013; Luke 
et al., 2008; Pfeiffer et al., 2013). However, so far there has not been a direct observation 
of this phenomenon in budding yeast. Having identified a mutant that accumulates R-
loops specifically at telomeres (rif2) coupled to the availability of a system that allows the 
visualization of TERRA molecules by microscopy (Cusanelli et al., 2013), we could 
approach the question of whether TERRA is the RNA counterpart of R-loops at telomeres 
and whether TERRA-telomere R-loops are restricted by Rif2. 
In this microscopy approach, telomere 6R (on the right arm of chromosome 6) is modified 
to harbor two MS2 cassettes 80 bp upstream of the telomeric repeats that, when 
transcribed, form hairpin structures in the product RNA (Figure 10A). These RNA 
structures are recognized by the MS2 phage protein, which is expressed as a GFP-fusion 
protein from a plasmid to allow its visualization by fluorescent microscopy. In addition, the 
transcription regulator and telomeric factor Rap1 was endogenously tagged with mCherry. 
This set of constructs allows the simultaneous visualization of TERRA molecules as MS2-
GFP foci, and of the nuclear space and telomeres by Rap1-mCherry. We analyzed the 
amount of cells containing one or more TERRA-MS2-GFP foci colocalizing with Rap1-
mCherry in a wild type background and in rif2 mutants. As previously observed (Cusanelli 
et al., 2013), rif2 mutants display a two-fold increased amount of TERRA foci-positive cells 
compared to wild type (Figures 10B and C). To investigate the nature of these TERRA 
foci, we overexpressed RNH1 in vivo from a plasmid in the same backgrounds. Strikingly, 
we observed a significant reduction in the number of cells with TERRA foci following RNH1 
overexpression in rif2 cells to almost wild type levels. RNH1 overexpression had a 
minimal, although significant, effect on wild type TERRA foci. This result hints at TERRA 
forming R-loops at telomeres, as its signal can be reduced by RNH1 overexpression; 
furthermore, it confirms that Rif2 regulates TERRA-telomere R-loop levels. 
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Figure 10. RIF2 restricts TERRA-telomere R-loops. 
(A) Scheme of the microscopy approach used to detect TERRA nuclear foci. Telomere 6R is modified to contain two 
MS2 sequences, which form hairpin structures in 6R-transcribed TERRA molecules. MS2 expressed from a plasmid is 
fused to GFP, and endogenous Rap1 is fused to mCherry. Blue arrowheads indicate telomeric repeats and the black 
arrow indicates approximate TERRA transcription start site. (B-C) rif2 mutants display increased amounts of nuclear 
6R-TERRA foci. (B) Live-cell analysis of Tel6R-TERRA-MS2-GFP foci and Rap1-mCherry. Representative images are 
shown of cells of the indicated genotypes containing either an empty vector (EV) or overexpressing RNH1. Scale bar: 
5 µm. (C) Quantification of the percent of cells containing a Tel6R-TERRA-MS2-GFP focus adjacent or overlapping with 
Rap1-mCherry signal. Data are shown as mean + SEM of two independent experiments in which more than 300 cells 
were counted. *: p<0.05; **: p<0.01 (ratio-paired Student’s t-test). 
 
3.5 Rif2 and RNase H2 are lost from short telomeres 
It has been previously observed that Rif2 binds to telomeres in a length-dependent 
manner, i.e. as telomeres shorten, less Rif2 can be found associated with them (McGee 
et al., 2010; Sabourin et al., 2007), while Rif1 binding is not affected. The model that was 
put forward is that Rif2 binds more towards the distal tip of the telomere, while Rif1 
associates with the centromere-oriented part of the telomere, providing a basis for the 
polar loss of Rif2 from short telomeres. 
When considering our above described results, we hypothesized that this Rif2 behavior 
might be mirrored by Rnh201. To test this, we freshly dissected a diploid strain in which 
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one copy of the telomerase RNA moiety, TLC1, was deleted, and harbored tagged 
versions of Rif2 and Rnh201, with 9myc-tag and TAP-tag respectively. This allowed us to 
generate telomerase negative spores of nearly wild type telomere length, as telomerase 
was expressed in the diploid strain. At the same time this strategy allows continued and 
controlled telomere shortening by subsequent streak outs of the spores, as verified by 
Southern blotting (Figure 11A). Importantly, Southern blot analysis of telomere length also 
confirmed that protein tags did not affect Rif2 and Rnh201 protein functions in respect to 
telomere length maintenance, as cells containing Rif2-9myc and Rnh201-TAP had 
telomeres of wild type length, while both rif2 and rnh201 mutants are known to display 
lengthened telomeres (Luke et al., 2008; Wotton and Shore, 1997). 
As previously reported, we observed by ChIP-qPCR a decrease in Rif2-9myc binding to 
telomeres when cells were propagated for 60 population doublings (PD60) after 
telomerase loss, corresponding to short telomeres (Figure 11A and B); we also observed 
decreased Rnh201-TAP binding to telomeres at PD60 (Figure 11C). This suggests that 
decreased Rif2 binding to shortened telomeres might be responsible for impaired RNase 
H2 localization at the same loci. As a control, we measured by western blot analysis 
Rif2-9myc and Rnh201-TAP protein levels at PD30 and PD60 after telomerase loss, and 
observed a slight decrease in the levels of both proteins at PD60 (Figure 11D and E), 
which might partially explain their reduced recruitment to telomeres at this stage (Figure 
11B and C). The implications of this phenomenon are consistent with the results obtained 
when examining R-loop levels at shortened telomeres. We performed a DRIP experiment 
in wild type and telomerase negative cells which had been propagated for 60 PDs: 
shortened telomeres showed an almost doubled amount of R-loops compared to 
telomeres of wild type length (Figure 11F). Taken together, these findings suggest a model 
in which Rif2 has a pivotal role in regulating telomeric R-loops in a telomere length-
dependent manner. When telomeres are of wild type length, Rif2 binding is permitted and 
in turn recruits RNase H2, thereby keeping R-loop levels to a minimum. When a telomere 
becomes critically short, Rif2 binding to that telomere is diminished, causing impaired 
RNase H2 localization, and as a consequence R-loops are not degraded and are allowed 
to accumulate.  
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Figure 11. RNase H2 binding is decreased at short telomeres. 
(A) Rif2-9myc and Rnh201-TAP are functional and progressive telomere shortening can be observed in telomerase 
negative cells. Southern blot analysis of bulk telomere length of cells of the indicated genotypes. Genomic DNA was 
digested with XhoI and hybridized with a radioactive telomeric probe. PD30 and PD60 samples were generated by 
subsequent streakouts of the indicated telomerase negative strains. (B-C) Rif2-9myc and Rnh201-TAP binding are 
decreased at short telomeres. Exponentially growing cultures of the indicated genotypes were crosslinked and assessed 
by ChIP using anti-myc antibodies (B) or IgG coupled beads (C). Chromatin associated to Rif2-9myc (B) or Rnh201-
TAP (C) was analyzed by qRT-PCR. Data is presented as mean % input + SEM; n=5. *: p<0.05; **: p<0.01; ***: p<0.001 
(Student’s t-test). (D-E) Rif2 and Rnh201 protein levels slightly decrease in pre-senescent cells. Protein extracts from 
cells of the indicated genotypes were analyzed by western blot. Rif2-9myc was detected with anti-myc antibodies and 
Rnh201-TAP was detected with PAP antibody, and Pgk1 serves as a loading control (F) R-loops accumulate at short 
telomeres. Exponentially growing cultures of the indicated genotypes were crosslinked and subjected to DRIP using the 
S9.6 antibody. R-loop associated chromatin was analyzed by qRT-PCR. Values are presented as mean % input + SEM; 
n=3. *: p<0.05 (Student’s t-test). (G) Rnh1-TAP is recruited to short telomeres. Exponentially growing cultures of the 
indicated genotypes were crosslinked and subjected to ChIP using IgG coupled beads. Chromatin associated to Rnh1-
TAP was analyzed by qRT-PCR. Values are presented as % input of DNA recovered relative to wild type, which is set 
to 1 for each primer set. Data are shown as mean + SEM; n=3. This panel was partially presented in figure 5A. *: p<0.05 
(Student’s t-test). The experiment presented in panel (A) was performed in collaboration with Diego Bonetti and the 
experiment presented in panel (F) was performed by Marco Graf. 
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Rnh1 contains a hybrid binding domain (HBD; reviewed in (Cerritelli and Crouch, 2009)) 
which we reasoned could lead to Rnh1 recruitment to the R-loop accumulating short 
telomeres. We therefore performed a ChIP for TAP-tagged Rnh1 in tlc1 cells propagated 
for 60 PDs. We could observe a small but consistent enrichment of telomeric sequences 
compared to untagged wild type cells (Figure 11G), indicating that Rnh1 might specifically 
localize to critically shortened telomeres. 
Telomeric R-loops can delay senescence onset by promoting homologous recombination 
(HR) events between telomeres, thereby partially compensating for telomere shortening 
(Balk et al., 2013). In line with this, mutants that accumulate telomeric R-loops (as RNase 
H mutants) display a delayed senescence onset, while cells that have decreased R-loop 
levels (overexpression of RNH1) senesce fast (Balk et al., 2013). On the other hand, 
telomerase mutants lacking Rif2 senesce fast perhaps due to the capping defect of this 
mutant, which causes an increased access of the DSB repair complex MRX to the 
telomeres (Bonetti et al., 2010; Chang et al., 2011). Based on these observations, we 
asked what would be the effect of overexpressing RNH1 in telomerase deficient rif2 
mutants, thereby degrading the telomeric R-loops that accumulate in this mutant (Figure 
9A).  
We performed a senescence curve in tlc1 and tlc1 rif2 mutants containing either an empty 
vector or overexpressing RNH1. As seen before (Balk et al., 2013), RNH1 overexpression 
led to faster senescence of tlc1 cells compared to tlc1 cells containing the empty vector 
(Figure 12). We also observed that tlc1 rif2 mutants bearing the empty vector senesced 
fast, as expected, but interestingly RNH1 overexpression in these already impaired cells 
led to further exacerbation of their accelerated senescence rate. This result suggests that 
although telomerase negative rif2 mutants display a fast senescence phenotype, the R-
loops that accumulate at the telomeres of this mutant still have a protective role in avoiding 
premature senescence onset, in a similar manner to loss of RNase H function. 
 
 
 
 
 
 Results 
82 
 
Figure 12. R-loops delay senescence in rif2 mutants.  
Senescence assay performed in selective media (SC -URA) on freshly dissected spores of the indicated genotypes, 
containing an empty vector (EV) or overexpressing RNH1 constitutively from a plasmid. Cell viability was estimated 
daily by measuring cell culture density. Data are shown as mean ± SEM; n=5 for all genotypes but tlc1 rif2 + RNH1 n=4. 
 
3.6 RNase H1 and RNase H2 play different roles at telomeres 
The initial observation that, while deletion of RNH1 or RNH201 has no effect on telomeric 
R-loop levels, deletion of both enzymes leads to a two-fold increase in R-loops, led to the 
conclusion that RNase H enzymes may play redundant roles at yeast telomeres (Balk et 
al., 2013). Nonetheless, in the work presented here we have shown that RNase H2 plays 
a critical role in controlling R-loops at telomeres in a telomere-length dependent manner, 
suggesting that the two enzymes might play non-overlapping roles at telomeres. Based 
on these new findings, we asked whether the single deletions of RNH1 or RNH201 would 
have an effect on senescence rates. 
We performed a senescence curve to compare senescence rates of est2 (telomerase 
negative), est2 rnh1, est2 rnh201 and est2 rnh1 rnh201 mutants (Figure 13A). 
Interestingly, est2 rnh201 cells senesce extremely slow compared to est2 mutants, 
indicating that RNH201 deletion can delay senescence onset dramatically, even when a 
wild type copy of RNH1 is present. This phenotype is consistent with accumulation of HR-
promoting R-loops at the telomeres of this mutant. On the other hand, est2 rnh1 cells 
showed a fast senescence phenotype compared to est2 cells, an unexpected result, and 
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opposite to that of rnh201. Additionally, we also observed that deletion of RNH1 
anticipated the senescence onset in est2 rnh201 mutants, again supporting a negative 
effect of RNH1 deletion on senescence kinetics.  
These observations are even more peculiar when considering the effect of RNH1 
overexpression on senescence. As observed before (Figure 12)(Balk et al., 2013), RNH1 
overexpression leads to early senescence onset, and this effect is dosage dependent 
(Figure 13B): when RNH1 is expressed from a multicopy plasmid (2µ RNH1, 50-100 
copies per genome) the increase in senescence rate of a tlc1 mutant is stronger than 
when RNH1 is overexpressed from a single-copy centromeric plasmid (CEN RNH1). In 
conclusion, both RNH1 deletion and overexpression accelerate senescence rates, and 
importantly RNase H1 and RNase H2 seem to play unique, and not redundant, roles at 
telomeres. 
 
 
Figure 13. RNase H1 and RNase H2 affect differently senescence onset. 
(A) Deletion of RNH1 and RNH201 have opposite effects on senescence rates. Senescence assay performed on freshly 
dissected spores of the indicated genotypes. Cell viability was estimated daily by measuring cell culture density. Data 
are shown as mean ± SEM; n=6 for all genotypes. (B) RNH1 overexpression has a dosage-dependent effect on 
senescence rates. Senescence assay performed in selective media (SC –HIS) on est2 cells containing either an empty 
vector (2µ EV), RNH1 overexpressed from a single copy plasmid (CEN RNH1) or from a multicopy plasmid (2µ RNH1). 
Telomerase negative cells covered with a URA plasmid expressing telomerase were selected for plasmid loss on 5-
FOA –HIS plates and then inoculated and assayed for senescence kinetics. n=6 for each genotype. 
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3.7 RNase H2 does not require its ribonucleotide excision activity at telomeres 
RNase H2 has two discernable activities: it can degrade longer RNA-DNA hybrids 
containing at least 4 ribonucleotides, such as R-loops, an activity that is shared with 
RNase H1, and it can remove single ribonucleotides (rNTPs) from the DNA (reviewed in 
(Cerritelli and Crouch, 2009)). This led us to question whether the unique role of 
RNase H2 at telomeres requires its single ribonuclease excision activity. An allele of 
RNH201 has been identified that is unable to remove rNTPs from the genome but fully 
maintains the ability to degrade longer RNA-DNA hybrids (Chon et al., 2013; Cornelio et 
al., 2017; Epshtein et al., 2016; Huang et al., 2017). This allele, which was named 
Rnh201-RED (ribonucleotide excision defective), is characterized by the two point 
mutations: P45D and Y219A. We therefore tested the effect of the Rnh201-RED allele on 
senescence onset. We generated telomerase negative strains bearing RNH201 deletion 
(est2 rnh201) that expressed the Rnh201-RED allele from a vector, and were tested for 
their senescence kinetics compared to est2 cells containing an empty vector. Interestingly, 
est2 rnh201 cells bearing the Rnh201-RED allele were fully complemented as they 
exhibited a senescence kinetic similar to est2 cells (Figure 14), while est2 rnh201 cells 
display delayed senescence onset (Figure 13A). This result indicates that the loss of 
ribonucleotide excision activity of RNase H2 does not account for the delay in senescence 
observed in telomerase negative mutants lacking Rnh201. 
 
Figure 14. The ribonucleotide excision function of Rnh201 doesn’t affect senescence rate. 
Senescence assay performed in selective media (SC -URA) on freshly dissected spores of the indicated genotypes, 
containing an empty vector (EV) or expressing the Rnh201 ribonucleotide excision defective allele from a single copy 
plasmid under its endogenous promoter (Rnh201-RED). Cell viability was estimated daily by measuring cell culture 
density. Data are shown as mean ± SEM; n=5 for each genotype. This experiment was performed by Vanessa Kellner. 
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3.8 Generation of S and G2/M phase restricted RNH1 alleles 
In order to better understand the unique roles that RNase H1 and RNase H2 perform at 
telomeres, and possibly also genome-wide, we addressed the question of when in the cell 
cycle their function is necessary. As a first approach, we restricted the expression of Rnh1 
either in the S phase or in the G2/M phases of the cell cycle. We made use of two 
previously published constructs that allow the tight expression of desired proteins in 
selected cell cycle phases (Hombauer et al., 2011; Karras and Jentsch, 2010). 
To construct an RNH1 allele that is only expressed in S phase (S-RNH1-TAP), a PCR-
generated construct was integrated in the genome that substituted the natural RNH1 
promoter with the cell-cycle regulated cyclin 6 (CLB6) promoter. Moreover, the N-terminus 
of Rnh1 was fused in frame to the first 195 amino acids of Clb6, which contain the putative 
Cdc4 degron motifs that promote degradation of the protein before G2 (Figure 15A). This 
construct allows transcription of S-RNH1-TAP in late G1/S phase and the degradation of 
the protein before G2. A complementary construct generated the G2-RNH1-TAP allele. 
The approach is based on the same strategy, but in this case the mitotic cyclin CLB2 
promoter was integrated in front of the RNH1 ORF and the first 180 amino acids of Clb2 
were fused to the N-terminus of Rnh1 (Figure 15A). In this construct, the CLB2 fragment 
contains the D- and KEN-box degrons that promote protein degradation at the end of M 
and in G1 phases; additionally the L26A mutation is present to prevent nuclear export of 
the protein. This allele is therefore expressed in late S phase and the protein is degraded 
after M. We confirmed the cell cycle specific expression of these two alleles by western 
blotting. Cells were arrested in G1 with α-factor and subsequently released at 25°C to 
allow cycling in a synchronous manner, and at 15 minutes timepoints samples for FACS 
and western blot were collected. FACS analysis confirmed successful arrest in G1 by α-
factor treatment, and subsequent synchronous and comparable release into the cell cycle 
(Figure 15B). By western blot we could observe that while in G1-arrested cells there was 
no detectable signal of both S- and G2-Rnh1-TAP, at the 15 minutes timepoint, when the 
G1 cyclin Sic1 starts to be degraded, S-Rnh1-TAP accumulated at high levels, and was 
well-expressed in the 30 and 45 minutes timepoints, corresponding to S phase, after which 
it quickly faded away as the G2/M cyclin Clb2 started to accumulate (Figure 15C). We 
also observed a re-accumulation of S-Rnh1-TAP at the 90-105 minutes timepoints, when 
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the population enters the next cell cycle (Figure 15B). On the other hand, G2-Rnh1-TAP 
expression completely mirrored the expression of the G2/M cyclin Clb2, with a peak at 60-
75 minutes, corresponding to G2/M phases, which then fades as the population enters 
the next cell cycle (Figure 15B and C). 
 
 
Figure 15. Generation of S and G2/M phase restricted RNH1-TAP alleles. 
(A) Schematics of the S- and G2-RNH1-TAP alleles. The promoter of CLB6 (pCLB6) or CLB2 (pCLB2) were cloned 
upstream of RNH1-TAP ORF, thereby rendering RNH1 endogenous promoter dysfunctional (pRNH1; dashed lines). In 
addition, the first 585 nucleotides of CLB6 (S) or the first 540 nucleotides of CLB2 (G2; additionally containing the 
mutation L26A) were cloned upstream of RNH1 ORF. Arrows indicate approximate transcription start site. (B) 
Synchronous release of S and G2-Rnh1-TAP cultures. Exponentially growing cultures of the indicated strains were 
arrested in G1 with α-factor and subsequently released at 25˚C. Samples for FACS and proteins were collected every 
15 minutes. (C) S- and G2-Rnh1-TAP are cell cycle regulated. Protein extracts collected at the indicated timepoints 
were analyzed by western blot. S- and G2-Rnh1-TAP were detected with PAP antibody; Clb2 is a cyclin specific for 
G2/M and Sic1 for G1. Pgk1 and the Ponceau staining serve as loading control. 
 
To better characterize these two novel RNH1 alleles, we compared their protein 
expression levels in the different cell cycle phases to the levels of endogenously 
expressed Rnh1-TAP, which we arrested in α-factor and released in the same manner as 
we did with S- and G2-RNH1-TAP alleles. The FACS profile of this α-factor arrest and 
release (Figure 16A) is fully comparable to the ones performed in figure 15B, allowing 
direct comparison of protein levels at the different time points. We thus loaded side-by-
side on a western blot protein extract from the different strains at the most relevant time 
points (Figure 16B). We could observe that wild type Rnh1-TAP is expressed at constant 
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levels throughout the cell cycle; in addition, we also acknowledged that both of the cell 
cycle-restricted RNH1-TAP alleles, when expressed, are present in higher levels 
compared to the wild type protein. Of note, we could detect an additional band in the G2-
Rnh1-TAP samples which resembled wild type length Rnh1-TAP (Figure 16B), suggesting 
that there might be another initiation site in the G2-RNH1-TAP allele or that the degron 
might be cleaved from G2-Rnh1-TAP. Altogether, we have obtained two novel alleles of 
RNH1 whose expression is restricted in S or G2/M phases, at levels moderately higher 
than wild type Rnh1.  
 
 
Figure 16. S- and G2-Rnh1-TAP are overexpressed compared to endogenous Rnh1-TAP. 
(A) Release of a culture expressing Rnh1-TAP from its endogenous promoter. An exponentially growing culture of the 
indicated strain was arrested in G1 with α-factor and subsequently released at 25˚C. Samples for FACS and proteins 
were taken every 15 minutes. (B) S- and G2-Rnh1-TAP are overexpressed. Protein extracts collected at the indicated 
timepoints were analyzed by western blot. Endogenous, S- and G2-Rnh1-TAP were detected with PAP antibody; Clb2 
is a cyclin specific for G2/M and Sic1 for G1. Pgk1 and the Ponceau staining serve as loading controls. FACS profiles 
of Rnh1-TAP are chosen as representative for FACS of all cultures, which are comparable (compare (A) and Figure 
15B). In G2-Rnh1-TAP samples an unspecific band (*) is detected. 
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3.9 Rnh1 is needed outside of G2/M phases to promote genome stability 
Together with RNase H2, RNase H1 has a role in maintaining genome stability (Lazzaro 
et al., 2012; O'Connell et al., 2015). We used the high sensitivity of rnh1 rnh201 cells to 
the genotoxic agent MMS as a readout to investigate when in the cell cycle Rnh1 is 
needed in absence of RNase H2 to support viability on MMS-containing plates. We 
therefore performed a spotting assay to test different combinations of the RNH1 alleles 
and RNH201 deletion (Figure 17A). As expected, cells containing the S- and G2-RNH1-
TAP alleles alone are not sensitive to MMS, consistent with rnh1 mutants not being 
sensitive. Interestingly, while expression of Rnh1 in S phase was able to sustain viability 
on MMS in an rnh201 background, its expression exclusively in G2/M led to high sensitivity 
in rnh201 cells, even greater than in the double mutant rnh1 rnh201.  
To exclude that the observed effect in G2-RNH1-TAP rnh201 cells was caused by the 
moderate overexpression of Rnh1 in G2/M phases (Figure 16B), we tested the effect of 
RNH1 overexpression in rnh1 rnh201 by a spotting assay on MMS-containing plates. We 
observed that overexpression of RNH1 in an rnh1 rnh201 background resulted in wild type 
growth capacity (Figure 17B), demonstrating that RNH1 overexpression per se is not 
detrimental in this context. Taken together, these results suggest that, in the absence of 
RNase H2 activity, Rnh1 expression is required outside of G2/M phases of the cell cycle 
to confer resistance to MMS. Furthermore, the increased sensitivity of the G2-RNH1-TAP 
rnh201 mutant compared to rnh1 rnh201 suggests that the presence of Rnh1 exclusively 
in the G2/M phases is more detrimental than complete absence of Rnh1. Lastly, this effect 
cannot be explained by the fact that the G2-RNH1-TAP allele is moderately 
overexpressed. 
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Figure 17. RNase H1 is required outside G2 phase to sustain viability on MMS. 
(A) rnh201 G2-RNH1-TAP mutants are hypersensitive to MMS. Cells of the indicated genotypes were spotted in serial 
dilutions onto YPD and MMS-containing YPD plates. Plates were imaged after 48 h (YPD) or 72 h (MMS plates) of 
incubation at 30˚C. (B) RNH1 overexpression doesn’t induce sensitivity to MMS. Cells of the indicated genotypes 
containing either and empty vector (EV) or overexpressing RNH1 from a plasmid were spotted in serial dilutions onto 
SC -URA and MMS-containing SC -URA plates. Plates were imaged after 48 h (SC –URA) or 72 h (MMS plates) of 
incubation at 30˚C. 
 
3.10 RNase H1 is required at telomeres in S phase during senescence 
Next, we addressed the cell cycle timing of RNase H1 function at telomeres. Loss of 
RNase H1 and H2 function causes accelerated senescence in the absence of both 
telomerase and the recombination machinery (rad52 background)(Balk et al., 2013). This 
phenotype has been explained by the accumulation of R-loops at telomeres of this mutant 
that cause instability (e.g. causing replication stress) which cannot be rescued by the HR 
pathway. We therefore tested the effect of the S- or G2-RNH1-TAP alleles in this 
background (Figure 18A). Unexpectedly, limited expression of Rnh1 in G2/M phases in 
this background (est2 rad52 rnh201 G2-RNH1-TAP) leads to senescence rates 
comparable to that of est2 rad52 rnh201 mutants, suggesting that restricted expression of 
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Rnh1 in G2/M phases has a phenotype similar to that of wild type Rnh1 expression. On 
the other hand, expression of Rnh1 in S phase alone in this background (est2 rad52 
rnh201 S-RNH1-TAP) led to the same accelerated senescence kinetics as the complete 
absence of rnh1 (est2 rad52 rnh201 rnh1). This result suggests that, in senescent cells 
lacking the recombination machinery, expression of Rnh1 in G2/M phases is enough to 
fully accomplish Rnh1 functions. 
We then tested the effect of the differential expression of Rnh1 in HR-proficient cells. In 
this experiment, we compared senescence rates of est2, est2 rnh1, est2 S-RNH1-TAP 
and est2 G2-RNH1-TAP mutants (Figure 18B). Again, restricting Rnh1 expression in S 
phase resulted in a fast senescence phenotype comparable to that of RNH1 deletion. 
Expression of Rnh1 in G2/M phases, while initially phenocopying est2 cells, eventually 
accelerated senescence rates as est2 rnh1 mutants. Taken together, these results 
suggest that Rnh1 is needed at telomeres in the G2/M phase of the cell cycle, especially 
when the recombination machinery is not functional. 
 
 
Figure 18. RNase H1 is required outside S phase during senescence. 
(A-B) S phase restricted expression of RNH1 accelerates senescence onset. Senescence assay performed on freshly 
dissected spores of the indicated genotypes. Cell viability was estimated daily by measuring cell culture density. Data 
are shown as mean ± SEM; n=6 for all genotypes but (A) est2 rad52 rnh1 rnh201 n=5. 
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3.11 Generation of an S phase restricted RNH202 allele 
Lastly, we turned to the cell cycle requirements for RNase H2 function at telomeres. We 
generated an S phase restricted allele of the RNase H2 subunit Rnh202 (S-RNH202-
TAP), adopting the same cloning strategy as for the creation of S-RNH1-TAP (Figure 
19A)(Hombauer et al., 2011). We reasoned that restricting RNH202 expression would limit 
RNase H2 complex activity, as the complex is active only in its trimeric form and deletion 
of any of the components leads to identical phenotypes (Lazzaro et al., 2012; Nguyen et 
al., 2011). 
We confirmed cell-cycle regulation of S-Rnh202-TAP expression by α-factor arrest and 
release, collecting samples for FACS and western blot. In parallel we also analyzed wild 
type Rnh202-TAP levels by the same means. We could observe that while expression of 
Rnh202-TAP is constant throughout the cell cycle (Figure 19B and C), S-Rnh202-TAP 
was not expressed in G1 but its levels increased at 15 minutes and peaked at 30 and 45 
minutes, corresponding to S phase, after which protein levels quickly fade as the G2/M 
cyclin Clb2 starts to accumulate again. A new peak emerges at 105 minutes, when cells 
enter the next cell cycle (Figure 19B). This assay confirms that S-Rnh202-TAP is 
expressed in S phase and, by comparing protein levels to Rnh202-TAP, reveals that its 
expression in S phase is at wild type levels. 
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Figure 19. Generation of an S phase restricted Rnh202-TAP allele. 
(A) Schematics of the S-RNH202-TAP allele. The promoter of CLB6 (pCLB6) was cloned upstream of RNH202-TAP 
ORF, thereby rendering RNH202 endogenous promoter dysfunctional (pRNH202; dashed lines). In addition, the first 
585 nucleotides of CLB6 were cloned upstream of RNH202 ORF. Arrows indicate approximate transcription start site. 
(B) Synchronous release of Rnh202-TAP and S-Rnh202-TAP cultures. Exponentially growing cultures of the indicated 
strains were arrested in G1 with α-factor and subsequently released at 25˚C. Samples for FACS and proteins were 
taken every 15 minutes. (C) S-Rnh202-TAP is cell cycle regulated. Protein extracts collected at the indicated timepoints 
were analyzed by western blot. Rnh202-TAP and S-Rnh202-TAP were detected with PAP antibody; Clb2 is a cyclin 
specific for G2/M. Pgk1 and the Ponceau staining serve as loading control. Band intensities of the PAP blots can be 
compared, as the two blots were exposed simultaneously. (*) indicates the Rnh202-TAP residual signal on the Clb2 
blot. 
 
3.12 RNase H2 is required outside of S phase in response to genotoxic stress and 
during senescence  
We now investigated the effect of restricting RNase H2 function in S phase on its role in 
genome maintenance. We performed a spotting assay on MMS-containing plates of 
different mutants containing the S-RNH202-TAP allele (Figure 20A). As expected, rnh1 
rnh202 mutants are highly sensitive to MMS. Surprisingly, expression of Rnh202 
exclusively in S phase in combination with RNH1 deletion lead to high MMS sensitivity, 
comparably to rnh1 rnh202 mutants. This suggests that RNase H2 is needed outside of S 
phase to support resistance to MMS in an rnh1 background, an observation that is in 
contrast to the need of RNase H1 in S phase (Figure 17A). 
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Finally, we tested the requirement for RNase H2 cell cycle specific role during 
senescence. To do this, we performed a senescence curve to compare est2 S-RNH202-
TAP senescence kinetics to that of est2 and est2 rnh202 mutants (Figure 20B). Strikingly, 
expression of Rnh202 in S phase phenocopied RNH202 deletion, displaying delayed 
senescence onset compared to est2 cells. Taken together, these results suggest that, as 
RNase H1, also RNase H2 is acting at telomeres of pre-senescent cells outside of S 
phase. On the other hand, while Rnh1 supports genome stability by acting in S phase, 
RNase H2 is needed outside of S phase.  
 
 
Figure 20. RNase H2 is required outside S phase to promote resistance to MMS and during senescence. 
(A) rnh1 S-RNH202-TAP mutants are hypersensitive to MMS. Cells of the indicated genotypes were spotted in serial 
dilutions onto YPD and MMS-containing YPD plates. Plates were imaged after 48 h of incubation at 30˚C. (B) S phase 
restricted expression of RNH202 delays senescence onset. Senescence assay performed on freshly dissected spores 
of the indicated genotypes. Cell viability was estimated daily by measuring cell culture density. Data are shown as mean 
± SEM; n=6 for all genotypes. 
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4. Discussion 
 
We have uncovered a mechanism that tightly regulates R-loop accumulation at 
S. cerevisiae telomeres. An interaction between the telomeric protein Rif2 and RNase H2 
directs RNase H activity to wild type length telomeres, thereby maintaining R-loop levels 
to a minimum. We found that the previously reported diminished Rif2 binding to short 
telomeres (McGee et al., 2010; Sabourin et al., 2007) is accompanied by reduced 
recruitment of RNase H2, which is functionally reflected in increased R-loop levels at short 
telomeres. The Rif2/RNase H2 axis thus provides a distinction between long and short 
telomeres: while long telomeres display a minimum amount of R-loops, short telomeres 
accumulate R-loops, which in telomerase negative cells promote compensatory HR 
events that can elongate short telomeres and hence buffer against premature senescence 
onset (Balk et al., 2013; Fallet et al., 2014). 
 
4.1 Avoidance of R-loops at long telomeres 
Telomeric R-loops form in early S phase, after TERRA transcription takes place (Graf et 
al., 2017). At long telomeres, both TERRA and R-loops are degraded towards the end of 
S phase by Rat1 and RNase H2 activities, respectively. Indeed, the localization of both 
enzymes to telomeres peaks in mid-to-late S phase (Graf et al., 2017). Long telomeres 
are replicated in late S phase (McCarroll and Fangman, 1988; Raghuraman et al., 2001), 
a time in which telomeric R-loops have already been degraded (Graf et al., 2017), thereby 
indicating that at long telomeres R-loops are degraded approximately at the same time of 
the replication fork arrival at telomeres. In this scenario, the replication machinery would 
neither collide with TERRA R-loops nor with RNA Pol II transcribing TERRA, two events 
that could be potentially deleterious for telomere stability (Hamperl and Cimprich, 2014; 
Santos-Pereira and Aguilera, 2015). Therefore, timely RNase H2 mediated removal of R-
loops at long telomeres might promote unperturbed telomere replication by providing a 
strict coordination between R-loop degradation and arrival of the replication fork at 
telomeres (Figure 21). In contrast, RNase H1 seems to play only a minor role in R-loop 
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removal at long telomeres, although it might play an auxiliary role when RNase H2 activity 
is impaired. Indeed, while rnh201 and rnh1 mutants do not display increased R-loop levels 
at telomeres, the double mutant rnh1 rnh201 does (observation by A. Maicher; (Balk et 
al., 2013)). 
Long telomeres are stable due to sufficient recruitment of telomere binding proteins that 
provide their capping. Moreover, long telomeres do not require elongation, suggesting that 
at long telomeres R-loops might be generated by default, while not having any 
physiological function. Consistently, degradation of telomeric R-loops by RNase H1 
overexpression has no effect on telomere length in wild type S. cerevisiae (D. Bonetti, 
personal communication and data not shown) nor on telomere stability in telomerase 
positive human cells (Arora et al., 2014).  
Whereas reduced telomeric R-loop levels do not seem to influence telomere maintenance 
in wild type cells, their untimely or impaired degradation might have a negative impact, 
leading to detrimental encounters of the replication fork with R-loops (Hamperl and 
Cimprich, 2014; Santos-Pereira and Aguilera, 2015). Interestingly, rnh201 mutants display 
elongated telomeres (Luke et al., 2008), a phenotype typically associated with mutants 
that experience replication stress at telomeres (Miller et al., 2006), which might be due to 
untimely resolution of telomeric R-loops. Similarly, RNase H1 silencing in human 
telomerase positive cancer cells leads to an increased frequency of telomere-free ends, 
which could be explained by DNA replication defects at telomeres (Parajuli et al., 2017). 
Moreover, accumulation of telomere-bound TERRA molecules in human cells depleted 
for UPF1 (Azzalin et al., 2007), an RNA helicase implicated in nonsense mediated decay 
(NMD; (Chang et al., 2007b)), might be the cause for the impaired telomeric leading strand 
replication in these mutants (Chawla et al., 2011), as TERRA R-loops form at the telomeric 
leading strand. Interestingly, UPF1 binds to telomeres in S and G2/M phases, when 
TERRA and possibly TERRA R-loops levels decrease (Chawla et al., 2011; Flynn et al., 
2011; Flynn et al., 2015; Porro et al., 2010), suggesting that UPF1 might protect telomere 
stability especially during replication of the leading strand by removing TERRA R-loops. 
Taken together, these observations suggest that at long telomeres, deregulated 
degradation of telomeric R-loops could lead to detrimental consequences. 
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Figure 21. A Rif2/RNase H2 axis provides a distinction between long and short telomeres. 
At long telomeres, efficient Rif2 binding allows RNase H2 localization to telomeres, and consequent degradation of 
telomeric R-loops (top). As telomeres shorten, loss of telomeric repeats leads to Rif2 loss from telomeres and reduced 
recruitment of RNase H2. Local depletion of RNase H2 is reflected in the accumulation of R-loops at telomeres, which 
promote HR-mediated re-elongation of the short telomere, thereby preventing premature senescence onset (bottom). 
HR induction by telomeric R-loops might be caused by the induction of replication stress or by prolonged displacement 
of the opposite 3’ single stranded end. Modified from (Graf et al., 2017).  
 
In conclusion, the formation of telomeric R-loops appears to be a ubiquitous phenomenon 
which is readily taken care of at long telomeres, while their stabilization at short telomeres 
seems to be an ‘emergency’ signal which targets them for elongation in cis. On the 
contrary, encounters of the replication machinery with R-loops at long telomeres would 
have no beneficial effect but rather cause telomere instability (Hamperl and Cimprich, 
2014; Santos-Pereira and Aguilera, 2015), potentially explaining why at long telomeres 
TERRA R-loops are timely degraded. Importantly, the increase of TERRA and telomeric 
R-loop levels at critically short telomeres does not influence TERRA and R-loop levels at 
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other telomeres in the same cells, and does not promote the elongation of all telomeres 
(Cusanelli et al., 2013; Graf et al., 2017). This suggests that increased TERRA and 
telomeric R-loop levels do not activate a cell-wide response, but strictly affect telomeres 
in cis. 
 
4.2 Functional accumulation of R-loops at short telomeres 
In telomerase negative cells, the accumulation of R-loops at critically short telomeres 
activates the DNA damage response, leads to the recruitment of recombination factors in 
cis (Graf et al., 2017), and promotes their recombination with sister chromatids to partially 
compensate for telomere loss, in a process that buffers against premature replicative 
senescence onset (Balk et al., 2013; Fallet et al., 2014). In the absence of telomerase, 
telomere shortening leads to R-loop accumulation in cis and local enrichment of the 
recombination protein Rad51 in an R-loop dependent manner (Graf et al., 2017), thereby 
suggesting that R-loops are required for efficient HR to ensue at short telomeres. 
Consistently, telomerase negative cells bearing an artificially induced critically short 
telomere senesce faster than the control cells in which telomere shortening was not 
induced, and are exquisitely sensitive to RNase H1 overexpression, which causes fast 
senescence kinetics at early timepoints after telomerase loss (Graf et al., 2017), thereby 
highlighting the protective role of R-loops at critically short telomeres.  
Short telomeres, as opposed to long telomeres, are replicated in early S phase, given 
Rif1’s weakened repression of origin firing (Bianchi and Shore, 2007; Lian et al., 2011). 
This different replication timing leads to the increased chance of the concomitant presence 
of two phenomena at telomeres: the passage of the replication fork and the presence of 
R-loops, which are stabilized by the diminished recruitment of RNase H2 to short 
telomeres. R-loops across the genome have been widely implicated in causing replication 
stress and DSB generation, processes that can initiate homologous recombination 
(Hamperl and Cimprich, 2014; Santos-Pereira and Aguilera, 2015), especially when the 
mechanisms that usually are in place to avoid their formation or remove them are 
impaired. Likewise, this might be true also for critically short telomeres; indeed, the novel 
findings of the impaired Rif2/RNase H2 mediated coordination between telomere 
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replication and R-loop resolution at short telomeres support the idea that telomeric R-
loops might promote HR at telomeres by causing replication stress (Balk et al., 
2013)(Figure 21, bottom left). Telomeric regions are by nature structures difficult to 
replicate, as suggested by the requirement for the action of the 5’ to 3’ DNA helicase 
Rrm3, which is found to localize to telomeres (Ivessa et al., 2002). Of note, a series of 
observation suggest that the replication stress normally present at telomeres is 
exacerbated during senescence. Pre-senescent cultures display checkpoint activation, 
which stems from critically short and uncapped telomeres (Ijpma and Greider, 2003; 
Sandell and Zakian, 1993). Interestingly, pre-senescent cells display increased Rnr3 
protein levels (Ijpma and Greider, 2003), a readout for DNA damage checkpoint activation 
and replication stress (Elledge and Davis, 1990). Importantly, Rnr3 levels can be reduced 
by RNase H1 overexpression in pre-senescent cells, indicating that telomeric R-loops that 
accumulate at short telomeres contribute to the activation of the DNA damage checkpoint 
(Graf et al., 2017); whether this outcome is directly caused by replication stress is still to 
be determined. Remarkably, Mrc1, a well described sensor of replication stress, is 
phosphorylated in pre-senescent cells and contributes together with Rad9 to activate the 
checkpoint (Grandin et al., 2005). Furthermore, Mms1, a subunit of the E3 ligase complex 
involved in maintenance of replication fork stability during replication stress by preventing 
fork collapse and promoting fork restart (Buser et al., 2016; Zaidi et al., 2008), supports 
cell viability in pre-senescent cells (Abdallah et al., 2009). These observations suggest 
that the replication of short telomeres is challenging, and that HR could be necessary for 
its completion to avoid premature entry in senescence induced by critically short 
telomeres. Furthermore, they suggest that the activation of DNA damage signaling 
pathways and the protection against replication stress promote viability in telomerase 
negative cells. Importantly, R-loops seem to play an important role in these processes. 
Interestingly, depletion of the telomeric proteins Taz1 and TRF1, in S. pombe and human 
cells respectively, causes replication stress at telomeres, which result in elongated 
telomeres (Miller et al., 2006; Sfeir et al., 2009). Interestingly, both mutants display 
increased TERRA levels, again suggesting a link between TERRA accumulation and 
replication stress at telomeres (Greenwood and Cooper, 2012; Porro et al., 2014). 
Alternatively, R-loop accumulation might promote recombination at short telomeres by 
causing prolonged displacement of the opposite 3’ single-stranded overhang, which might 
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become covered by the single-strand binding protein RPA, and successively Rad51, 
leading to strand invasion and HR ensue (Figure 21, bottom right). This second hypothesis 
would not be mutually exclusive with R-loops promoting HR by causing replication stress, 
and importantly could take place also in the absence of the replication machinery passage 
through telomeres. 
 
4.3 Telomeric R-loops are increased in ICF syndrome cells 
The increase of R-loop levels at short telomeres and the consequent activation of the DNA 
damage response could be conserved from yeast to human cells. Interestingly, recently it 
has been reported that stable R-loops accumulate at short telomeres in ICF 
(Immunodeficiency, centromeric instability and facial anomalies) syndrome cells (Sagie et 
al., 2017). Furthermore, these R-loops activate the DNA damage signaling at telomeric 
ends and cause telomere dysfunction, as RNase H1 overexpression could highly reduce 
the damage signaling stemming from telomeres in ICF syndrome cells (Sagie et al., 2017). 
ICF syndrome is caused by hypomorphic mutations in the DNA methyltransferase 
DNMT3B, which de novo methylates repetitive sequences during development (Okano et 
al., 1999; Xu et al., 1999). Indeed, the subtelomeres in ICF syndrome patients’ cells are 
hypomethylated, resulting in increased TERRA levels throughout the cell cycle and 
telomeric R-loop accumulation (Sagie et al., 2017; Yehezkel et al., 2008). Telomeres in 
ICF cells are short, undergo accelerated shortening and enter replicative senescence 
prematurely (Yehezkel et al., 2008; Yehezkel et al., 2013). Increased TERRA expression 
in ICF syndrome cells appears not to be a mere consequence of telomere shortening, as 
telomere elongation in ICF syndrome cells by ectopic overexpression of telomerase does 
not downregulate TERRA levels in these cells (Yehezkel et al., 2008). These observations 
suggest that TERRA and telomeric R-loop levels need to be kept in check in order to 
preserve telomere maintenance homeostasis also in human cells. While telomeric R-loops 
might promote telomere maintenance by HR mechanisms, rampant R-loop accumulation 
might have a contrary effect, inducing excessive replicative stress at telomeres and abrupt 
telomere loss, as seen in human ALT cancer cells accumulating excessive R-loops (Arora 
et al., 2014). In conclusion, while telomeric R-loops do not seem to be needed at long 
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telomeres, they should not accumulate in an uncontrolled manner also in human cells 
(Arora et al., 2014; Parajuli et al., 2017; Sagie et al., 2017), and regulated removal of R-
loops before arrival of the replication fork might be a conserved mean to avoid R-loop 
induced instability at human long telomeres. 
 
4.4 Telomeric R-loops promote HR-mediated telomere maintenance mechanisms 
S. cerevisiae type II survivors and ALT cancer cells are thought to be functionally 
equivalent. Indeed, both cell types maintain their telomeres in a telomerase-independent 
fashion, and elongate them by a BIR-dependent recombination mechanism (Dilley et al., 
2016; Lydeard et al., 2007). In both cell types, in fact, terminal telomeric repeats are 
elongated by replicating through other telomeres in the cell, which serve as a template. In 
recent years, additional features have been identified that are shared between these two 
cell types: both display increased TERRA levels (Misino et al., manuscript submitted; Tina 
Balk PhD thesis; (Arora et al., 2014; Lovejoy et al., 2012; Pfeiffer and Lingner, 2012)), and 
more importantly, both ALT cancer cells and yeast type II survivors appear to rely on 
telomeric R-loops for efficient telomere maintenance by prompting recombination at 
telomeres (Misino et al., manuscript submitted; (Arora et al., 2014)). Although the 
accumulation of telomeric R-loops seems to be required for this process in ALT cells, 
telomeric R-loops must nonetheless be regulated to a certain extent, and must not 
accumulate in an uncontrolled manner. Indeed, in ALT cancer cells RNase H1 is 
specifically recruited to telomeres and both its downregulation and upregulation 
destabilize cellular integrity (Arora et al., 2014). RNase H1 depletion leads to increased 
telomeric R-loop levels, increased formation of ssDNA at telomeres and abrupt telomere 
excisions especially at leading strand telomeres (where the R-loops form). On the other 
hand, RNase H1 overexpression, by decreasing telomeric R-loop levels, reduces the 
recombinogenic potential of telomeres, and leads to telomere shortening thereby 
impairing ALT cell growth (Arora et al., 2014). Interestingly, we observed the same 
outcome in S. cerevisiae telomerase negative cells: both RNase H1 deletion and 
overexpression (in a level dependent manner) lead to premature senescence onset, again 
suggesting that R-loops are required but their levels must also be regulated.  
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Furthermore, novel data indicate that telomeric R-loops sustain type II survivor growth, as 
RNase H1 overexpression in unchallenged established type II survivors decreases their 
viability, while it has no effect on wild type cells (Misino et al., manuscript submitted). 
Importantly, telomeric R-loops have been shown to promote the generation of type II 
survivors (Yu et al., 2014). While telomerase negative cells that accumulate excessive 
telomeric R-loops form type II survivors efficiently, RNase H1 and H2 overexpression 
inhibits type II survivor formation (Yu et al., 2014). Interestingly, while rnh1 mutants seem 
to efficiently form type II survivors, rnh201 mutants, while still forming them, seem to 
generate type II survivors in a less efficient manner; this could be caused simply by the 
delay in senescence (and survivor formation) of rnh201 mutants, but also by a defect in 
the establishment of type II survivors in this mutant. This observation might point to 
different roles of RNase H1 and 2 also in established type II yeast survivors and suggest 
that impaired R-loop processing reduces their recombinogenic potential (Yu et al., 2014). 
Moreover rif2, but not rif1, mutants preferentially form type II survivors (Teng et al., 2000), 
which could be linked to the accumulation of R-loops in this mutant. Interestingly, 
telomeres in S. cerevisiae type II survivors undergo shortening at each replication round, 
comparable to pre-senescent cells, and only when they become critically short they 
undergo abrupt and dramatic HR-dependent lengthening events (Fu et al., 2014; Teng et 
al., 2000). It is tempting to speculate that R-loops accumulate exclusively at these critically 
short telomeres, as we propose for pre-senescent cells, and thereby allow HR-mediated 
lengthening. However, neither the preservation of the Rif2/RNase H2 pivotal role in 
regulating R-loops nor the accumulation of R-loops exclusively at short telomeres in type 
II survivors has been shown yet. 
Replication stress has been identified at telomeres in ALT cancer cells, and has been 
hypothesized to be a promoter of telomere recombination (Flynn et al., 2015; O'Sullivan 
et al., 2014). Chronic replication stress is reflected in SMARCAL1 localization to ALT 
telomeres (Cox et al., 2016), a DNA annealing helicase which promotes fork restart and 
is highly enriched at stalled replication forks (Bansbach et al., 2009; Dungrawala et al., 
2015). SMARCAL1 is required to resolve replication stress at ALT telomeres and maintain 
their stability (Cox et al., 2016). Importantly, the removal of TERRA foci at ALT telomeres, 
which might represent R-loops, is impaired: while in normal cells TERRA foci colocalizing 
with telomeres are removed throughout S phase into G2/M, in ALT cells this regulation is 
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impaired, and telomere-associated TERRA foci are stabilized in S phase and G2/M (Flynn 
et al., 2015). This deregulation of telomeric TERRA foci removal at ALT telomeres has 
been proposed to be caused by the common lack of the ATRX helicase expression in ALT 
cells (Flynn et al., 2015). Whether TERRA deregulated accumulation at ALT telomeres is 
the cause for the replication stress present at these telomeres has not been directly tested, 
although several indications suggest that this might be the case (Arora et al., 2014; Flynn 
et al., 2015). Finally, TERRA has been identified as novel component of APBs, the 
telomere recombination factories characteristic of ALT cells (Arora et al., 2014), again 
pointing to a direct involvement of TERRA in the promotion of the ALT mechanism. 
Therefore, the dependence on telomeric R-loops seems to be a feature shared between 
type II survivors and ALT cancer cells. While in ALT cells the role of RNase H2 has not 
yet been investigated at telomeres, previous data and our new observations in yeast show 
a clear important role for this enzyme. Indeed, it will be of great interest to study if 
RNase H2 has a role also at normal human and ALT telomeres, thereby allowing the 
understanding of the fine regulation of telomeric R-loops. Interestingly, we could detect a 
minor but consistent enrichment of RNase H1 at S. cerevisiae short telomeres in pre-
senescent cells, an observation reminiscent of the exclusive recruitment of RNase H1 at 
R-loop accumulating telomeres in ALT cancer cells (Arora et al., 2014). Furthermore, it 
will be interesting to test whether also in type II survivors the Rif2/RNase H2 axis regulates 
telomeric R-loop accumulation in a telomere length dependent manner. 
 
4.5 Telomeric R-loops might promote efficient telomerase-mediated elongation of 
short telomeres. 
There are indications that the role of TERRA and telomeric R-loops in promoting short 
telomere elongation in telomerase negative cells might be a pathway conserved in 
telomerase positive cells. Paradoxically, initially TERRA had been thought to be an 
inhibitor of telomerase, as it can basepair with the template sequence for telomeric repeats 
on the telomerase RNA moiety. Indeed, in vitro TERRA-mimicking oligonucleotides are 
potent inhibitors of telomerase enzymatic activity (Redon et al., 2010; Schoeftner and 
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Blasco, 2008). Importantly, additional studies revealed that TERRA can interact with 
telomerase in vivo in a variety of organisms (Cusanelli et al., 2013; Moravec et al., 2016; 
Redon et al., 2010). But in contrast to the initial hypothesis, the latest results propose 
instead a positive outcome deriving from this interaction, namely the recruitment of 
telomerase to critically short telomeres in order to promote their elongation (Cusanelli et 
al., 2013; Moravec et al., 2016).  
The gradual or abrupt generation of critically short telomeres in telomerase positive cells 
renders them targets of the enzyme telomerase, which will subsequently elongate them. 
Indeed, telomerase preferentially acts on short telomeres compared to long (Marcand et 
al., 1999; Teixeira et al., 2004). Also in telomerase positive cells, Rif2 and RNase H2 loss 
from the short telomere would lead to telomeric R-loops stabilization in cis; additionally, 
short telomeres would be unique due to the increased amounts of free (not chromatin 
associated) TERRA molecules transcribed from them (Cusanelli et al., 2013; Graf et al., 
2017; Moravec et al., 2016). An appealing idea would be that these newly identified 
features of short telomeres would have a role in the elongation of critically short telomeres 
by telomerase. Recent work carried out in S. cerevisiae investigated TERRA localization 
by live cell microscopy, and led to the observation that, after transcription, TERRA 
molecules originating from a short telomere formed a focus in the nucleoplasm. 
Subsequently, telomerase molecules clustered over this focus (forming a telomerase 
recruitment cluster or T-Rec) and together they re-localized with high preference to the 
same telomere from which TERRA had been transcribed. Whether this interaction of 
TERRA with telomerase is functional, was not further investigated in this study, but it put 
forward the idea that increased TERRA levels deriving from short telomeres could direct 
telomerase to its substrate. The induction of a critically short telomere containing a 
terminator sequence downstream of TERRA TSS, causing reduced TERRA expression, 
led to impaired elongation of the short telomere by telomerase in cis (Marco Graf PhD 
thesis). This observation suggests that TERRA might promote the efficient elongation of 
critically short telomeres in S. cerevisiae. Indeed, one could speculate that free TERRA 
could help to direct telomerase in a specific manner to the parental telomere by base 
pairing with it, i.e. forming an R-loop, which would be stabilized at short telomeres due to 
the absence of RNase H2 (Figure 22). A preliminary experiment, in which telomerase-
mediated elongation of an induced critically short telomere was measured in RNase H1 
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overexpressing cells or control cells resulted in slightly reduced telomere elongation 
kinetics in the presence of RNase H1 overexpression (data not shown), suggesting that 
telomeric R-loops accumulating at short telomeres might promote telomerase recruitment 
in cis. Of note, we can exclude that this mechanism is required for telomerase action at 
telomeres, as overexpression of RNase H1 has no effect on bulk telomere length in 
telomerase positive cells (D. Bonetti, personal communication and data not shown). 
However, this leaves open the possibility that R-loops might affect the kinetics of 
telomerase recognition of the short telomeres while not affecting the final outcome, bulk 
telomere length. Interestingly, rif2 and rnh201 mutants display increased telomere length, 
and in light of the novel results on RNase H2 pivotal role in regulating telomeric R-loops, 
it would be tempting to speculate that increased stability of R-loops in these mutants could 
stabilize T-Recs recruitment/binding even to long telomeres, and therefore lead to 
increased bulk telomere length.  
Figure 22. TERRA and telomeric R-loops might promote telomerase recruitment to short telomeres. 
At long telomeres, telomerase action is inhibited by the telomeric proteins Rif1 and Rif2 (Wotton and Shore, 1997). As 
telomeres shorten, telomerase inhibition is released, and R-loops accumulate due to RNase H2 loss; furthermore, 
TERRA levels are upregulated (Graf et al., 2017). TERRA interacts with telomerase in the nucleoplasm, forming T-Recs 
(telomerase recruitment clusters) that re-localize to the telomere from which TERRA was transcribed to elongate it 
(Cusanelli et al., 2013). The formation of an R-loop might be involved in this process, conferring specificity of the 
TERRA-telomere interaction and improving the efficiency of short telomere recognition by telomerase. 
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Importantly, a role for TERRA in promoting telomerase activity has been identified in a 
novel study in S. pombe, in which a functional interaction between polyadenylated TERRA 
and telomerase was observed (Moravec et al., 2016). The generation of a short telomere 
leads to increased TERRA transcription in cis, and especially leads to the accumulation 
of the polyadenylated TERRA form; moreover, this TERRA pool was found to physically 
interact with telomerase. Importantly, artificial induction of TERRA expression from one 
telomere led to telomere elongation in cis, thereby demonstrating that increased TERRA 
expression at short telomeres is functional in promoting and directing telomerase activity 
to that same telomere (Moravec et al., 2016). Conversely, artificially highly induced 
transcription of a single S. cerevisiae telomere leads to telomere shortening in cis, in a 
telomerase-independent manner (Maicher et al., 2012; Pfeiffer and Lingner, 2012). The 
observed shortening requires the passage of the replication fork, and is mediated by Exo1 
resection, which is active in S and G2/M phases (Maicher et al., 2012; Pfeiffer and Lingner, 
2012). It can be speculated that the increased chance of encounters between the 
replication machinery and RNA Pol II transcribing TERRA might be the cause of this effect, 
and not TERRA inhibition of telomerase. Furthermore, such forced transcription of 
telomeric ends is fundamentally different from what happens at natural short telomeres, 
where increased TERRA levels are not caused by increased transcription but rather 
increased TERRA stabilization, due to loss of the exonuclease Rat1 from short telomeres 
(Graf et al., 2017). 
In conclusion, a functional interaction between TERRA and telomerase has not been 
formally proven yet in S. cerevisiae, but it would definitely explain the increased pool of 
“free TERRA” molecules that derives from short telomeres, both in telomerase positive 
and negative cells (Cusanelli et al., 2013; Graf et al., 2017). Whether free TERRA has a 
role in telomerase negative cells remains unclear, especially because TERRA regulation 
seems to be independent of R-loop regulation, as RNase H1 overexpression, while 
decreasing R-loop levels in pre-senescent cells, has no effect on TERRA levels (Graf et 
al., 2017). 
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4.6 RNase H1 and H2 play different roles genome-wide in the removal of R-loops 
We have identified a differential requirement for RNase H1 and H2 in response to 
genome-wide replication stress: interestingly, the two enzymes are required in different 
cell cycle phases (Figures 17A and 20A). Previous data showed that, in the presence of 
low doses of replication stress, expression of one of the two RNase H enzymes is 
sufficient to support cell growth, while lack of both enzymes leads to high sensitivity to 
replication stress, suggesting that RNase H1 and H2 act redundantly (Lazzaro et al., 
2012). By making use of cell-cycle regulated RNase H1 and H2 enzymes, we could 
identify that the timing of RNases H action must be tightly regulated, and that the two 
enzymes act in different cell cycle phases in response to MMS-induced replication stress, 
thereby suggesting non-overlapping functions of RNase H enzymes in this context. 
 
4.6.1 RNases H1 and H2 may act in different cell cycle phases.  
In this work, we have found that, when replication stress is induced by MMS treatment, 
the exclusive expression of RNase H2 in S phase leads to a phenotype equal to that of 
the depletion of RNase H enzymes (Figure 20A). This suggests that, in the presence of 
genome-wide replication stress, RNase H2 cannot remove all R-loops present during S 
phase, which might persist until G2 and cause cell lethality. Differently, the exclusive 
expression of RNase H1 in S phase in presence of replication stress can fully support cell 
viability (Figure 17A). On the contrary, alone RNase H1 expression exclusively in G2/M 
phases leads to high sensitivity to replication stress, more acute than when both RNase 
H enzymes are depleted. Taken together, these results might suggest that RNase H1 is 
the main enzyme that restricts R-loops genome-wide during S phase, while RNase H2 
might be needed outside the S phase. Furthermore, it suggests that the exclusive activity 
of RNase H1 in G2/M might generate some damage that cannot be repaired. 
These results are striking, as RNase H2 in known to take part in many functions connected 
to replication, which would suggest a role for RNase H2 in R-loop removal during S phase. 
Importantly, R-loops are known obstacles for replication fork progression and RNase H2 
movement with the replication fork may lead to their recognition and degradation (Hamperl 
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and Cimprich, 2014; Santos-Pereira and Aguilera, 2015). Indeed, RNase H2 is thought to 
associate to the replisome thanks to its PIP-box domain (Bubeck et al., 2011; Chon et al., 
2013; Chon et al., 2009), and in human cells RNase H2 has been found to colocalize with 
replication foci (Bubeck et al., 2011). Furthermore, RNase H2 functions during Okazaki 
primer removal and removal of misincorporated rNTPs from the DNA (Chon et al., 2013; 
Rydberg and Game, 2002; Sparks et al., 2012). Importantly, RNase H2 roles during 
replication, which are not shared by RNase H1, are redundant with other pathways. This 
suggests that the sensitivity of rnh1 rnh201 mutants to genotoxic agents might be 
explained by excessive genome-wide accumulation of R-loops in cells which are 
additionally challenged by exogenously induced replication stress, which could increase 
the load of replication stress to unmanageable levels. To date, there is no information on 
the timing of RNase H2 removal of R-loops, which, taking into account our novel data, 
might be independent from its interaction with the replication fork. Interestingly, an Rnh202 
allele that lacks the PIP-box motif has not been found to be defective in any conditions 
tested so far, including R-loop removal (Lafuente-Barquero et al., in press; (Chon et al., 
2013; Sparks et al., 2012)), suggesting that the interaction of RNase H2 with the 
replication machinery is not required for RNase H2 function.  
 
4.6.2 R-loops must be degraded to allow repair completion 
In the recent years, several studies have identified the involvement of R-loops in DSB 
processing, implicating the need for RNase H activity to allow efficient DSB repair (Amon 
and Koshland, 2016; Li et al., 2016; Ohle et al., 2016). Of note, a recent study from the 
Koshland group proposed a novel and largely unexplored idea: R-loop removal activities 
are not only necessary in order to avoid generation of replication stress, but these 
activities also have to take place during R-loop induced damage resolution (Amon and 
Koshland, 2016). The presence of unprocessed R-loops during the repair of R-loop 
induced DSBs could lead to inaccessibility of the DNA strand which partakes in the RNA-
DNA hybrid, in a way that might inhibit resection (if it is on the 5’ strand) or strand invasion 
into a homologous sequence after resection of the opposite strand (if it is on the 3’ strand; 
Figure 23). rnh1 rnh201 mutants increasingly accumulate Rad52 foci from late S until M 
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phase, indicative of DNA damage which is difficult to repair. When the R-loop load is 
further increased in rnh1 rnh201 mutants, the excessive DNA damage cannot be resolved 
and cells arrest permanently in G2/M. This phenotype could be rescued by depleting 
factors involved in the BIR repair mechanism, and especially in BIR processivity. 
Importantly, this did not prevent DNA damage formation, but promoted damage resolution 
in G2/M.  
 
 
Figure 23. R-loop removal is required for efficient processing of R-loop induced DSBs. 
After the generation of a DSBs at the site of a stabilized R-loop, the R-loop must be removed by RNase H activity in 
order to allow efficient HR-dependent repair (center). When the R-loop involves the 3’ end of a break, if not removed it 
would cover the 3’ recombinogenic DNA end, inhibiting strand invasion and HR ensue (left). When the R-loop involves 
the 5’ end of the DSB, if not removed it may inhibit the activity of exonucleases, needed to generate a recombinogenic 
3’ ssDNA (right). In both cases, the chromosome part containing the unresolved R-loop would be lost and the other 
DSB end must be repaired by the mutagenic BIR mechanism (Deem et al., 2008; Smith et al., 2007). Modified from 
(Amon and Koshland, 2016). 
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These results suggest that the absence of RNase H activity generates damage that is 
difficult to repair after S phase completion. Furthermore, excessive R-loop stabilization 
results in the promotion of BIR-mediated repair, which is a pathway that is active when 
only one strand of a DSB is available. During BIR, one end of the DSB invades the 
homologous chromosome and replicates through it (Malkova and Ira, 2013; Malkova et 
al., 1996); this process can replicate entire chromosomes, and therefore could be highly 
detrimental for genome stability and is not the preferred repair mechanism at DSBs (Deem 
et al., 2008; Smith et al., 2007). Indeed, BIR activation at DSB containing stable R-loops 
is a source of genome instability (Amon and Koshland, 2016).  
Two other studies have detected R-loop accumulation around DSBs upon DSB generation 
and the need for their processing (Li et al., 2016; Ohle et al., 2016). A work by the Fischer 
lab in S. pombe has identified the need for regulated action of RNAse H activity at DSBs 
(Ohle et al., 2016). While in the absence of RNase H1 and H2 R-loop deregulated 
processing led to impaired resection of DSBs, and therefore diminished recombination 
efficiency, when RNase H1 was overexpressed resection was excessive and led to 
genome instability. This work indicates that RNase H activity, by removing R-loops at 
DSBs, allows the correct processing of DSB ends to permit efficient HR-mediated repair 
(Ohle et al., 2016). An additional study in human cells has implied the need for protecting 
the single stranded DNA generated by resection from forming R-loops with RNAs that had 
been transcribed prior to DSB formation, to allow efficient HR-mediated repair (Li et al., 
2016). Finally, some preliminary data from S. cerevisiae suggest that R-loops might be 
DSB repair intermediates also in this organism. When wild type cells are grown in medium 
containing low doses of MMS, overexpression of RNase H1 causes a slight but significant 
reduction of cellular viability compared to the empty vector control (Misino et al., 
manuscript submitted). This observation might be in line with the scenario presented in 
(Ohle et al., 2016). In conclusion, RNase H activity appears to be essential for efficient 
repair of DSBs, especially when they contain R-loops at their extremities. 
By considering the requirement of RNase H enzymes in the cell cycle when cells are under 
replication stress and the novel data just described, we can imagine the following scenario 
(Figure 24). During S phase, RNase H1 is able to remove all R-loops that are potentially 
deleterious for genome instability, as RNase H1 expression in S phase in rnh201 mutants 
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leads to survival upon replication stress induction (Figure 17A). On the contrary, RNase 
H2 might only play a minor role in removing R-loops in this cell cycle phase. Indeed, 
expression of RNase H2 only in S phase in rnh1 mutants led to a phenotype equal to rnh1 
rnh201 (Figure 20A). In G2/M, RNase H2 might be the enzyme dedicated to the removal 
of R-loops in order to allow efficient repair of DSBs containing R-loops. On the contrary, 
RNase H1 action in this phase might be inhibited, as expression of RNase H1 exclusively 
in G2/M phase in rnh201 mutants leads to high replication stress sensitivity (Figure 17A). 
Indeed, rnh201 mutants display increased loss of heterozygosity (O'Connell et al., 2015). 
It is possible that the presence of RNase H activity after BIR has already initiated might 
generate a recombinogenic end that would interfere with the repair process already in act, 
leading to genome instability. 
 
 
 
Figure 24. Possible requirement for RNase H1 and H2 function in the cell cycle. 
Left: RNase H1 might provide the major RNase H activity during S phase, while RNase H2 might play a minor role. In 
G2, R-loops present at DSBs might be processed by RNase H2, while RNase H1 might play a minor role, or even be 
inhibited. In rnh1 mutants, unprocessed R-loops might generate DSBs upon collision with the replication fork. Repair of 
DSBs in G2/M phase might be aided by RNase H2 removal of R-loops to allow efficient resection. In rnh201 mutants, 
RNase H1 might process R-loops to prevent the generation of DSBs upon collision with the replication fork; R-loops 
present at DSBs might be processed by RNase H1. Right: in rnh1 rnh201 mutants, unprocessed R-loops will cause 
replication-mediated DSBs, which will be difficult to repair and lead to BIR. 
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4.7 RNase H1 and H2 have non-overlapping functions at telomeres 
The requirement for RNase H1 and H2 in pre-senescent cells appears to be strikingly 
different from their requirement in response to replication stress in the rest of the genome. 
We observed that the deletion of each RNase H enzyme has a strong effect on 
senescence onset, while in response to replication stress deletion of each RNase H has 
no effect on cell viability (Lazzaro et al., 2012). Furthermore, while in the absence of 
telomerase the deletion of RNase H2 leads to extremely delayed senescence onset, the 
deletion of RNase H1 leads to accelerated senescence, similar to RNase H1 
overexpression (Figure 13). The combination of both RNases H enzymes deletions leads 
to a delayed senescence onset, with senescence kinetics intermediate between otherwise 
wild type telomerase negative strains and telomerase negative RNase H2 deficient 
mutants. These results suggest that RNases H enzymes play very diverse roles at 
telomeres during senescence and that the exclusive presence of RNase H1 during 
senescence has the most positive outcome, by delaying senescence onset.  
The differences we detected in RNase H requirement at telomeres compared to their 
genome-wide requirement might be due to the fact that the consequences of R-loop 
accumulation at telomeres are very different to the consequences of R-loop accumulation 
genome-wide, even though in both cases a similar response is activated, namely the 
ensue of homologous recombination (Balk et al., 2013; Hamperl and Cimprich, 2014; 
Santos-Pereira and Aguilera, 2015). At critically short telomeres in pre-senescent cells 
the accumulation of R-loops has a positive outcome: the promotion of HR, leading to 
telomere elongation in cis and delay of senescence onset (Balk et al., 2013; Fallet et al., 
2014; Graf et al., 2017). Instead, R-loop accumulation across the genome is deleterious, 
leading to hyper-recombination and genome instability (Hamperl and Cimprich, 2014; 
Santos-Pereira and Aguilera, 2015). Telomeres resemble one-sided DSBs, and are 
subjected to BIR-based recombination mechanisms (Dilley et al., 2016; Lydeard et al., 
2007). While at short telomeres BIR delays senescence onset and sustains telomere 
maintenance in the absence of telomerase (Lydeard et al., 2007; Xu et al., 2015), and 
therefore is a favorable outcome, BIR-mediated repair of DSBs in the genome is highly 
mutagenic and can lead to genome instability and loss of heterozygosity (Deem et al., 
2008; Smith et al., 2007), and therefore must be repressed. Interestingly, BIR was shown 
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to be the prevalent repair mechanism active at DSBs generated by R-loops in rnh1 rnh201 
S. cerevisiae mutants (Amon and Koshland, 2016). Therefore, RNase H activity must lead 
to different outcomes at telomeres and genome wide. 
The different roles that RNase H enzymes play at telomeres could be linked to their 
differential binding to long compared to short telomeres: while RNase H2 could be 
identified at long telomeres, but was decreased at short (Figure 11C), we could not detect 
RNase H1 binding to long telomeres but it was enriched at short (Figure 11G). The modest 
enrichment levels of RNase H1 at short telomeres as determined by ChIP might be due 
to transient localization of the protein. Thereby, the use of a catalytically dead RNase H1 
mutant that has been previously identified (Ginno et al., 2012; Zimmer and Koshland, 
2016), which can bind R-loops but cannot resolve them causing a more stable recruitment 
to these structures, could be useful to allow a more robust detection of RNase H1 at short 
telomeres. While we saw that at short telomeres RNase H2 localization is decreased due 
to the reduced recruitment of Rif2, this does not exclude independent localization of the 
enzyme by either interaction with the replication fork (PCNA) or simply by the R-loops 
themselves, although importantly RNase H2 binding to long telomeres was completely 
lost in rif2 cells (Figure 5B).  
Therefore, the two RNase H enzymes might have access to R-loops at different times or 
act at different steps. As proposed by the Koshland lab, processing of R-loops is not only 
important to inhibit replication stress and eventually the formation of DSBs, but also to 
repair R-loop induced damage (Amon and Koshland, 2016). Indeed, we can imagine a 
scenario whereby short telomeres accumulate R-loops in a way that could cause 
replication stress and HR as a mean to rescue telomere replication. During the repair 
process, the R-loop must be removed in order to allow access to exonucleases to 
generate a recombinogenic ssDNA that will invade another telomere. In such scenario, 
RNase H2 could be dedicated to the regulation of R-loops at long telomeres to avoid 
replication stress, but as telomeres shorten, where R-loops accumulate and HR ensues, 
RNase H1 might localize to telomeres and allow efficient HR. How RNase H1 might be 
recruited preferentially to short telomeres is discussed in the following section. 
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4.7.1 RPA might recruit RNase H1 to R-loops and promote is activity 
Novel data indicate that human RNase H1 physically and functionally interacts with the 
trimeric single-stranded DNA binding protein complex RPA (Nguyen et al., 2017b). The 
interaction with RPA stimulates RNase H1 binding to R-loops both in vitro and in vivo, and 
additionally it stimulates RNase H1 catalytic activity on R-loops in vitro. Indeed, RPA and 
RNase H1 colocalize at R-loops in cells. In RNase H1 mutants that retain R-loop resolution 
activity in vitro but are compromised in RPA binding, RNase H1 fails to localize to R-loops 
and cannot process them in vivo. Furthermore, when overexpressed, mutant RNase H1 
cannot rescue the R-loop mediated genome instability in R-loop accumulating mutants, 
whereas overexpression of wild type RNase H1 can (Nguyen et al., 2017b). These data 
indicate that RPA is an R-loop sensor and that the interaction between RPA and RNase 
H1 is important for the ability of RNase H1 to bind R-loops and to promote their 
degradation; interestingly, no interaction between RPA and RNase H2 has been detected 
in this study (Nguyen et al., 2017b), suggesting that RPA might not be required for RNase 
H2 recruitment to R-loops. The RPA-RNase H1 interaction is conserved in bacteria, as in 
E. coli the single-stranded DNA-binding protein (SSB) binds to RNase HI in vivo and 
stimulates its activity on R-loops in vitro (Petzold et al., 2015). Moreover, in S. cerevisiae 
RNase H1 was found to interact with two subunits of the RPA complex, namely Rfa1 and 
Rfa3, by a proteomic approach (Gavin et al., 2002).  
The functional interaction between RPA and RNase H1 could therefore be a conserved 
mechanism in place to recruit RNase H1 to R-loops. Importantly, this interaction could be 
relevant for the recruitment of RNase H1 to short telomeres: R-loop stabilization at short 
telomeres due to local RNase H2 depletion might lead to increased recruitment of RPA to 
the displaced single stranded filament; indeed, RPA localizes to stabilized R-loops in 
human cells (Nguyen et al., 2017b). RPA binding to stabilized telomeric R-loops might 
recruit RNase H1 and promote its activity. Furthermore, the exonucleolytic processing of 
the 5’ C-strand (the one involved in the R-loop) to allow HR initiation, would lead to further 
RPA accumulation on the telomeric 3’ overhang, and thereby enhanced local RNase H1 
recruitment/activation. Importantly, short telomeres possess long ssDNA overhangs 
generated by resection activities (Fallet et al., 2014)(Figure 25). This RPA-mediated 
RNase H1 recruitment might be required for efficient resection of the C-strand (Ohle et 
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al., 2016) and promotion of HR by generating a long recombinogenic single stranded DNA. 
In line with this, RNase H1 depletion in telomerase negative cells leads to accelerated 
senescence onset, which could be due to impaired HR at these telomeres. Interestingly, 
RPA accumulates at telomeres in ALT cancer cells and seems to be regulated by ATRX 
activity, as upon ATRX knockdown RPA accumulates at ALT telomeres in G2 phase, 
which is when TERRA foci at telomeres are stabilized (Flynn et al., 2015; O'Sullivan et al., 
2014). Therefore, RPA increased presence at ALT telomeres, which may be due to 
increased R-loop presence, might be what allows RNase H1 binding exclusively at ALT 
telomeres and not at telomeres in normal cells. 
 
 
Figure 25. Possible explanation for RNase H1 recruitment to short telomeres. 
The single stranded component of stabilized R-loops at short telomeres might be bound by RPA. After R-loop mediated 
induction of replication stress, resection of the 5’ end ensues and recruits more RPA to the opposite strand. Local 
increased RPA concentration might promote RNase H1 recruitment and activity to remove the R-loop, thereby allowing 
efficient resection and subsequent BIR-mediated recombination. 
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We can therefore propose the following model (Figure 26). At long telomeres, RNase H2 
has a major role in regulating the timing of R-loops removal, in order to avoid collisions 
with the replication machinery; RNase H1 might play a compensatory role if RNase H2 is 
impaired, which could explain why only the double mutant rnh1 rnh201 displays increased 
R-loop levels (observation by A. Maicher). As telomeres shorten and RNase H2 
recruitment to telomeres is reduced, RNase H1 instead localizes to telomeres; RNase H1 
localization and activity might be promoted by RPA enrichment at short telomeres, and 
may allow efficient resection of the 5’-strand. This model would explain the different 
senescence kinetics of cells depleted for RNase H enzymes. In the absence of RNase 
H1, critically short telomeres accumulating R-loops may be impaired in the resection of 
the 5’ strand, leading to impaired recombination and therefore faster senescence. In the 
absence of RNase H2, the timing of R-loop removal at long telomeres might be impaired, 
although RNase H1 might still be able to partially remove them. This might lead to 
recombination already at long telomeres and following efficient resection of the C-strand, 
therefore causing delayed senescence onset. In the double mutant, R-loop deregulation 
at long telomeres will promote early recombination, which might be resected inefficiently 
due to stabilization of the R-loop which might render the 5’ strand less accessible to 
exonucleases, and therefore result in an intermediate phenotype of senescence kinetics. 
On the contrary, in the case of RNase H1 overexpression, degradation of telomeric R-
loops at all steps will impair telomere recombination and lead to fast senescence. 
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Figure 26. RNase H1 and H2 might functions at telomeres in different steps. 
At long telomeres, Rif2 recruits RNase H2 to remove R-loops before the arrival of the replication fork to telomeres. 
RNase H1 might act at long telomeres when RNase H2 is impaired. As telomeres shorten, RNase H2 loss allows R-loop 
accumulation and consequent replication stress; RPA might bind to the R-loop. RNase H1 might be recruited to short 
telomeres by increased localization of RPA, and promote efficient 5’ end resection, which initiates BIR-dependent 
telomere elongation. 
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4.7.2 Cell cycle regulation of RNase H1 and H2 action at telomeres 
The results presented in this thesis suggest that during senescence RNase H1 activity is 
exclusively required during G2/M phases, independently of RNase H2 presence. Similarly, 
cells expressing RNase H2 only in S phase during senescence behave as RNase H2 
depleted cells, suggesting that also RNase H2 action might be needed in other cell cycle 
phases. A caveat of the experimental setup using cell cycle specific promoters might be 
that the expression of proteins using the S phase specific construct seem to lead to 
degradation of the protein at the end of S phase. Because long telomeres are replicated 
in late S phase (McCarroll and Fangman, 1988; Raghuraman et al., 2001), which is when 
RNase H2 must decrease the telomeric R-loops to avoid replication stress, we cannot 
exclude that the phenotype of RNase H2 expression exclusively in S phase is simply due 
to its absence in late S phase. RNase H1 requirement outside of S phase might be 
explained by its proposed role in promoting resection at short telomeres, which might take 
place in this phase of the cell cycle. 
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4.8 Future perspectives 
We have identified a mechanism that regulates the level of telomeric R-loops, whereby 
R-loop accumulation is restricted at long telomeres, where they could potentially induce 
DNA damage upon collision with the replication fork (Hamperl and Cimprich, 2014; 
Santos-Pereira and Aguilera, 2015). On the contrary, R-loops are stabilized at short 
telomeres, where they promote HR-mediated telomere elongation and buffer against 
premature senescence onset (Balk et al., 2013; Fallet et al., 2014). These findings 
highlight the need for a tight regulation of R-loop accumulation such that telomeric R-loops 
would be stabilized only when the outcome would be favorable. Indeed, the generation of 
a single critically short telomere in telomerase negative cells is enough to induce 
senescence (Abdallah et al., 2009), suggesting that the rescue of short telomeres by 
homologous recombination might benefit the cell survival; importantly, telomeric R-loops 
seem to play a pivotal role in this process (Balk et al., 2013; Graf et al., 2017; Yu et al., 
2014). This mechanism might be especially important in multicellular organisms, in which 
accelerated telomere shortening may result in defective tissue regeneration and 
premature aging.  
It would be interesting to map the domain of Rif2 which is required for the interaction with 
RNase H2. The C-terminus of Rif2 contains a domain required for the interaction with 
Rap1, and a Rap1 Binding Motif (RBM) is also present in the unstructured N-terminus, 
which is thought to bridge together two Rap1 molecules (Figure 27; (Shi et al., 2013)). In 
the middle of the protein is a long AAA+ domain containing Walker A and B motifs; 
furthermore, in the N-terminus there is a BAT domain (Blocks Addition of Telomeres), 
which is sufficient to inhibit telomerase action at telomeres (Kaizer et al., 2015; Shi et al., 
2013). By constructing truncation mutants of Rif2 which maintain the C-terminal Rap1-
binding domain to allow its localization to telomeres, it would be possible to identify the 
domain required for RNase H2 interaction. This would allow the creation of a Rif2 mutant 
defective for RNase H2 recruitment, which would be interesting to analyze relative to its 
effect of R-loops accumulation at telomeres and its effect on senescence kinetics. 
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Figure 27. The Rif2 protein contains multiple domains. 
Rif2 contains an unstructured N-terminus domain, which is sufficient to inhibit telomerase action at telomeres (BAT 
domain), and a Rap1-binding domain (RBM). The middle of the protein contains an AAA+ domain, comprising Walker 
A and Walker B domains, and the C-terminus contains a domain necessary for Rap1 binding. Modified from (Kaizer et 
al., 2015). 
 
Several observations suggest that pre-senescent cells suffer from replication stress at 
telomeres (Abdallah et al., 2009; Grandin et al., 2005; Ijpma and Greider, 2003), and 
multiple studies have suggested that a source of replication stress at telomeres might be 
the accumulation of R-loops (Arora et al., 2014; Balk et al., 2013; Chawla et al., 2011; 
Sagie et al., 2017). It will be important to investigate in a direct manner whether the 
replication stress present in pre-senescent cells is due to R-loop accumulation, as the 
answer will allow us to explain mechanistically how telomeric R-loops promote 
recombination at telomeres (Balk et al., 2013). It will therefore be interesting to monitor 
the phosphorylation status of the replication checkpoint protein Mrc1 in pre-senescent 
cells upon overexpression of RNase H1 or when R-loops are allowed to accumulate in 
excess, as for example in rnh1 rnh201 mutants.  
Another interesting area to explore is the deeper understanding of the requirement for 
RNase H activity to promote efficient repair of DSBs (Amon and Koshland, 2016; Li et al., 
2016; Ohle et al., 2016). It will be important to further analyze how R-loops influence DSB 
repair in S. cerevisiae, and especially if R-loops are formed upon DSB formation, as in 
S. pombe and human cells (Li et al., 2016; Ohle et al., 2016). In line with that, RNase H 
activity might also be important at short telomeres in order to promote efficient resection 
of the strand containing the RNA-DNA hybrid to initiate HR. This question might be 
addressed by measuring the telomeric overhang extension in RNase H mutants or upon 
RNase H1 overexpression, especially in pre-senescent cells. This approach might 
indicate whether this hypothesis is correct, and whether there is a preferential requirement 
for one of the RNase H enzymes in this process. 
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Finally, emerging evidence suggests that the uncontrolled accumulation of telomeric 
R-loops in human cells might cause telomere instability and might be at the basis of 
telomeric diseases such as IPF syndrome (Sagie et al., 2017). Importantly, telomeric R-
loop accumulation has been shown to be an essential factor involved in the maintenance 
of ALT cancer telomeres (Arora et al., 2014), reminiscent of yeast type II survivors (Misino 
et al., manuscript submitted). It will be thus important in the first place to understand how 
R-loop levels are kept in check at telomeres in human cells, and especially if RNase H2 
might play a role in this process. Furthermore, it will be important to understand how R-
loops are regulated in type II survivors and by which mechanism they promote telomere 
maintenance via HR, in order to obtain insights into how telomeres are maintained in ALT 
cancer cells. In conclusion, it would be of great interest to explore the possibility of 
targeting R-loops or TERRA as a strategy to selectively impair the growth of ALT tumor 
cells and as a therapy for IPF syndrome patients. 
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5. Abbreviations 
5-FOA 5-fluoroorotic acid 
A Adenine 
aa Amino acid 
AGS Aicardi-Goutières syndrome 
AID Auxin-inducible degron 
AID Activation-induced cytidine deaminase 
ALT Alternative lengthening of telomeres 
Amp Ampicillin 
APB ALT-associated PML bodies 
ARS Autonomously replicating sequence 
BIR Break-induced replication 
bp Base pairs 
C Cytosine 
CEN Centromeric 
ChIP Chromatin immunoprecipitation 
Co-IP Co-immunoprecipitation 
CSR Class switch recombination 
CST Cdc13-Stn1-Ten1 
DKC Dyskeratosis congenita 
DNA Deoxyribonucleic acid 
DRIP DNA-RNA immunoprecipitation 
ds Double stranded 
DSB Double strand break 
E. coli Escherichia coli 
EV Empty vector 
FACS Fluorescence-activated cell sorting 
FLC Flowering locus C 
G Guanine 
GAL Galactose 
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GFP Green fluorescent protein 
HA Hemagglutinin 
HBD Hybrid binding domain 
HIS Histidine 
HR Homologous recombination 
HTT HeT-A, TART, TAHRE 
HU Hydroxyurea 
HYG Hygromycin 
IAA Indole-3-acetic acid 
ICF Immunodeficiency, centromeric instability and facial anomalies 
IgG Immunoglobulin G 
IgH Immunoglobulin H 
IPF Idiopathic pulmonary fibrosis 
KAN Kanamycin 
kb Kilobases 
kDa KiloDaltons 
LEU Leucine 
LTR Long terminal repeats 
mDNA Mitochondrial DNA 
MMS Methyl methanesulfonate 
mRNP Messenger ribonucleoprotein particle 
MRX Mre11-Rad50-Xrs2 
NAT Nourseothricin 
NER Nucleotide excision repair 
NHEJ Non-homologous end joining 
NMD Nonsense mediated decay 
NPC Nuclear pore complex 
nt Nucleotides 
ORF Open reading frame 
PCR Polymerase chain reaction 
PD Population doublings 
PIP PCNA-interacting protein 
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PML Promyelocytic leukaemia 
qPCR Quantitative PCR 
RAFF Raffinose 
rDNA Ribosomal DNA 
RED Ribonucleotide excision defective 
RNA Ribonucleic acid 
RNA pol RNA polymerase 
RNase H Ribonuclease H 
rNTP Ribonucleoside triphosphate 
rRNA Ribosomal RNA 
S. cerevisiae Saccharomyces cerevisiae 
S. pombe Schizosaccharomyces pombe 
SASP Senescence-associated secretory phenotype 
SC Synthetic complete 
SEM Standard error of the mean 
ss Single stranded 
STR Subtelomeric repeated elements 
T Thymine 
TAP Tandem affinity purification 
TERRA Telomeric repeat containing RNA 
TPE Telomere position effect 
T-Rec Telomerase recruitment cluster 
tRNA Transfer RNA 
TRP Tryptophan 
TSS Transcription start site 
URA Uracil 
YAC Yeast artificial chromosome 
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